Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ABRACL	"C6orf115, Costars, HSPC280, PRO2013"	ENSG00000146386	"ABRA C-terminal like"	Q9P1F3	6	139028745-139043302	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 440.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 501.5;NB-4: 530.8;U-937: 515.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030217	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		9200000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA030217: AB_10602335"	"unprognostic (1.10e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.30e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.93e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.07e-3)"	"unprognostic (5.90e-3)"	"unprognostic (3.63e-2)"	"unprognostic (3.29e-2)"	"prognostic favorable (1.65e-6)"	20.1	9.6	16.8	73.7	16.2	87.7	44.9	13.5	20.8	20.7	14.7	95.0	74.1	22.0	136.0	42.0	12.4	36.0	13.3	18.6	15.7	50.0	60.7	31.2	123.1	14.7	14.6	4.1	16.1	49.1	14.4	29.1	16.2	16.3	86.5	5.4	40.8	12.2	3.0	38.8	74.4	23.5	14.9	73.9	34.4	32.3	16.4	139.6	42.4	7.5	87.9	79.6	17.1	16.0	76.8	40.7	100.7	94.8	39.7	62.2	110.6	59.7	42.9	44.5	91.2	91.2	87.4	0.4	105.8	59.8	189.5	112.9	90.4	130.0	51.9	204.4	167.4	297.8	20.7	31.6	57.6	501.5	130.5	55.9	108.2	59.9	49.1	79.4	237.5	204.9	38.4	100.4	129.5	162.7	314.2	530.8	120.9	119.1	78.5	199.8	62.3	23.8	121.7	225.0	225.4	24.8	40.5	112.3	194.5	141.9	45.1	369.8	175.7	28.2	24.0	58.9	107.7	54.1	169.2	20.9	35.7	515.5	84.2	232.3	178.0	114.2	161.1	334.3	252.2	93.8	259.3	208.2	193.9	96.9	250.9	235.9	48.8	152.1	514.5	215.9	260.2	347.8	16.8	16.2	13.5	20.8	18.6	15.7	14.7	14.6	16.2	14.9	16.4	16.0	54.2	19.2	22.2	2.0	87.1	139.6	71.4	195.2	108.1	0.3	86.6	67.8	3.8	27.1	126.2	44.1	0.0	77.1	151.3	304.5	60.7	145.3	4.8	85.8	20.1	55.0	43.1	75.7	12.8	145.0	207.7	23.5	55.5	129.0	79.4	59.9	53.6	254.3	353.1	0.0	9.1	116.8	162.8	286.1	133.9	13.7	4.7	187.6	87.2	5.6	167.9	49.8	189.5	1.0	1.0	167.4	250.6	12.8	121.0	47.9	247.5	440.3	74.1	1.3	32.9	7.2	37.3	3.6	7.7	116.6	90.1	48.6	198.5	17.7	123.6	133.8
ACP2	LAP	ENSG00000134575	"Acid phosphatase 2, lysosomal"	P11117	11	47239302-47248906	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 89.3;Hofbauer cells: 113.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 69.9"	"Lineage enriched"	"Detected in all"	5	"monocytes: 69.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		12000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 4: Macrophages - Innate immune response"				"unprognostic (5.27e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.86e-2)"	"prognostic favorable (1.04e-4)"	"unprognostic (7.90e-3)"	"unprognostic (2.93e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.28e-3)"	"unprognostic (2.64e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.68e-3)"	"unprognostic (1.57e-1)"	25.2	36.6	17.3	22.9	17.1	6.4	21.8	17.0	18.5	16.5	22.1	23.3	42.9	15.8	29.8	14.3	14.1	19.6	21.7	19.8	26.0	27.4	80.5	21.4	29.4	20.8	19.6	11.1	45.9	21.3	21.3	28.7	23.1	25.4	18.1	11.9	50.3	18.3	14.0	11.4	31.9	16.9	16.9	29.1	24.8	12.2	22.0	13.7	19.3	14.8	15.3	22.0	13.1	17.2	16.5	33.5	31.9	28.2	28.1	13.6	24.4	26.6	47.1	47.5	49.4	23.3	26.3	4.3	21.9	34.2	14.3	23.7	16.9	24.6	22.5	85.5	29.1	11.1	48.1	24.6	38.4	16.4	27.1	34.1	15.2	24.6	14.5	28.3	34.9	14.1	20.3	33.9	31.5	26.8	13.4	14.2	21.5	24.8	20.0	10.8	43.1	36.2	34.9	37.6	16.7	26.0	36.8	80.1	19.2	16.3	49.0	14.0	21.0	23.9	19.8	31.4	38.4	28.1	40.0	3.6	35.0	8.2	37.6	12.5	16.9	7.2	12.3	69.9	9.4	2.5	7.6	11.1	15.1	1.5	6.6	5.7	2.8	9.7	48.2	0.6	8.3	10.9	17.3	17.1	17.0	18.5	19.8	26.0	20.8	19.6	23.1	16.9	22.0	17.2	13.3	19.2	18.6	6.2	5.6	4.1	9.3	42.2	10.2	14.4	13.5	9.1	9.2	21.5	29.4	18.4	6.2	41.3	2.6	37.6	9.8	50.6	1.8	7.7	15.6	18.3	15.0	13.5	6.9	60.1	33.3	15.3	17.3	12.1	12.0	10.7	45.7	89.3	113.5	11.8	8.9	26.7	22.4	80.0	3.9	3.5	5.0	33.8	24.9	3.7	29.8	20.6	7.2	8.5	4.3	33.5	29.5	10.5	21.1	10.9	55.3	33.4	19.2	11.9	19.7	8.1	14.5	11.8	19.1	9.5	2.4	29.3	5.8	25.2	14.3	8.6
ADAP1	"CENTA1, GCS1L"	ENSG00000105963	"ArfGAP with dual PH domains 1"	O75689	7	897900-955407	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 85.9;intestine: 43.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 97.7;Intestinal goblet cells: 42.5;Oligodendrocytes: 43.6;Paneth cells: 64.4;Proximal enterocytes: 48.5;Undifferentiated cells: 50.6"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 15.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 108.1;CAPAN-2: 74.1;HMC-1: 71.0;OE19: 191.5;THP-1: 122.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007033, HPA012049"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 45: Intestine - Brush border"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"		"HPA007033: AB_1846529, HPA012049: AB_1846527"	"unprognostic (2.45e-1)"	"unprognostic (7.15e-2)"	"prognostic unfavorable (5.25e-4)"	"unprognostic (4.41e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (9.13e-4)"	"unprognostic (3.06e-1)"	"unprognostic (9.10e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.69e-1)"	"prognostic favorable (4.13e-5)"	"unprognostic (5.88e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.79e-2)"	4.9	3.8	51.2	11.2	55.8	9.8	3.4	57.3	73.6	4.1	11.2	43.2	19.7	6.0	0.6	9.0	8.8	6.0	8.1	59.4	42.9	22.3	3.6	10.4	3.8	63.5	63.1	1.5	13.3	6.1	4.7	2.7	56.9	6.6	22.8	1.6	4.6	2.9	0.7	3.9	26.8	8.3	48.7	17.2	19.6	1.1	55.4	0.9	7.6	0.5	2.1	8.9	3.8	85.9	108.1	4.0	0.1	3.7	1.4	0.2	1.1	3.6	0.1	0.7	0.1	43.1	74.1	0.2	10.3	0.5	0.2	44.5	5.9	8.1	0.5	0.6	4.7	0.0	6.0	25.4	1.7	0.7	71.0	1.8	21.4	0.2	0.0	0.1	0.0	3.1	0.4	0.0	0.0	33.2	0.1	30.1	3.2	191.5	0.0	14.4	0.2	0.4	4.7	25.0	3.1	1.0	3.3	1.3	0.5	0.4	25.9	122.6	0.6	0.8	2.8	0.1	0.3	0.0	0.2	0.0	0.2	22.3	3.3	1.0	6.5	3.3	6.0	7.3	2.8	1.1	1.6	5.5	5.1	0.9	0.5	2.6	3.1	1.6	11.7	0.3	0.8	4.0	51.2	55.8	57.3	73.6	59.4	42.9	63.5	63.1	56.9	48.7	55.4	85.9	0.4	0.0	10.3	2.9	3.6	1.0	2.9	3.3	2.8	4.7	2.5	1.5	8.5	7.2	2.9	7.3	0.0	0.3	19.4	97.7	9.8	3.9	0.2	8.6	0.9	0.5	16.2	0.0	13.2	4.6	0.9	1.5	17.9	7.6	7.0	1.3	0.0	0.6	12.2	0.0	12.6	42.5	4.1	23.0	15.7	0.4	0.0	22.1	10.6	2.8	13.2	1.3	15.5	3.0	43.6	17.5	64.4	0.0	2.6	3.0	48.5	7.1	8.2	1.1	0.0	0.1	1.9	0.3	1.2	1.1	1.3	0.7	9.0	0.0	50.6	5.5
ADAP2	CENTA2	ENSG00000184060	"ArfGAP with dual PH domains 2"	Q9NPF8	17	30906344-30959322	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 86.2;Hofbauer cells: 195.8;Kupffer cells: 186.8;Macrophages: 97.2;monocytes: 88.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"classical monocyte: 22.4;intermediate monocyte: 34.3;myeloid DC: 12.6;non-classical monocyte: 43.5"	"Group enriched"	"Detected in many"	9	"dendritic cells: 12.6;monocytes: 43.5"	"Cell line enhanced"	"Detected in some"		"EFO-21: 7.0;HAP1: 17.6;HEK 293: 11.0;RPMI-8226: 22.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 4: Macrophages - Innate immune response"				"unprognostic (4.00e-2)"	"unprognostic (1.68e-2)"	"prognostic unfavorable (5.62e-4)"	"unprognostic (2.25e-1)"	"unprognostic (9.26e-2)"	"prognostic favorable (3.97e-4)"	"prognostic unfavorable (3.12e-4)"	"unprognostic (2.38e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.51e-1)"	"unprognostic (9.49e-2)"	"prognostic unfavorable (2.36e-6)"	"unprognostic (1.42e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.14e-2)"	11.3	8.9	6.6	15.3	7.6	3.9	4.6	6.7	8.5	2.9	9.1	6.5	5.7	3.2	2.9	3.1	3.3	9.2	4.4	6.2	8.0	5.1	11.0	9.8	9.8	12.1	9.6	1.9	3.1	9.1	1.9	19.7	10.4	2.4	8.0	1.3	3.1	3.1	1.8	6.7	5.6	9.8	8.6	22.5	4.3	2.0	14.7	4.6	3.2	6.4	6.7	9.0	2.2	12.9	0.1	1.7	0.2	0.4	0.4	0.5	4.5	0.1	0.0	0.3	0.1	0.7	0.7	1.0	7.0	0.1	0.2	0.1	17.6	0.2	0.3	0.4	11.0	0.0	1.0	2.0	2.9	0.4	1.9	1.1	4.4	0.9	0.6	0.2	0.0	0.0	0.2	1.8	0.6	3.6	0.1	0.3	0.1	0.4	0.1	0.3	0.0	22.9	2.4	2.3	0.3	0.1	0.3	0.2	0.1	1.5	3.8	2.9	0.0	0.4	1.1	0.8	0.1	0.8	0.5	1.0	0.4	0.4	0.0	0.2	22.4	0.0	0.0	34.3	0.0	3.0	0.1	0.1	12.6	2.1	0.1	0.1	1.7	0.0	43.5	0.4	0.4	6.6	6.6	7.6	6.7	8.5	6.2	8.0	12.1	9.6	10.4	8.6	14.7	12.9	5.4	3.2	5.2	2.6	8.6	2.0	0.5	0.5	2.2	0.8	0.7	2.4	1.5	1.5	0.9	0.0	2.1	23.5	0.2	3.1	0.0	0.3	0.6	1.7	0.6	7.8	0.0	0.4	1.1	1.4	86.2	1.9	0.0	1.2	3.8	0.4	4.6	1.6	195.8	0.0	1.4	0.6	0.0	186.8	13.1	0.5	0.9	97.2	0.0	40.3	88.2	0.6	2.1	2.0	1.3	0.9	0.9	0.4	2.6	0.9	0.3	8.3	2.2	2.8	39.5	1.2	26.5	0.9	0.9	1.0	6.5	26.4	1.6	0.2	0.3	0.6
AGTRAP	ATRAP	ENSG00000177674	"Angiotensin II receptor associated protein"	Q6RW13	1	11736084-11754802	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 446.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 196.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044120	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 1: Pancreatic cells - Digestion"	Vesicles	"Golgi apparatus"	"HPA044120: AB_10960748"	"unprognostic (1.08e-3)"	"unprognostic (2.98e-3)"	"unprognostic (6.10e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.92e-3)"	"prognostic unfavorable (6.57e-7)"	"unprognostic (4.44e-2)"	"unprognostic (7.96e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.33e-3)"	"unprognostic (5.89e-2)"	44.1	50.3	26.6	30.2	28.5	132.3	44.3	27.1	32.4	34.6	44.0	29.3	11.2	24.7	47.7	53.6	48.3	25.2	37.0	24.5	30.5	65.8	29.5	62.3	23.4	37.3	28.8	26.9	67.3	25.7	31.2	22.0	31.3	79.1	9.3	3.4	39.0	21.0	54.3	38.8	25.7	20.3	28.4	83.4	33.7	24.7	31.8	11.3	40.8	12.4	13.3	43.9	43.3	31.1	55.9	66.7	16.7	36.9	27.5	34.9	30.5	28.6	49.0	34.8	30.2	42.0	129.7	5.4	126.7	35.4	87.3	45.8	27.9	135.3	10.7	3.1	61.5	1.6	38.4	51.8	84.9	27.6	64.3	34.6	105.4	112.9	59.2	42.4	46.9	17.3	73.8	52.8	19.8	44.6	13.7	80.9	29.7	24.0	67.3	4.6	15.0	27.5	56.7	5.2	14.6	22.0	52.5	26.4	48.4	22.3	59.8	57.4	26.0	44.1	30.8	70.3	30.9	19.6	24.2	33.3	111.7	196.1	20.7	483.4	844.2	694.6	185.7	442.7	90.4	47.0	66.9	109.8	312.2	38.2	72.0	93.5	756.8	73.0	385.2	25.5	90.8	577.4	26.6	28.5	27.1	32.4	24.5	30.5	37.3	28.8	31.3	28.4	31.8	31.1	46.2	22.4	27.4	3.9	12.1	11.6	30.7	112.4	16.5	1.0	54.8	56.0	12.0	32.9	41.6	36.8	6.2	15.7	60.1	6.9	9.8	95.5	20.6	75.3	30.8	36.1	7.2	21.0	0.2	446.7	92.4	45.3	11.2	41.1	88.0	19.1	42.1	7.7	118.3	3.3	0.2	12.3	20.3	143.5	18.9	23.4	37.9	97.8	28.4	1.9	107.4	19.4	122.6	0.5	7.0	96.9	22.5	27.1	8.6	66.5	8.6	55.3	78.5	5.6	13.1	13.0	23.8	3.5	36.1	34.4	13.5	13.1	45.0	50.4	18.2	25.2
AIF1	"AIF-1, Em:AF129756.17, IBA1, IRT-1"	ENSG00000204472	"Allograft inflammatory factor 1"	P55008	6	31615217-31617021	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 235.0;lymphoid tissue: 346.6"	"Group enriched"	"Detected in many"	22	"Hofbauer cells: 1777.1;Kupffer cells: 2140.2;Langerhans cells: 1359.1;Macrophages: 1494.0;monocytes: 1022.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	26	"classical monocyte: 3823.3;intermediate monocyte: 6550.1;myeloid DC: 2043.3;neutrophil: 2943.0;non-classical monocyte: 7744.5"	"Group enriched"	"Detected in all"	74	"dendritic cells: 2043.3;granulocytes: 2943.0;monocytes: 7744.5"	"Group enriched"	"Detected in some"	4	"HEL: 204.6;HMC-1: 329.6;NB-4: 264.7;THP-1: 184.2;U-937: 114.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049234, HPA062949"	Enhanced		Uncertain	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol		"HPA049234: AB_2680685, HPA062949: AB_2732694"	"unprognostic (3.20e-2)"	"unprognostic (7.21e-3)"	"unprognostic (6.11e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.98e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (2.30e-5)"	"unprognostic (1.29e-1)"	"unprognostic (1.02e-2)"	"unprognostic (9.59e-2)"	"unprognostic (4.89e-2)"	79.6	46.6	24.9	182.3	25.5	235.0	47.2	26.6	33.0	29.3	32.2	48.3	36.4	17.1	12.1	18.7	19.7	61.3	21.1	25.0	31.3	74.3	81.2	99.3	116.8	45.1	36.4	14.4	12.4	12.9	17.3	109.5	36.8	22.3	57.2	3.9	20.3	24.0	6.1	11.7	44.5	74.7	34.3	346.6	22.2	8.7	32.1	69.1	13.8	16.6	57.1	95.3	13.5	42.7	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	204.6	0.0	0.0	0.0	30.0	329.6	0.0	0.0	0.0	0.0	0.0	0.0	51.6	0.9	0.2	0.0	0.0	2.3	264.7	0.4	0.0	0.0	35.9	0.4	8.9	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	184.2	0.1	0.0	0.2	0.1	0.3	0.2	0.0	1.3	0.2	114.6	0.0	33.1	3823.3	177.9	10.2	6550.1	12.7	57.5	10.8	9.3	2043.3	6.3	33.1	26.2	2943.0	14.5	7744.5	144.2	10.7	4449.8	24.9	25.5	26.6	33.0	25.0	31.3	45.1	36.4	36.8	34.3	32.1	42.7	12.0	25.6	59.6	0.0	39.2	32.5	0.7	0.0	0.6	0.1	5.3	24.3	7.5	18.6	19.2	42.3	0.0	11.1	31.2	1.0	0.0	0.3	1.9	0.6	0.7	28.7	1.2	65.0	0.0	0.4	15.4	20.6	0.5	0.4	68.3	0.4	35.3	13.4	1777.1	0.0	0.0	0.1	0.0	2140.2	1359.1	4.9	7.5	1494.0	39.2	10.3	1022.6	0.0	32.0	0.5	0.1	0.2	11.1	0.7	7.2	0.4	0.3	4.2	10.2	0.1	52.6	4.7	6.5	0.5	1.5	2.1	28.3	22.7	46.1	1.9	0.6	0.3
ALDH3B1	ALDH7	ENSG00000006534	"Aldehyde dehydrogenase 3 family member B1"	P43353	11	68008578-68029282	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 46.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 115.4;Alveolar cells type 2: 58.4;Endometrial ciliated cells: 54.5;Kupffer cells: 59.0;Respiratory ciliated cells: 211.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 163.2"	"Group enriched"	"Detected in many"	10	"dendritic cells: 67.5;granulocytes: 163.2;monocytes: 125.8"	"Cell line enhanced"	"Detected in many"		"A549: 154.4;CAPAN-2: 154.9;RPMI-8226: 85.9;U-87 MG: 89.1"	"Low region specificity"	"Detected in all"							HPA038525	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA038525: AB_2676062"	"unprognostic (3.50e-1)"	"unprognostic (4.22e-1)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (1.56e-2)"	"unprognostic (9.66e-3)"	"unprognostic (9.73e-2)"	"unprognostic (7.93e-3)"	"unprognostic (2.62e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (6.07e-4)"	"unprognostic (8.27e-2)"	"unprognostic (6.49e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.75e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.06e-1)"	12.7	26.7	2.9	10.6	4.5	46.5	5.5	5.1	4.2	11.4	8.9	9.8	23.4	6.4	0.9	13.9	39.6	8.8	4.0	2.5	3.8	16.3	4.1	44.4	5.6	6.0	5.6	3.6	8.0	0.6	7.7	11.7	4.9	4.7	6.5	0.5	11.1	4.1	2.0	5.7	18.0	5.6	4.5	20.0	20.7	2.1	5.4	1.3	2.5	1.7	2.6	10.8	8.9	6.2	11.4	154.4	1.1	3.3	9.9	31.0	26.8	15.1	24.8	10.9	5.3	5.7	154.9	0.7	26.9	35.9	15.3	12.9	0.3	2.1	2.7	0.4	0.9	1.6	64.3	13.4	61.0	9.1	0.5	22.5	6.8	5.4	14.6	24.6	0.6	0.8	0.4	27.3	17.8	9.5	0.9	9.0	1.2	76.1	9.2	3.7	5.9	85.9	17.9	1.5	1.8	0.8	35.7	29.7	15.2	0.8	34.3	19.7	16.2	15.7	21.3	76.2	5.3	0.4	3.0	0.2	89.1	24.5	7.4	47.6	91.0	163.2	0.2	125.8	0.3	0.4	0.2	0.2	67.5	0.5	0.2	0.1	26.6	11.8	118.1	7.0	0.1	47.7	2.9	4.5	5.1	4.2	2.5	3.8	6.0	5.6	4.9	4.5	5.4	6.2	0.4	115.4	58.4	1.0	1.4	2.2	2.7	8.4	1.2	0.5	1.7	1.3	3.1	20.0	53.6	5.5	0.0	0.8	2.9	6.6	0.0	7.4	21.6	54.5	9.2	1.8	2.4	7.8	0.2	2.5	8.2	6.5	12.8	5.1	25.2	2.0	1.4	2.3	34.0	3.3	0.1	9.0	12.2	59.0	10.6	10.0	1.8	33.1	3.6	1.9	30.9	2.1	1.0	0.5	5.7	19.3	7.5	1.5	1.3	3.1	36.2	30.1	211.6	0.4	0.0	6.9	6.5	0.4	0.4	1.0	1.0	0.7	2.2	0.0	9.8	6.2
AMDHD2	CGI-14	ENSG00000162066	"Amidohydrolase domain containing 2"	Q9Y303	16	2520357-2531422	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 64.1;Hofbauer cells: 127.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041184, HPA041321"	Enhanced		Approved	Nucleoli,Cytosol		No	No		110000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 71: Testis - DNA repair"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli, Cytosol"		"HPA041184: AB_10803998, HPA041321: AB_10795588"	"unprognostic (1.20e-1)"	"prognostic favorable (5.19e-4)"	"unprognostic (7.86e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.88e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.30e-1)"	"unprognostic (8.37e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.20e-1)"	14.7	20.2	2.7	5.6	3.4	5.5	13.7	2.4	4.8	12.9	2.8	12.6	9.1	12.2	0.7	10.6	10.8	4.3	7.0	3.3	2.0	18.7	13.8	12.2	7.9	3.4	3.1	9.3	8.2	3.1	8.5	4.5	2.8	10.8	0.8	0.4	13.7	3.2	8.8	15.4	17.3	1.4	2.4	26.1	9.9	37.0	4.2	3.7	12.1	1.3	1.9	10.9	9.8	4.3	9.6	11.7	3.1	6.7	3.5	2.5	15.4	9.0	3.4	7.4	9.0	8.7	16.9	4.4	4.4	1.7	14.0	9.3	1.7	2.5	0.2	6.0	7.8	6.6	13.8	12.7	12.9	4.6	16.8	6.6	2.5	4.9	0.8	1.8	4.0	12.5	14.3	9.3	3.1	19.0	7.8	11.7	6.7	0.8	10.1	29.6	4.4	14.0	2.4	5.4	10.3	9.9	5.7	13.1	21.4	0.5	13.1	1.5	6.9	7.4	11.3	14.3	4.7	15.7	14.1	8.9	8.1	9.5	7.4	9.5	3.3	9.6	4.8	7.5	3.8	6.4	3.5	2.9	1.2	4.1	2.7	2.4	8.4	3.1	9.9	9.9	3.8	2.9	2.7	3.4	2.4	4.8	3.3	2.0	3.4	3.1	2.8	2.4	4.2	4.3	8.0	3.2	11.6	1.3	16.7	8.9	5.2	3.2	4.0	10.3	13.6	11.6	2.5	10.0	5.2	5.5	6.2	16.7	16.4	16.2	5.9	30.3	64.1	6.0	4.1	8.3	12.6	11.0	1.6	17.0	27.1	9.9	7.1	5.2	7.0	13.1	18.2	11.9	127.0	23.5	1.1	12.8	6.1	47.6	12.1	27.4	10.5	28.9	19.6	1.9	26.9	11.0	20.6	0.5	0.8	14.5	26.4	6.4	11.5	4.1	59.4	48.9	9.1	13.0	0.0	7.8	8.4	52.9	16.3	5.1	8.9	27.9	13.2	7.6	10.4	4.2
AMPD3		ENSG00000133805	"Adenosine monophosphate deaminase 3"	Q01432	11	10308313-10507579	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 62.9;skeletal muscle: 73.3"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 111.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 44.2;CAPAN-2: 34.6;HMC-1: 36.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038662, HPA047408"	Uncertain		Approved	"Nuclear membrane"		NA	NA		77000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear membrane"		"HPA038662: AB_2676136, HPA047408: AB_2680034"	"unprognostic (2.24e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.44e-2)"	"prognostic favorable (2.37e-4)"	"unprognostic (1.89e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.91e-3)"	"unprognostic (1.25e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.68e-1)"	"unprognostic (3.06e-2)"	"unprognostic (7.07e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.12e-2)"	4.2	19.6	10.8	20.7	22.5	62.9	3.0	19.1	15.3	6.0	10.8	4.9	6.5	4.2	4.0	7.6	11.1	6.4	2.9	10.4	15.9	7.8	1.8	6.9	17.6	21.1	20.5	2.6	3.3	24.1	18.2	4.1	20.5	7.4	6.6	7.5	6.4	3.5	73.3	15.6	7.8	4.4	14.0	12.1	6.7	1.8	21.4	13.9	3.6	9.3	20.3	9.7	7.9	30.2	14.1	2.0	0.5	0.2	7.1	5.0	0.8	12.4	44.2	3.0	3.1	6.9	34.6	5.1	1.2	5.7	11.9	8.6	0.2	11.8	8.8	12.7	0.5	12.5	1.8	1.0	2.4	17.2	36.0	18.5	17.9	6.0	7.7	7.5	1.4	8.3	19.4	5.3	10.1	0.5	10.2	22.3	1.6	1.1	12.2	3.7	15.9	18.2	0.6	11.5	5.1	2.6	2.7	0.4	0.8	1.0	0.4	5.8	3.4	13.7	0.2	9.6	0.5	4.8	2.9	5.5	15.7	16.9	0.3	9.5	6.4	19.4	2.2	3.9	5.4	7.7	3.3	2.6	4.2	5.3	3.6	2.5	8.4	3.8	1.7	2.7	2.1	2.8	10.8	22.5	19.1	15.3	10.4	15.9	21.1	20.5	20.5	14.0	21.4	30.2	0.5	0.0	3.9	5.2	14.3	12.5	10.6	8.1	4.0	23.6	1.6	1.8	6.3	5.7	9.8	14.7	2.1	0.9	1.6	1.9	17.6	2.9	7.3	14.0	1.7	1.6	10.2	20.2	11.9	1.6	1.5	8.1	3.1	2.9	12.0	0.9	1.1	0.7	14.5	0.0	7.0	3.9	20.3	15.2	7.6	20.6	0.9	18.3	3.6	28.1	14.0	6.5	1.0	5.0	111.8	6.3	3.0	0.0	1.7	26.5	4.9	0.8	24.2	1.3	0.0	12.3	1.9	0.4	0.6	2.2	12.5	1.2	6.6	0.3	2.2	16.8
ARHGAP30	FLJ00267	ENSG00000186517	"Rho GTPase activating protein 30"	Q7Z6I6	1	161046946-161069970	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 57.6;lymphoid tissue: 77.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 71.6;dendritic cells: 103.4;Kupffer cells: 77.8;Macrophages: 79.1;monocytes: 133.0;NK-cells: 268.8;T-cells: 105.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 118.2;HL-60: 92.5;HMC-1: 123.4;Karpas-707: 93.1;MOLT-4: 75.8;THP-1: 90.9;U-266/70: 138.6;U-266/84: 97.7;U-698: 97.9;U-937: 72.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA036300	Enhanced		Supported	Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA036300: AB_10601117"	"unprognostic (7.31e-2)"	"unprognostic (8.83e-3)"	"unprognostic (7.46e-3)"	"unprognostic (1.77e-3)"	"unprognostic (7.41e-2)"	"unprognostic (1.68e-3)"	"unprognostic (3.05e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.89e-2)"	"unprognostic (7.91e-2)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (9.78e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.65e-2)"	12.1	4.9	3.1	55.9	3.6	57.6	5.3	3.7	4.3	3.4	3.3	8.1	9.5	2.9	2.8	14.1	4.5	10.2	2.8	2.9	3.6	3.4	6.6	25.2	77.0	6.1	4.5	2.0	2.4	1.4	1.8	7.0	5.4	3.4	8.4	0.6	6.4	2.3	2.6	19.8	23.9	8.0	5.0	75.5	11.6	2.3	6.3	63.7	2.9	2.7	61.2	13.8	6.5	6.8	0.8	0.1	0.2	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.3	1.2	118.2	0.6	0.0	0.1	2.3	0.0	0.0	0.2	55.3	0.2	39.7	0.2	0.0	0.0	92.5	123.4	0.0	1.2	0.1	0.0	0.1	0.0	56.8	0.3	93.1	0.0	1.0	75.8	21.3	0.1	0.7	0.1	46.8	0.6	1.6	0.0	1.0	0.7	0.3	0.2	0.7	0.2	0.7	0.8	90.9	0.9	0.1	0.7	0.2	0.5	138.6	97.7	97.9	0.4	72.3	0.1	7.1	29.6	33.1	32.9	32.2	25.1	11.9	21.9	27.1	21.8	12.6	17.9	25.0	48.5	19.3	46.4	15.0	23.8	33.5	3.1	3.6	3.7	4.3	2.9	3.6	6.1	4.5	5.4	5.0	6.3	6.8	1.5	3.2	20.5	0.3	71.6	5.6	3.3	6.8	0.0	0.5	5.2	2.9	1.3	2.8	13.8	0.0	4.2	0.6	103.4	0.5	0.0	3.4	2.2	6.6	1.2	2.3	0.0	14.5	0.3	6.0	1.9	1.9	3.1	13.7	68.3	0.0	6.1	1.7	55.5	0.0	0.3	0.4	8.2	77.8	44.6	0.7	0.3	79.1	5.4	14.0	133.0	0.1	268.8	0.5	1.2	12.5	0.2	0.0	49.8	5.4	0.0	0.5	15.3	3.0	0.0	1.0	1.9	0.1	0.1	9.9	24.6	4.5	105.1	0.2	0.5	16.7
ASGR2	CLEC4H2	ENSG00000161944	"Asialoglycoprotein receptor 2"	P07307	17	7101322-7115700	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Endocytosis, Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	48	"liver: 840.7"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 878.6"	"Cancer enriched"	"Detected in many"	66	"liver cancer: 214.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"classical monocyte: 110.0;myeloid DC: 64.1"	"Group enriched"	"Detected in many"	51	"dendritic cells: 64.1;monocytes: 110.0"	"Cell line enriched"	"Detected in some"	9	"Hep G2: 528.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA014899, HPA015998"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane"		NA	NA		14000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	"Endoplasmic reticulum, Plasma membrane"		"HPA014899: AB_1845085, HPA015998: AB_1845084"	"unprognostic (6.76e-2)"	"unprognostic (7.45e-7)"	"unprognostic (1.61e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.03e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.35e-4)"	"unprognostic (1.54e-3)"	"unprognostic (6.95e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.31e-2)"	1.5	0.3	0.8	7.9	1.0	7.0	0.5	0.9	1.3	0.4	1.3	0.5	0.3	0.3	0.1	0.5	0.6	17.6	0.5	0.8	1.0	1.2	840.7	2.5	0.9	1.0	1.1	0.2	0.5	0.1	0.2	0.5	1.2	0.4	0.4	0.0	0.5	0.2	0.2	5.2	0.6	1.3	1.0	6.8	0.5	0.5	1.4	0.5	0.3	0.1	1.0	2.0	0.4	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	62.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	528.3	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	42.3	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	1.0	110.0	0.8	0.1	11.2	0.2	0.0	0.0	0.0	64.1	0.0	0.1	0.0	1.7	0.1	0.1	1.6	0.3	31.8	0.8	1.0	0.9	1.3	0.8	1.0	1.0	1.1	1.2	1.0	1.4	1.2	0.0	0.0	5.1	0.3	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	150.2	0.0	0.0	0.0	0.1	0.0	0.1	1.9	0.0	0.4	0.0	0.0	1.3	7.1	19.6	1.9	0.0	0.2	0.1	0.0	0.1	2.5	0.0	16.1	878.6	8.4	0.0	0.1	0.1	0.0	41.1	7.7	0.7	0.0	19.6	0.0	0.0	15.3	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	6.6	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.3	0.4	1.4	0.0	0.0	0.1
ATP6V0D1	"ATP6D, ATP6DV, P39, VATX, Vma6, VPATPD"	ENSG00000159720	"ATPase H+ transporting V0 subunit d1"	P61421	16	67438014-67481181	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cilium biogenesis/degradation, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 380.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016938	Uncertain					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA016938: AB_1845191"	"unprognostic (1.12e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.79e-3)"	"unprognostic (8.57e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.20e-2)"	"unprognostic (8.30e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.20e-5)"	"unprognostic (5.72e-3)"	"prognostic favorable (1.76e-8)"	"unprognostic (2.72e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.63e-2)"	"unprognostic (4.33e-3)"	51.3	112.9	103.1	66.9	107.1	82.3	50.3	84.1	118.4	65.2	82.4	89.8	69.0	69.2	56.6	88.6	57.8	55.9	71.5	119.9	145.1	86.2	73.0	78.7	66.9	112.6	107.4	35.1	59.2	116.3	107.7	55.8	136.0	60.5	72.7	41.4	62.8	55.0	127.6	85.9	79.9	79.6	82.6	96.1	69.4	69.5	99.4	64.7	75.1	84.7	64.0	66.8	62.2	98.5	78.9	111.6	67.3	87.5	167.2	91.2	64.3	92.7	149.1	187.0	224.3	116.5	82.6	33.0	74.2	134.7	125.3	91.9	99.0	117.7	108.8	40.3	90.5	60.5	58.4	97.6	159.4	60.5	243.3	139.8	115.1	187.4	44.5	68.2	117.9	38.0	69.7	41.9	151.9	193.7	45.7	134.9	65.2	70.6	77.9	80.2	78.5	92.1	113.3	129.3	130.4	60.4	244.0	65.8	103.1	52.3	104.8	91.1	114.4	93.4	38.6	113.9	49.8	69.5	106.8	94.9	130.1	63.8	56.3	312.7	732.5	542.4	130.1	511.7	89.9	189.4	96.3	120.3	469.2	174.5	73.1	91.3	936.5	155.5	485.5	168.4	128.0	742.7	103.1	107.1	84.1	118.4	119.9	145.1	112.6	107.4	136.0	82.6	99.4	98.5	46.0	16.0	47.2	11.1	80.1	73.8	61.5	138.2	45.5	73.3	65.7	50.5	38.8	54.3	78.0	68.0	73.0	112.1	74.7	258.8	181.9	127.7	109.6	93.3	46.4	42.6	121.9	68.8	22.7	111.0	73.1	61.5	68.3	74.5	50.1	44.2	42.5	50.2	380.4	82.4	25.7	160.2	154.6	149.4	186.7	50.1	58.7	183.1	124.5	7.5	260.9	70.6	77.2	13.6	23.1	102.0	179.5	53.0	57.0	38.8	203.1	173.6	92.7	52.9	118.3	26.6	53.2	125.7	64.0	55.0	87.5	283.6	54.7	91.3	101.6	63.2
BLVRA	BLVR	ENSG00000106605	"Biliverdin reductase A"	P53004	7	43758680-43807342	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 259.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019709, HPA042865, HPA054322"	Approved		Supported	Cytosol		NA	NA		1200000	"Cluster 7: Monocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Cytosol		"HPA019709: AB_2670239, HPA042865: AB_10797024, HPA054322: AB_2682450"	"unprognostic (2.47e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.79e-2)"	"unprognostic (2.16e-3)"	"unprognostic (6.45e-3)"	"unprognostic (5.01e-2)"	"unprognostic (1.63e-2)"	"prognostic favorable (8.65e-4)"	"unprognostic (1.42e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.93e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.63e-3)"	"unprognostic (3.18e-1)"	"unprognostic (2.13e-3)"	"unprognostic (4.56e-2)"	53.2	28.0	31.4	39.7	33.4	65.6	49.9	32.0	40.1	44.3	31.4	61.4	12.5	38.5	129.9	67.5	40.9	33.4	52.7	32.3	34.7	41.3	14.6	62.7	58.6	34.1	33.6	46.6	23.5	54.9	26.2	28.9	34.2	38.4	19.8	25.4	36.5	46.0	59.7	33.4	27.7	54.1	33.1	82.0	35.3	13.1	34.0	43.0	31.3	69.3	52.6	43.5	40.4	32.0	48.6	92.2	26.2	110.5	55.0	72.7	1.3	32.3	99.3	54.0	65.4	22.2	28.3	0.3	60.6	51.5	190.7	62.1	82.1	81.7	46.2	227.3	56.8	104.1	86.6	138.1	139.5	11.8	37.5	49.9	135.7	57.2	37.8	108.5	92.7	51.1	70.2	55.7	41.4	52.5	37.0	6.3	35.9	11.0	104.7	80.4	45.6	261.4	121.1	26.6	34.0	104.4	65.9	65.1	55.2	46.2	146.7	77.7	57.0	49.3	53.9	21.8	56.0	74.7	63.2	0.2	80.8	46.9	78.4	51.1	291.9	169.2	39.1	374.9	36.7	26.9	75.7	64.9	135.4	17.0	39.7	31.0	26.5	22.4	368.4	20.1	82.2	208.5	31.4	33.4	32.0	40.1	32.3	34.7	34.1	33.6	34.2	33.1	34.0	32.0	22.0	60.9	85.0	7.5	10.7	29.1	64.2	102.4	34.1	18.0	29.6	36.1	59.4	17.2	75.7	35.0	2.1	9.7	9.3	0.3	56.7	52.6	0.7	31.6	20.2	27.3	0.0	74.7	8.4	35.1	8.1	39.7	8.2	41.4	111.5	17.2	24.3	1.9	259.1	8.4	11.5	0.4	59.0	136.5	53.7	1.6	37.0	80.4	46.2	2.8	147.3	36.6	13.4	7.5	4.3	25.2	1.2	29.0	16.6	87.9	7.1	110.5	69.6	13.0	46.0	23.0	50.6	3.0	14.2	52.9	34.4	5.2	23.4	4.9	0.6	48.7
BRI3		ENSG00000164713	"Brain protein I3"	O95415	7	98252379-98310441	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 42.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042215	Uncertain					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 4: Macrophages - Innate immune response"			"HPA042215: AB_10794790"	"unprognostic (1.51e-2)"	"unprognostic (5.03e-2)"	"unprognostic (7.08e-3)"	"unprognostic (3.48e-2)"	"unprognostic (3.04e-2)"	"prognostic unfavorable (3.35e-4)"	"unprognostic (2.04e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.93e-1)"	"unprognostic (4.68e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.71e-1)"	132.7	159.3	42.2	37.0	45.0	94.8	102.2	42.8	46.2	88.3	50.0	94.0	67.6	80.1	31.7	63.6	72.1	45.3	150.6	36.4	42.0	122.6	179.4	167.3	32.9	46.4	44.2	73.9	127.4	24.1	98.5	69.1	44.3	84.6	35.8	10.8	93.5	26.4	237.0	82.1	81.2	33.6	41.6	122.4	133.1	53.2	56.6	14.1	78.8	65.1	18.3	99.3	69.4	46.0	130.5	20.6	36.6	47.3	231.8	104.0	86.6	105.1	122.4	86.6	114.5	17.1	60.0	13.6	220.3	191.8	275.6	45.5	46.9	66.7	59.9	46.5	53.4	8.7	15.0	29.9	228.2	10.0	43.3	85.7	95.3	74.2	135.2	119.8	107.6	15.9	26.6	84.2	164.4	9.1	32.1	32.9	44.1	87.8	55.3	30.8	20.2	43.7	83.2	9.3	30.6	62.3	27.7	114.4	279.2	63.2	12.2	64.0	108.4	175.1	103.4	228.1	82.6	91.5	128.3	35.9	199.5	44.4	91.8	2.5	15.0	24.2	0.9	25.3	1.3	0.9	0.9	1.0	7.0	1.1	1.5	1.3	42.8	0.2	24.0	10.3	3.0	3.1	42.2	45.0	42.8	46.2	36.4	42.0	46.4	44.2	44.3	41.6	56.6	46.0	354.9	83.3	120.3	18.3	52.8	146.3	278.2	24.1	47.3	90.6	191.1	277.6	121.9	204.5	37.4	134.3	33.3	122.9	118.4	193.5	569.4	62.1	680.8	176.9	149.2	223.9	78.5	49.0	13.8	119.5	431.4	161.6	122.3	192.0	22.8	140.8	238.1	258.0	695.0	129.5	17.8	161.9	26.4	482.9	329.4	132.1	100.3	503.0	167.2	20.6	167.5	291.4	28.8	15.1	26.6	82.4	234.2	121.5	37.4	416.5	261.5	670.8	35.8	84.2	111.7	166.2	145.6	61.6	58.5	59.0	171.5	169.4	48.7	131.3	154.6	473.3
BTK	"AGMX1, ATK, IMD1, PSCTK1, XLA"	ENSG00000010671	"Bruton tyrosine kinase"	Q06187	X	101349447-101390796	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Apoptosis, Immunity, Innate immunity, Transcription, Transcription regulation"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.6;lymphoid tissue: 78.0"	"Cell type enhanced"	"Detected in some"		"B-cells: 84.7;granulocytes: 211.4;Hofbauer cells: 56.6;Kupffer cells: 63.5;Macrophages: 61.1;monocytes: 71.1;Plasma cells: 43.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 557.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 557.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 206.7;HEL: 287.4;HMC-1: 990.3;U-937: 149.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001198, HPA002028, CAB016689"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		2300000	"Cluster 38: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane, Cytosol"		"CAB016689: AB_1611894, HPA001198: AB_1078305, HPA002028: AB_1078306"	"unprognostic (3.19e-2)"	"unprognostic (2.51e-3)"	"unprognostic (1.06e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.69e-2)"	"unprognostic (3.76e-3)"	"unprognostic (6.55e-2)"	"unprognostic (3.58e-3)"	"unprognostic (6.02e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.08e-3)"	"unprognostic (7.80e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.14e-2)"	6.3	2.9	2.3	30.7	2.6	32.6	4.4	2.8	3.4	3.9	3.1	6.6	4.8	2.5	1.5	3.6	1.9	7.6	1.6	2.3	3.1	1.3	5.4	19.6	55.5	4.7	3.6	0.8	1.2	0.9	0.9	7.0	4.7	1.9	9.1	0.3	2.8	2.3	0.6	2.9	14.7	7.1	3.8	38.4	7.0	1.4	3.9	9.3	1.3	2.0	78.0	9.3	1.5	6.5	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	206.7	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.3	287.4	0.0	0.0	0.0	116.7	990.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	61.9	2.3	0.0	0.0	0.6	81.5	1.6	0.0	0.0	87.2	0.1	13.2	0.0	0.0	0.2	0.0	0.3	0.1	0.5	1.0	0.0	68.5	0.4	0.0	0.3	0.2	0.1	2.6	1.4	98.3	0.5	149.8	0.3	557.5	62.2	110.5	0.2	99.9	0.2	72.4	0.2	0.1	72.7	73.0	0.4	0.1	24.7	0.2	123.9	33.1	0.1	38.4	2.3	2.6	2.8	3.4	2.3	3.1	4.7	3.6	4.7	3.8	3.9	6.5	1.5	3.2	8.9	0.3	84.7	1.0	0.2	0.0	0.6	0.0	0.9	1.4	0.6	0.0	0.6	0.0	0.0	1.4	30.1	0.1	0.0	0.0	0.2	1.3	0.3	0.8	0.0	27.1	0.5	0.0	0.5	0.9	1.1	2.3	211.4	0.0	0.7	0.3	56.6	0.0	0.3	0.3	0.0	63.5	31.0	0.1	0.3	61.1	3.6	10.3	71.1	0.0	2.1	0.0	0.1	0.1	0.5	0.0	43.8	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.5	0.7	1.7	0.5	0.3	1.9	5.7	0.2	0.1	0.1
C2		ENSG00000166278	"Complement C2"	P06681	6	31897785-31945672	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 477.9"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 2: 142.4;Hepatocytes: 380.3;Hofbauer cells: 282.7;Kupffer cells: 99.3"	"Cancer enriched"	"Detected in all"	9	"liver cancer: 100.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 21.1;non-classical monocyte: 25.9"	"Lineage enriched"	"Detected in single"	35	"monocytes: 25.9"	"Cell line enriched"	"Detected in some"	5	"Karpas-707: 284.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB016775	Supported				"Secreted to blood"	NA	NA		34000000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB016775: "	"unprognostic (2.05e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.49e-3)"	"unprognostic (7.40e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.88e-3)"	"unprognostic (3.02e-1)"	"unprognostic (2.59e-3)"	"unprognostic (3.27e-2)"	"unprognostic (3.15e-3)"	"prognostic unfavorable (2.64e-7)"	"unprognostic (2.05e-1)"	"unprognostic (4.42e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.55e-2)"	42.6	12.1	0.8	27.6	1.0	3.2	11.7	0.9	1.4	8.1	1.7	14.3	16.7	7.0	1.3	7.6	12.0	23.0	8.5	0.7	1.1	23.2	477.9	80.0	27.8	3.0	2.6	5.3	1.9	0.9	3.8	48.4	3.0	5.4	13.0	0.4	9.1	0.9	2.1	5.8	30.2	23.6	2.1	46.3	12.0	4.1	3.7	5.5	3.3	2.7	12.5	23.6	5.3	2.1	0.3	0.1	0.1	0.6	0.1	0.0	6.8	0.5	0.3	0.4	0.3	0.4	0.3	0.6	3.5	1.0	0.6	0.5	0.1	0.0	0.3	0.2	0.4	0.3	0.4	52.8	1.1	0.1	0.7	2.7	0.3	0.6	0.1	0.6	0.0	0.7	0.5	284.0	0.0	0.0	0.4	0.5	0.3	0.1	0.0	0.2	16.5	3.0	0.0	0.1	0.3	0.3	2.6	0.3	0.2	0.3	0.2	9.5	0.2	0.2	0.7	0.5	0.1	0.9	31.6	2.7	0.8	0.9	0.1	0.1	5.6	0.0	0.1	21.1	0.1	0.0	0.0	0.0	0.7	0.1	0.1	0.1	0.5	0.1	25.9	0.0	0.0	2.2	0.8	1.0	0.9	1.4	0.7	1.1	3.0	2.6	3.0	2.1	3.7	2.1	2.1	25.6	142.4	2.6	1.9	3.3	1.1	2.0	0.6	1.4	1.3	1.3	0.6	25.8	11.2	1.8	0.0	2.1	0.1	1.8	0.0	0.6	0.3	1.5	18.7	1.9	2.4	10.7	6.6	2.7	2.7	19.8	3.1	1.3	3.8	0.2	21.0	380.3	282.7	1.7	6.3	11.3	0.0	99.3	5.0	1.3	6.8	32.6	3.6	7.5	7.3	0.1	0.0	1.0	1.7	4.5	33.1	1.2	0.4	4.0	55.2	35.7	9.4	0.9	0.0	5.6	3.5	0.8	1.4	0.7	2.8	4.0	2.0	0.5	15.8	4.5
CABP4	CSNB2B	ENSG00000175544	"Calcium binding protein 4"	P57796	11	67452406-67461752	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"retina: 68.2"	"Group enriched"	"Detected in many"	6	"Cone photoreceptor cells: 141.8;Rod photoreceptor cells: 254.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 12.1"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"HMC-1: 19.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 79: Retina - Phototransduction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"				"unprognostic (2.24e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.78e-3)"	"unprognostic (2.91e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.32e-3)"	"unprognostic (2.57e-1)"	"unprognostic (7.10e-4)"	"unprognostic (5.35e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.44e-3)"	1.2	0.6	1.2	0.5	1.4	0.7	1.4	2.2	1.7	1.4	1.5	0.7	0.6	0.5	1.7	0.3	0.4	0.8	0.5	1.3	1.2	0.8	0.7	1.7	1.0	1.6	1.2	0.2	0.8	0.1	0.1	1.4	1.6	1.4	0.4	68.2	0.9	0.6	0.9	0.7	1.2	0.3	1.1	7.2	1.4	0.2	1.5	0.2	0.5	0.2	0.4	0.6	0.3	2.4	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	4.5	0.1	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.1	0.2	0.1	4.1	0.1	0.0	0.1	19.4	0.0	0.0	0.1	0.0	0.1	0.6	0.1	0.0	0.6	1.0	0.3	0.0	0.5	0.1	0.0	0.1	0.1	0.1	0.6	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.0	1.9	0.1	0.1	0.3	0.1	0.2	0.0	0.6	0.1	0.2	0.1	4.0	3.3	0.8	0.7	1.7	0.5	0.6	0.6	0.5	2.5	1.1	0.6	0.7	2.7	1.3	12.1	0.9	0.4	3.5	1.2	1.4	2.2	1.7	1.3	1.2	1.6	1.2	1.6	1.1	1.5	2.4	2.2	0.0	0.5	0.3	1.9	0.9	1.2	0.0	0.6	17.0	2.2	2.0	2.0	2.8	0.0	5.5	141.8	0.1	0.9	0.4	0.0	1.6	0.4	3.8	0.6	3.6	0.0	0.0	0.2	1.5	0.2	0.7	2.6	2.8	0.0	0.1	3.9	0.2	3.9	13.5	0.3	0.7	0.0	9.5	1.9	0.2	0.3	1.9	1.8	2.8	0.3	28.9	5.2	0.0	0.4	1.7	0.1	0.0	1.5	1.5	0.1	1.2	0.7	254.4	0.0	4.8	0.6	0.0	0.3	0.2	0.3	0.8	1.4	0.0	0.2	1.0
CARD9		ENSG00000187796	"Caspase recruitment domain family member 9"	Q9H257	9	136361903-136373681	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.0;lymphoid tissue: 9.9"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 14.1;Hofbauer cells: 21.2;Horizontal cells: 15.2;Kupffer cells: 18.8;Langerhans cells: 12.9;Macrophages: 22.3;monocytes: 16.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 57.6;non-classical monocyte: 50.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 22.5;HMC-1: 69.7;NB-4: 50.0;THP-1: 63.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA059502	Enhanced					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA059502: AB_2684042"	"unprognostic (7.03e-2)"	"unprognostic (5.61e-2)"	"unprognostic (8.62e-3)"	"unprognostic (2.06e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.89e-3)"	"unprognostic (6.36e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.55e-2)"	"unprognostic (7.68e-3)"	"unprognostic (6.97e-2)"	"unprognostic (2.02e-6)"	"unprognostic (2.52e-1)"	"unprognostic (4.87e-3)"	"unprognostic (3.06e-1)"	"unprognostic (1.06e-1)"	1.2	1.3	0.5	4.7	0.5	13.0	1.2	2.5	1.0	2.0	0.3	1.0	1.3	0.8	0.4	1.0	1.8	1.0	0.5	0.5	0.7	1.0	0.9	3.4	1.2	1.9	0.9	0.3	0.5	0.1	0.8	0.9	1.3	1.8	0.4	0.2	1.1	1.0	0.2	2.7	1.8	1.1	1.4	9.9	0.6	0.4	1.1	0.4	0.4	0.0	1.5	1.2	1.1	1.7	0.1	0.0	0.3	0.0	0.0	0.0	4.6	9.5	0.3	0.2	0.0	0.7	0.0	0.0	0.1	3.5	0.0	0.0	0.3	0.0	0.1	0.0	0.2	22.5	0.1	6.8	4.9	12.2	69.7	0.0	0.1	0.2	0.2	0.0	0.1	0.0	5.3	0.0	0.0	0.2	0.0	50.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	12.3	0.0	16.0	0.1	0.0	4.1	63.7	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.1	16.0	0.0	6.9	34.5	11.5	0.0	57.6	0.9	0.0	0.0	0.0	26.0	0.0	0.0	0.0	2.3	0.7	50.5	0.1	0.5	14.1	0.5	0.5	2.5	1.0	0.5	0.7	1.9	0.9	1.3	1.4	1.1	1.7	0.8	0.0	4.6	4.6	1.1	1.8	0.6	0.3	3.4	0.2	4.2	4.3	2.6	0.0	4.9	3.7	0.0	0.4	2.2	0.4	1.9	0.1	1.0	1.2	14.1	1.1	0.0	2.5	2.1	0.0	0.4	2.1	1.5	1.4	10.8	0.4	0.7	0.1	21.2	15.2	1.1	0.0	0.0	18.8	12.9	6.9	0.3	22.3	1.8	6.5	16.3	4.6	3.1	0.0	0.2	0.0	0.1	0.0	1.4	0.1	0.0	0.3	0.6	0.9	0.0	0.3	1.5	1.0	1.5	0.9	1.7	0.4	1.4	0.2	0.2	0.6
CD209	"CDSIGN, CLEC4L, DC-SIGN, DC-SIGN1"	ENSG00000090659	"CD209 molecule"	Q9NNX6	19	7739993-7747564	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Cell adhesion, Endocytosis, Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 34.2;placenta: 22.8"	"Group enriched"	"Detected in some"	4	"Kupffer cells: 15.6;Langerhans cells: 14.7;Macrophages: 12.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"classical monocyte: 1.4;intermediate monocyte: 1.4;myeloid DC: 1.2"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.2;monocytes: 1.4"	"Cell line enriched"	"Detected in single"	14	"THP-1: 3.3"									"CAB032436, CAB033831"	Supported				"Intracellular and membrane"	NA	NA		3100000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 19: Lung - Lung function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"CAB032436: AB_639039, CAB033831: AB_1121347"	"unprognostic (2.76e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.36e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.45e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.65e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (1.15e-5)"	"unprognostic (1.70e-1)"	"unprognostic (5.51e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.09e-1)"	34.2	3.9	0.3	8.6	0.6	0.4	4.4	1.3	3.0	4.0	5.7	10.5	14.3	1.4	1.0	4.8	2.5	8.6	4.5	0.3	0.7	2.1	3.3	4.9	18.1	1.0	0.6	1.0	1.0	0.8	0.7	22.8	0.8	0.8	13.9	0.1	2.1	1.9	0.9	1.4	19.3	10.6	0.9	2.4	4.1	2.1	0.6	5.4	1.4	1.5	2.3	20.2	0.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.0	1.4	0.0	0.1	0.0	0.0	1.2	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.4	0.3	0.6	1.3	3.0	0.3	0.7	1.0	0.6	0.8	0.9	0.6	0.8	0.3	0.0	0.0	0.0	0.4	0.5	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	1.3	0.0	0.0	0.1	3.5	0.0	0.0	0.0	0.0	15.6	14.7	0.3	0.0	12.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.1	0.9	0.1	0.1	0.0	0.0	0.1
CD84	"hCD84, mCD84, SLAMF5"	ENSG00000066294	"CD84 molecule"	Q9UIB8	1	160541095-160579516	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Autophagy, Cell adhesion, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 24.2"	"Cell type enhanced"	"Detected in many"		"granulocytes: 187.1;Hofbauer cells: 91.1;Kupffer cells: 177.0;Macrophages: 90.6;monocytes: 76.4;T-cells: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 23.8;HEL: 45.3;HL-60: 13.1;HMC-1: 49.7;MOLT-4: 12.9;U-698: 30.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063316, HPA068020, HPA070502"	Enhanced		Enhanced	"Vesicles,Plasma membrane"		NA	NA		35000000	"Cluster 46: Basophils - DNA binding"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"	Vesicles	"HPA063316: , HPA068020: , HPA070502: AB_2686274"	"unprognostic (4.38e-2)"	"unprognostic (6.16e-3)"	"unprognostic (1.00e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.84e-1)"	"unprognostic (2.54e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.80e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.08e-1)"	3.3	2.4	1.9	19.4	2.1	7.9	2.7	2.3	2.4	2.8	1.9	3.2	2.4	1.4	0.9	2.2	1.1	6.2	1.4	1.7	1.9	0.8	5.2	7.8	24.2	5.2	3.1	1.5	2.0	0.9	0.4	7.1	4.5	1.1	4.5	0.2	1.4	3.4	0.4	1.3	4.6	4.0	3.8	15.2	3.6	1.9	5.2	9.9	1.1	0.7	13.2	4.7	0.8	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	45.3	0.1	0.0	0.0	13.1	49.7	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.9	0.1	0.0	0.0	12.9	9.7	0.0	0.0	0.0	0.4	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	30.8	0.0	2.9	0.0	32.7	9.6	15.0	8.2	8.0	6.5	6.3	7.0	10.1	7.1	6.0	4.0	7.4	1.2	1.4	3.2	4.1	10.5	8.8	1.9	2.1	2.3	2.4	1.7	1.9	5.2	3.1	4.5	3.8	5.2	7.2	1.3	0.0	6.4	0.0	27.4	2.4	0.7	0.0	0.6	0.2	0.6	1.5	1.2	2.8	1.3	0.0	0.0	0.5	20.5	0.2	0.0	0.1	0.9	0.5	0.2	4.2	0.0	21.5	0.1	0.2	0.5	1.2	2.6	0.2	187.1	0.1	3.3	1.1	91.1	0.0	0.2	0.1	0.0	177.0	42.2	1.5	0.6	90.6	5.4	34.7	76.4	0.0	4.1	0.0	0.1	0.0	0.0	0.0	10.8	0.9	0.3	0.3	0.7	0.2	0.0	1.6	1.5	0.1	0.4	0.5	2.4	1.0	46.8	2.9	0.2	0.6
CEP55	"C10orf3, CT111, FLJ10540"	ENSG00000138180	"Centrosomal protein 55"	Q53EZ4	10	93496612-93529092	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 27.4;testis: 21.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 29.4;Extravillous trophoblasts: 17.1;Granulosa cells: 19.8;Spermatocytes: 77.3;Spermatogonia: 17.3"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	8	"T-reg: 1.3"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA023430	Approved		Approved	"Plasma membrane,Midbody,Centriolar satellite"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Centriolar satellite"	Midbody	"HPA023430: AB_10960212"	"unprognostic (9.85e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.26e-2)"	"prognostic unfavorable (3.20e-9)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (2.66e-5)"	"unprognostic (3.99e-2)"	"prognostic unfavorable (0.00e+0)"	"prognostic favorable (3.15e-4)"	"unprognostic (7.86e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-1)"	1.3	0.6	0.0	7.6	0.0	5.0	1.4	0.0	0.2	1.7	0.0	7.0	6.7	1.4	0.1	7.3	0.4	1.4	0.3	0.0	0.1	0.3	0.6	1.3	14.7	0.1	0.3	0.2	0.2	0.2	0.3	3.5	0.2	0.3	8.8	0.0	1.2	0.3	0.1	4.5	6.3	5.2	0.0	2.4	4.6	21.7	0.4	27.4	0.5	0.2	15.5	3.1	2.3	0.1	208.5	81.5	53.0	67.7	5.8	12.0	29.6	112.4	78.2	103.5	106.4	87.2	108.6	55.4	48.2	72.8	69.6	115.4	64.8	54.8	123.4	167.2	33.7	21.0	49.2	29.9	0.6	36.3	46.3	2.8	3.8	110.6	133.5	30.7	97.1	89.9	19.3	101.8	118.5	48.3	96.3	54.8	20.9	64.2	58.8	41.3	86.9	30.3	47.1	25.5	21.7	30.7	86.3	26.3	64.9	40.1	68.9	36.4	61.4	65.3	90.6	90.5	186.7	45.1	66.1	66.8	51.0	134.8	59.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.3	0.2	0.0	0.4	0.1	0.2	0.0	1.3	0.0	2.7	3.6	0.9	1.9	0.0	0.0	1.8	2.0	0.4	2.8	0.2	0.0	0.0	7.7	0.9	3.3	0.0	0.6	29.4	1.7	2.0	1.5	0.0	2.5	0.5	0.2	17.1	2.3	8.2	3.6	0.0	19.8	2.2	0.3	12.9	0.0	0.3	4.5	4.1	7.0	5.1	8.2	0.3	5.1	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.3	0.0	0.4	14.8	1.1	0.4	0.0	0.2	0.0	0.0	0.5	4.5	77.3	17.3	16.1	1.3	1.5	4.3	1.6	7.9	1.7
CHID1	"FLJ42707, MGC3234, SI-CLP"	ENSG00000177830	"Chitinase domain containing 1"	Q9BWS9	11	867859-915058	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 404.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039374	Uncertain		Uncertain	"Nucleoplasm,Intermediate filaments"	"Intracellular and membrane"	No	No		1500000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Intermediate filaments"		"HPA039374: AB_10673609"	"unprognostic (1.85e-1)"	"unprognostic (2.19e-1)"	"unprognostic (8.96e-2)"	"prognostic favorable (6.76e-4)"	"unprognostic (4.82e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.62e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.53e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.89e-2)"	43.9	63.3	43.1	22.7	44.1	46.2	40.2	41.0	51.7	44.5	60.0	34.2	30.9	38.0	89.5	34.8	63.5	41.3	54.4	44.1	47.2	52.5	85.8	30.9	27.2	42.9	42.9	58.0	149.9	46.1	62.8	42.7	42.5	42.3	29.7	25.2	82.2	41.3	37.0	34.9	27.7	35.7	42.6	71.6	47.1	74.1	45.7	20.1	47.3	31.1	20.2	34.3	35.3	47.0	75.6	71.7	53.2	131.6	203.3	107.5	90.1	83.2	97.0	78.8	76.7	78.7	214.6	61.1	75.1	121.7	78.4	145.2	53.1	95.9	57.3	53.7	131.9	44.1	25.9	75.1	92.6	102.9	37.4	104.1	59.2	53.9	77.2	130.3	67.2	76.6	81.2	152.6	55.8	52.9	58.4	134.0	47.2	141.6	107.3	49.0	50.9	111.8	57.5	21.5	101.8	84.5	90.3	124.0	78.4	53.0	50.4	156.8	66.6	89.6	38.9	25.3	68.3	88.9	81.4	36.0	100.2	88.6	71.7	21.1	50.4	19.2	34.7	45.0	37.1	45.7	33.2	36.8	74.0	32.1	34.9	35.3	6.2	43.4	45.6	69.6	32.4	46.0	43.1	44.1	41.0	51.7	44.1	47.2	42.9	42.9	42.5	42.6	45.7	47.0	33.0	41.7	36.7	4.2	28.6	22.8	62.2	78.9	22.2	38.5	69.9	75.7	25.6	51.5	49.0	53.3	18.8	121.3	34.4	25.2	72.4	62.3	120.9	44.0	44.4	31.5	53.3	56.4	7.8	58.3	79.7	69.6	20.9	36.8	29.2	107.6	50.0	91.2	81.1	30.3	7.8	42.8	57.0	66.6	24.7	404.8	62.7	34.0	55.2	1.9	35.2	60.6	20.6	6.0	6.8	38.0	43.2	58.3	123.7	86.5	71.5	85.1	45.7	53.2	52.6	45.9	41.7	208.3	139.9	37.2	23.3	91.5	19.2	85.4	59.9	62.6
CLEC4G	"LSECtin, UNQ431"	ENSG00000182566	"C-type lectin domain family 4 member G"	Q6UXB4	19	7728958-7733906	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 14.9;liver: 53.3;lymphoid tissue: 15.1"	"Cell type enriched"	"Detected in some"	15	"Hepatic stellate cells: 730.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 18.8;myeloid DC: 15.1"	"Group enriched"	"Detected in many"	4	"dendritic cells: 15.1;monocytes: 18.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB003789, HPA014044"	Enhanced					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"		"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB003789: , HPA014044: AB_1846916"	"unprognostic (7.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.64e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.29e-2)"	"unprognostic (7.45e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.13e-8)"	"unprognostic (5.21e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.65e-2)"	14.9	0.5	1.9	2.4	1.9	1.2	2.6	4.0	2.9	0.1	2.0	1.4	0.4	0.1	0.3	0.4	4.8	1.6	1.2	2.5	1.9	0.5	53.3	1.0	15.1	2.3	2.1	0.5	0.3	0.0	0.1	1.0	2.1	0.3	0.9	0.0	1.1	0.3	0.4	1.1	2.0	1.0	2.1	3.4	0.9	0.4	4.3	0.2	0.5	0.0	0.3	7.7	0.4	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	18.8	0.0	0.0	4.2	0.0	0.3	0.0	0.0	15.1	4.2	0.1	0.0	0.4	0.5	0.5	0.7	0.0	4.5	1.9	1.9	4.0	2.9	2.5	1.9	2.3	2.1	2.1	2.1	4.3	2.1	0.1	0.0	0.0	0.3	3.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	7.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.0	0.0	18.7	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	730.3	7.1	0.8	0.0	1.1	0.0	0.0	46.7	2.9	0.0	0.3	2.6	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.7	0.0	0.3	0.3	1.1	0.8	0.0	0.1
COMMD9	"FLJ31106, HSPC166"	ENSG00000110442	"COMM domain containing 9"	Q9P000	11	36269284-36289449	"Predicted intracellular proteins"	"Ion transport, Sodium transport, Transcription, Transcription regulation, Transport, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 105.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009142	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA009142: AB_1847105"	"unprognostic (1.56e-2)"	"unprognostic (4.75e-3)"	"unprognostic (7.57e-2)"	"unprognostic (4.40e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.16e-3)"	"unprognostic (2.62e-1)"	"unprognostic (6.15e-2)"	"prognostic favorable (8.54e-4)"	"unprognostic (4.94e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.08e-3)"	"unprognostic (7.24e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.31e-3)"	"unprognostic (1.88e-1)"	26.8	32.1	33.8	21.8	34.1	50.8	24.3	35.1	36.7	17.2	29.6	19.6	21.1	14.1	25.1	24.9	20.3	20.5	31.1	33.8	33.8	38.7	36.6	26.8	26.0	34.2	34.4	19.4	26.4	27.4	23.2	24.8	33.9	14.0	24.2	20.3	21.9	13.3	64.2	27.1	20.2	21.9	36.9	26.8	19.7	14.9	36.0	30.6	25.1	61.7	32.0	20.6	16.6	39.1	28.8	33.4	36.1	38.2	54.5	37.8	20.0	33.6	42.6	74.7	69.8	27.3	23.9	33.0	32.5	67.1	57.5	41.4	64.0	45.2	69.6	39.9	75.2	18.2	57.6	48.0	51.0	71.6	52.3	48.0	49.5	40.9	25.0	38.5	62.2	43.3	45.7	34.7	59.4	36.9	47.9	49.6	38.5	55.6	70.3	52.1	81.7	38.9	78.6	26.6	44.1	49.2	47.9	47.1	43.6	29.2	102.7	27.0	41.9	45.0	34.4	107.9	49.8	24.3	53.2	37.2	51.8	66.4	44.0	85.6	376.6	173.7	91.4	359.0	86.8	130.7	87.5	88.4	383.6	138.3	99.8	83.4	42.7	94.8	300.9	145.8	114.5	315.2	33.8	34.1	35.1	36.7	33.8	33.8	34.2	34.4	33.9	36.9	36.0	39.1	26.9	22.4	29.4	2.6	27.0	15.3	12.7	37.4	13.1	16.6	25.6	38.7	29.9	12.8	20.2	18.4	10.4	43.2	28.3	16.9	78.2	70.1	9.5	13.2	20.3	22.8	25.7	23.1	9.4	46.4	52.9	21.2	11.7	17.0	19.0	25.6	15.4	17.1	105.1	5.0	8.7	20.4	34.6	59.5	35.6	28.9	17.7	57.5	24.9	1.9	61.3	36.3	33.0	4.5	8.8	46.5	17.7	11.7	10.4	4.9	30.3	62.5	8.5	22.9	13.1	12.3	22.8	32.8	33.3	19.6	21.6	24.9	19.2	28.4	24.6	12.0
CORO1A	"coronin-1, HCORO1, p57"	ENSG00000102879	"Coronin 1A"	P31146	16	30182827-30189076	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 568.8;lymphoid tissue: 583.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 523.9;dendritic cells: 588.7;Hofbauer cells: 494.4;Kupffer cells: 395.8;Macrophages: 342.7;monocytes: 583.7;NK-cells: 968.1;T-cells: 663.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 924.0;HL-60: 645.7;HMC-1: 1086.7;JURKAT: 603.0;MOLT-4: 632.5;NB-4: 771.8;RPMI-8226: 980.9;U-698: 618.2;U-937: 829.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046473, HPA051132"	Enhanced		Approved	Cytosol		NA	NA		45000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB046473: AB_10602363, HPA051132: AB_2681355"	"unprognostic (4.17e-3)"	"unprognostic (3.64e-3)"	"unprognostic (3.86e-2)"	"prognostic favorable (6.91e-4)"	"unprognostic (2.41e-1)"	"prognostic favorable (4.42e-4)"	"unprognostic (1.99e-2)"	"unprognostic (8.27e-3)"	"unprognostic (8.26e-3)"	"unprognostic (4.30e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (5.74e-7)"	"unprognostic (2.55e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.01e-1)"	29.1	20.8	34.4	306.4	37.1	568.8	11.2	24.9	52.0	10.6	23.6	26.8	44.3	10.0	3.1	22.5	17.9	45.0	11.3	36.9	31.9	11.5	13.1	49.5	583.8	37.6	32.0	6.4	8.4	4.3	9.3	18.4	32.2	11.4	15.3	0.9	32.9	7.3	6.7	17.6	111.0	22.2	35.8	321.4	49.0	4.8	33.9	257.6	12.7	8.8	309.1	57.6	10.4	50.0	3.1	3.6	10.9	21.5	0.1	0.1	6.1	2.6	0.7	5.4	3.0	0.7	6.9	924.0	6.1	0.9	1.5	4.4	5.2	10.8	1.3	302.3	2.5	97.9	0.5	15.0	1.7	645.7	1086.7	2.8	0.0	4.3	0.5	0.4	2.0	603.0	1.5	467.6	3.4	80.7	632.5	771.8	4.0	3.1	6.4	340.0	17.5	980.9	1.3	5.1	17.3	13.0	2.2	110.7	2.0	0.2	1.9	373.0	1.6	4.0	9.0	2.7	3.1	348.5	497.7	618.2	3.0	829.6	6.3	797.2	773.6	2671.1	637.5	859.7	597.8	505.5	567.3	625.6	843.2	512.0	537.1	566.2	1318.9	531.0	898.0	482.1	858.7	1647.2	34.4	37.1	24.9	52.0	36.9	31.9	37.6	32.0	32.2	35.8	33.9	50.0	6.3	22.4	32.5	0.3	523.9	11.3	1.2	3.2	2.2	1.2	4.7	5.5	1.5	17.2	6.0	1.8	0.0	4.6	588.7	2.3	0.0	3.5	0.5	1.1	2.0	12.3	6.0	60.2	3.3	0.9	17.4	9.5	18.8	1.3	83.7	0.6	21.8	4.8	494.4	0.0	1.7	2.2	6.1	395.8	197.9	1.2	0.6	342.7	32.0	4.7	583.7	0.8	968.1	1.5	0.4	11.1	47.5	0.0	201.4	0.8	1.0	4.8	3.5	0.9	6.6	2.9	5.1	0.1	0.9	2.4	9.1	4.9	663.0	2.7	3.3	0.9
CPVL		ENSG00000106066	"Carboxypeptidase vitellogenic like"	Q9H3G5	7	28995235-29195451	"Enzymes, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 219.0"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 306.1;Kupffer cells: 290.3;Langerhans cells: 531.0;Macrophages: 266.2;monocytes: 176.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 61.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 1136.9;intermediate monocyte: 953.5;myeloid DC: 1319.5"	"Group enriched"	"Detected in all"	52	"dendritic cells: 1319.5;monocytes: 1136.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 190.8;RPTEC TERT1: 801.1;U-266/84: 205.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB003697, HPA045715, HPA056466"	Enhanced		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		760000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 41: Macrophages - Immune response"	"Endoplasmic reticulum"		"CAB003697: AB_425990, HPA045715: AB_2679429, HPA056466: AB_2683140"	"unprognostic (4.72e-2)"	"unprognostic (7.08e-2)"	"unprognostic (5.96e-2)"	"prognostic unfavorable (8.56e-6)"	"unprognostic (1.63e-1)"	"unprognostic (2.49e-2)"	"unprognostic (6.85e-3)"	"unprognostic (7.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.07e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.21e-1)"	"unprognostic (7.46e-3)"	"prognostic unfavorable (4.99e-4)"	44.0	23.5	7.5	66.3	8.7	59.8	24.9	48.9	12.0	28.5	39.6	28.9	32.8	17.1	34.6	25.4	19.8	42.1	79.3	6.8	9.9	96.7	52.9	57.6	92.9	15.2	11.4	18.1	7.9	5.4	10.1	84.9	15.4	17.9	25.7	0.9	5.3	21.3	12.5	19.3	46.5	34.1	11.8	219.0	15.5	34.4	8.8	66.7	128.4	8.3	35.8	50.6	15.8	23.4	1.5	0.2	20.3	0.1	0.1	0.0	190.8	0.0	0.0	1.9	0.4	59.8	0.1	0.0	90.3	0.8	94.4	3.2	51.8	4.2	0.6	0.4	47.9	67.0	1.2	144.5	0.0	0.0	0.3	0.3	5.9	0.7	1.6	0.0	0.6	27.5	45.5	0.1	1.6	0.0	63.4	0.4	31.6	0.1	16.0	0.3	0.0	0.6	801.1	22.8	11.9	9.4	53.6	125.5	101.7	97.0	15.1	49.6	0.0	0.4	0.8	0.5	12.0	17.5	205.5	1.0	0.2	25.0	20.8	19.5	1136.9	5.7	2.6	953.5	3.4	1.8	1.3	1.9	1319.5	1.2	1.2	1.2	23.4	5.8	327.8	34.8	1.5	1142.7	7.5	8.7	48.9	12.0	6.8	9.9	15.2	11.4	15.4	11.8	8.8	23.4	12.3	6.4	16.0	3.3	7.2	12.5	1.3	0.7	5.7	0.0	2.6	3.4	69.1	10.0	2.5	71.7	0.0	138.0	2.1	0.2	35.2	0.5	24.7	3.7	0.3	21.1	1.8	34.1	3.7	15.6	118.3	29.4	1.1	0.6	5.1	2.3	6.8	1.1	306.1	0.0	1.7	1.2	0.0	290.3	531.0	7.6	9.3	266.2	10.6	45.9	176.8	0.2	2.1	2.0	1.3	0.8	0.4	3.0	2.9	0.5	0.4	30.6	1.5	0.4	0.0	31.0	3.0	27.1	92.8	27.2	8.8	118.5	3.3	3.6	1.2	0.9
CREG1	CREG	ENSG00000143162	"Cellular repressor of E1A stimulated genes 1"	O75629	1	167529117-167553805	"Predicted secreted proteins"	"Growth regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 545.7;Kupffer cells: 559.7;monocytes: 322.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 55.4;classical monocyte: 128.4;eosinophil: 75.7;intermediate monocyte: 75.7;myeloid DC: 89.9;neutrophil: 43.7;non-classical monocyte: 72.3"	"Group enriched"	"Detected in all"	6	"dendritic cells: 89.9;granulocytes: 75.7;monocytes: 128.4"	"Cell line enhanced"	"Detected in all"		"RPMI-8226: 1237.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056390			Approved	Vesicles,Microtubules	"Secreted to blood"	NA	NA		520000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Microtubules	Vesicles	"HPA056390: AB_2683113"	"unprognostic (3.25e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.91e-1)"	"unprognostic (9.65e-3)"	"unprognostic (4.64e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.02e-2)"	"unprognostic (2.07e-3)"	"unprognostic (8.54e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.24e-3)"	"unprognostic (2.99e-1)"	"unprognostic (4.63e-2)"	"unprognostic (3.78e-3)"	"unprognostic (3.16e-1)"	130.5	127.7	37.5	79.0	41.1	125.9	109.7	39.0	45.9	76.8	47.8	77.1	60.3	61.8	109.7	91.7	70.9	128.2	82.2	36.5	40.4	132.1	295.2	99.1	98.9	46.0	39.1	84.2	70.7	75.4	64.8	110.8	44.4	62.9	82.7	80.0	104.5	74.6	71.4	109.8	63.0	77.9	45.7	136.9	61.4	50.1	49.3	35.5	125.8	78.2	63.5	116.3	63.3	61.2	93.5	41.5	21.1	43.5	325.8	89.8	53.0	39.2	17.8	30.7	39.8	67.8	104.4	101.7	112.2	43.6	57.2	143.3	24.3	84.9	20.9	140.3	82.3	41.5	31.1	37.9	111.5	93.6	295.2	94.5	250.5	35.6	38.7	42.7	10.3	35.9	218.5	405.0	42.6	39.2	19.6	95.9	22.8	214.0	63.9	32.5	58.8	1237.2	54.7	64.9	14.0	25.7	98.1	132.8	112.8	70.1	175.5	252.7	19.1	8.0	39.6	126.2	25.9	79.4	168.4	67.7	131.6	96.0	16.3	55.4	128.4	75.7	5.1	75.7	8.0	4.3	7.5	6.5	89.9	2.1	16.6	8.8	43.7	11.0	72.3	6.2	3.9	57.6	37.5	41.1	39.0	45.9	36.5	40.4	46.0	39.1	44.4	45.7	49.3	61.2	44.7	35.3	90.1	5.9	15.3	44.1	49.1	23.1	56.9	17.9	61.7	63.8	55.7	65.8	32.2	55.2	89.6	91.5	18.3	15.6	23.5	36.0	27.6	33.9	19.3	34.2	29.3	124.8	24.7	39.7	41.7	78.4	21.9	64.1	29.9	62.0	48.2	90.3	545.7	15.2	22.1	44.5	14.2	559.7	57.6	27.4	43.5	213.8	24.9	26.2	322.8	30.5	6.2	10.1	14.6	21.0	31.5	28.6	27.8	34.0	46.3	60.6	18.5	31.5	13.1	43.2	40.8	65.5	42.0	86.3	51.1	126.7	17.3	38.9	50.4	44.0
CSF1R	"C-FMS, CD115, CSFR, FMS"	ENSG00000182578	"Colony stimulating factor 1 receptor"	P07333	5	150053291-150113372	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Immunity, Inflammatory response, Innate immunity"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Neurodegeneration, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 113.3;placenta: 103.3"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 103.2;Hofbauer cells: 340.4;Kupffer cells: 291.2;Langerhans cells: 73.4;Macrophages: 196.3;Microglial cells: 134.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 444.6;non-classical monocyte: 646.9"	"Lineage enriched"	"Detected in many"	5	"monocytes: 646.9"	"Group enriched"	"Detected in some"	4	"BEWO: 123.0;SK-BR-3: 47.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008970, HPA012323"	Uncertain		Supported	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		1600000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 4: Macrophages - Innate immune response"	"Vesicles, Plasma membrane"		"CAB008970: , HPA012323: AB_1848977"	"unprognostic (3.82e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-3)"	"unprognostic (9.83e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (3.67e-2)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (1.72e-2)"	"unprognostic (4.61e-2)"	51.3	31.0	19.6	75.1	17.1	5.6	19.3	20.2	21.4	21.6	19.3	21.9	24.3	12.1	5.8	21.0	17.2	40.6	16.6	19.8	33.8	7.1	27.5	36.6	54.4	41.4	35.5	12.7	9.9	11.8	5.7	103.3	40.1	9.1	21.5	1.5	10.1	20.8	3.2	13.4	37.3	41.9	36.6	113.3	21.0	7.0	40.6	14.3	6.0	11.8	21.7	42.6	3.8	67.6	4.5	0.2	0.0	0.0	1.9	0.4	123.0	0.2	0.2	0.0	0.0	3.8	0.0	5.9	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.2	1.1	3.0	0.0	6.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	6.1	0.1	0.0	0.0	0.0	1.9	0.6	0.0	0.0	0.2	0.2	0.0	47.8	0.0	1.9	0.0	20.7	0.0	0.8	0.2	0.1	3.3	0.0	0.3	0.1	6.6	2.6	0.0	3.0	138.4	4.0	0.6	444.6	0.6	0.3	0.2	0.4	139.0	0.2	0.3	0.2	21.6	0.2	646.9	11.1	0.5	132.7	19.6	17.1	20.2	21.4	19.8	33.8	41.4	35.5	40.1	36.6	40.6	67.6	2.0	0.0	3.8	0.0	4.3	2.8	0.0	0.0	1.2	0.0	0.5	2.3	3.1	4.3	0.0	0.0	0.0	6.2	2.8	0.0	0.0	0.0	4.8	0.0	0.1	10.5	0.0	2.5	0.4	0.0	103.2	2.2	1.5	0.2	2.5	8.3	2.9	1.5	340.4	0.0	0.5	0.3	0.0	291.2	73.4	5.4	1.8	196.3	3.6	134.9	39.4	0.0	1.0	1.5	0.3	0.1	1.7	0.0	1.0	0.0	0.0	0.1	0.7	0.5	13.1	1.2	2.0	2.2	0.2	0.4	1.3	26.4	1.3	2.2	0.2	0.0
CTDNEP1	"DULLARD, HSA011916, NET56"	ENSG00000175826	"CTD nuclear envelope phosphatase 1"	O95476	17	7243591-7252491	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 410.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037439, HPA066466"	Uncertain		Approved	"Lipid droplets"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	"Lipid droplets"		"HPA037439: AB_10601264, HPA066466: AB_2732745"	"unprognostic (7.11e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.33e-2)"	"prognostic favorable (6.45e-4)"	"unprognostic (3.12e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.98e-1)"	"unprognostic (9.90e-2)"	"prognostic favorable (1.81e-4)"	"unprognostic (3.37e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.43e-1)"	"unprognostic (9.97e-2)"	"unprognostic (2.02e-2)"	99.7	94.2	53.0	41.4	52.5	48.8	91.4	49.2	55.1	102.4	51.2	89.8	36.4	97.6	37.1	105.2	88.2	32.1	119.0	49.9	49.0	85.5	69.1	91.6	45.9	55.9	52.7	103.4	98.5	44.4	83.8	41.1	51.2	81.8	46.7	29.7	82.6	33.6	410.0	114.7	93.8	45.0	50.5	115.9	95.4	66.5	55.8	56.2	81.2	179.2	61.8	88.2	87.0	52.8	86.2	123.9	68.4	73.7	105.0	128.0	52.5	62.4	102.8	97.4	83.1	59.6	57.7	80.6	65.6	111.5	68.6	70.5	90.8	95.4	108.6	118.5	74.6	55.2	79.7	104.1	96.5	63.3	100.3	103.4	113.8	111.9	118.3	99.9	105.2	76.2	50.9	56.3	93.3	53.4	77.3	67.0	48.3	75.7	50.9	85.3	61.3	62.6	77.9	44.1	26.3	75.5	49.8	48.9	69.8	67.6	46.3	51.5	61.6	70.9	61.3	57.5	119.4	49.2	46.0	40.6	91.5	85.8	75.1	4.2	6.3	11.0	5.5	6.7	4.4	7.8	5.2	5.9	4.6	7.4	4.0	5.9	8.4	4.1	4.5	9.7	5.7	2.3	53.0	52.5	49.2	55.1	49.9	49.0	55.9	52.7	51.2	50.5	55.8	52.8	48.0	25.6	23.2	12.7	47.1	47.2	42.4	36.1	19.9	44.8	73.9	70.1	13.1	37.1	33.5	40.5	22.9	66.1	68.3	84.5	11.7	63.7	4.8	50.0	59.9	47.2	73.7	18.5	14.7	85.2	129.9	43.5	22.4	68.5	20.3	71.3	44.6	35.6	90.6	30.3	17.0	79.6	22.4	104.4	62.2	7.9	57.8	69.8	28.4	14.0	69.2	47.9	59.8	11.6	21.9	84.5	52.1	47.0	41.3	58.3	62.8	34.8	25.8	35.4	26.3	42.5	51.4	23.7	35.5	32.5	67.1	83.2	41.3	68.3	69.6	61.8
CYB561D2	"101F6, TSP10"	ENSG00000114395	"Cytochrome b561 family member D2"	O14569	3	50350845-50358460	"Enzymes, Predicted membrane proteins"	"Electron transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071862	Approved					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA071862: "	"unprognostic (4.89e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.98e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.28e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.41e-2)"	"prognostic favorable (1.86e-4)"	"unprognostic (3.26e-1)"	"prognostic favorable (6.16e-5)"	"unprognostic (4.33e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.18e-1)"	"unprognostic (7.57e-2)"	13.3	20.7	8.1	16.7	9.8	22.0	13.9	9.7	9.2	10.6	10.5	19.7	22.0	7.6	25.8	14.6	9.7	14.6	10.1	8.3	8.6	19.8	34.3	14.1	22.2	9.8	9.6	7.0	19.5	18.2	13.8	11.1	9.8	16.3	18.0	3.1	20.3	11.5	10.0	9.8	22.7	7.1	9.6	24.7	21.7	10.5	9.2	13.2	20.3	3.5	15.3	12.3	9.3	11.3	16.2	33.5	8.4	15.8	17.2	14.7	19.2	27.4	20.4	24.5	28.0	24.1	25.3	25.3	29.3	33.8	29.8	16.5	12.8	25.2	10.7	38.5	31.9	23.7	40.7	22.5	24.2	26.3	52.3	23.0	11.3	29.3	13.5	12.4	21.1	19.1	10.5	32.3	19.7	30.3	17.0	22.9	13.4	24.6	52.1	11.6	5.8	50.2	26.3	27.0	8.4	23.7	13.7	56.1	17.5	8.4	19.8	30.9	23.1	22.5	18.9	37.6	35.8	24.6	26.2	16.8	30.2	32.1	24.4	145.8	113.9	176.1	144.3	140.1	95.6	88.4	96.1	115.7	86.3	79.3	67.1	99.6	110.8	109.3	136.2	89.0	114.7	112.4	8.1	9.8	9.7	9.2	8.3	8.6	9.8	9.6	9.8	9.6	9.2	11.3	13.3	6.4	21.7	5.5	24.4	5.0	12.0	37.4	8.6	6.8	26.5	12.3	0.0	0.0	30.9	25.8	6.2	35.0	40.2	47.1	11.7	44.9	19.9	19.7	14.7	9.1	31.8	6.7	6.7	68.1	46.0	13.0	31.1	18.4	21.5	8.4	0.0	0.0	57.3	8.4	5.8	47.0	46.8	0.0	12.3	9.1	8.7	29.1	19.6	6.5	36.2	22.2	45.3	6.0	13.3	43.3	49.4	7.9	36.7	17.9	55.6	22.3	38.4	8.2	13.1	8.0	15.6	6.1	14.1	14.0	7.4	55.1	32.9	15.9	28.1	18.4
CYRIB	"BM-009, CYRI, CYRI-B, FAM49B"	ENSG00000153310	"CYFIP related Rac1 interactor B"	Q9NUQ9	8	129839593-130017129	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 198.6"	"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 117.7;dendritic cells: 66.2;Extravillous trophoblasts: 158.5;Hofbauer cells: 239.7;Syncytiotrophoblasts: 60.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009076	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		1100000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA009076: AB_1848402"	"unprognostic (4.35e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (2.80e-2)"	"unprognostic (9.61e-3)"	"prognostic unfavorable (3.02e-6)"	"unprognostic (4.75e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.53e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.62e-1)"	"prognostic unfavorable (3.09e-10)"	"unprognostic (3.85e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.46e-1)"	41.3	26.3	24.8	97.4	37.9	198.6	25.9	29.9	46.1	13.5	23.1	31.1	30.3	15.9	21.1	29.4	15.3	30.7	18.4	28.3	32.2	22.9	26.5	39.0	119.7	35.9	33.1	11.4	15.9	17.8	17.6	42.0	34.9	14.8	35.8	28.5	18.2	13.1	25.8	19.0	42.3	28.8	35.7	83.6	28.6	29.9	33.6	79.2	28.5	24.3	105.1	50.6	14.1	49.9	167.5	87.7	93.6	52.9	8.2	12.1	124.2	49.4	47.8	67.2	71.4	50.9	111.8	165.5	105.9	32.6	53.3	81.2	78.2	130.6	100.3	349.1	54.5	166.4	44.6	57.7	31.9	109.2	137.1	19.3	60.1	45.3	93.9	54.9	60.2	132.0	121.2	186.3	74.5	74.5	372.0	80.3	79.8	130.4	119.7	160.1	63.3	278.3	138.4	67.4	62.1	81.2	99.2	61.9	152.5	84.1	72.4	139.0	37.5	24.7	158.5	52.8	106.8	61.5	195.7	275.1	38.8	233.5	65.3	350.7	212.5	404.4	161.6	256.2	124.7	122.7	91.2	134.0	280.9	98.7	80.1	132.3	553.9	189.6	232.8	179.8	136.7	306.0	24.8	37.9	29.9	46.1	28.3	32.2	35.9	33.1	34.9	35.7	33.6	49.9	8.4	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.9	0.0	0.0	0.0	0.0	117.7	66.2	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	158.5	6.5	0.0	0.0	0.0	0.0	0.0	0.0	239.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	60.5	8.4	0.0	0.0	0.0
EMILIN2	"FLJ33200, FOAP-10"	ENSG00000132205	"Elastin microfibril interfacer 2"	Q9BXX0	18	2847006-2916003	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 76.0"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 98.0;Hofbauer cells: 61.1;Kupffer cells: 52.9;Langerhans cells: 99.7;Macrophages: 97.5;monocytes: 51.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 5.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 48.2;BEWO: 37.8;HL-60: 37.8;HMC-1: 60.6;HSkMC: 26.1;SuSa: 25.7;THP-1: 36.7;U-2197: 46.7"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"spinal cord: 25.7"	HPA064576	Supported				"Secreted to extracellular matrix"	NA	NA		840000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"			"HPA064576: AB_2732717"	"unprognostic (1.31e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.91e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.98e-3)"	"unprognostic (9.91e-3)"	"prognostic unfavorable (6.30e-4)"	"unprognostic (2.01e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (1.49e-1)"	"unprognostic (3.15e-3)"	"unprognostic (3.72e-2)"	"unprognostic (2.96e-1)"	13.0	1.3	1.2	17.2	2.2	11.3	5.1	4.8	1.7	5.3	2.2	2.8	1.6	6.4	0.8	2.4	4.7	5.9	6.8	0.7	1.2	1.1	1.5	11.9	2.4	8.1	4.4	5.9	1.4	76.0	0.4	21.9	5.8	1.0	3.3	0.1	2.3	1.2	0.8	2.7	2.2	8.4	6.6	3.9	1.6	1.8	7.4	2.9	1.6	2.4	2.0	8.0	4.0	10.6	0.2	0.4	2.9	0.0	48.2	19.9	37.8	7.9	0.0	1.4	2.4	5.6	0.1	0.0	0.6	19.3	0.5	0.1	1.0	0.0	2.6	0.0	2.6	0.5	0.2	0.4	1.6	37.8	60.6	26.1	0.0	1.5	0.0	0.0	0.2	0.6	0.1	0.1	0.0	0.0	0.1	10.4	4.9	0.4	0.1	0.1	2.5	0.0	0.1	0.2	0.4	0.2	0.2	0.3	1.4	25.7	0.0	36.7	0.4	0.0	5.2	46.7	0.4	0.0	0.0	0.0	3.1	9.1	1.0	5.5	1.1	0.3	0.4	0.8	0.3	0.2	0.4	0.3	1.1	0.3	0.2	0.4	1.1	1.5	0.7	0.7	0.3	0.4	1.2	2.2	4.8	1.7	0.7	1.2	8.1	4.4	5.8	6.6	7.4	10.6	6.8	3.2	6.7	0.0	13.7	5.7	3.3	0.5	0.6	0.1	2.8	3.0	15.7	1.5	5.3	3.7	0.0	4.7	14.5	2.8	1.9	2.7	2.3	19.3	98.0	8.8	3.0	6.7	0.5	1.1	11.9	31.4	5.6	46.0	46.3	5.7	2.9	0.5	61.1	0.0	1.2	4.9	0.0	52.9	99.7	2.3	15.2	97.5	5.4	2.8	51.0	0.0	7.2	11.1	9.1	2.4	7.9	1.2	2.7	3.5	1.5	1.7	4.0	0.2	0.0	2.3	8.7	4.9	5.5	0.4	4.0	2.9	9.6	14.7	5.1	2.8
FCGRT	"alpha-chain, FCRN"	ENSG00000104870	"Fc fragment of IgG receptor and transporter"	P55899	19	49506816-49526428	"Predicted intracellular proteins, Predicted membrane proteins"		"IgG-binding protein, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 1362.6;Kupffer cells: 877.7;Paneth cells: 883.9;Proximal enterocytes: 1787.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 2346.7"	"Group enriched"	"Detected in all"	17	"dendritic cells: 922.9;granulocytes: 2346.7;monocytes: 1364.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 153.7;Hep G2: 144.0;OE19: 165.4;THP-1: 196.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012122, HPA015130"	Enhanced					NA	NA		24000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 4: Macrophages - Innate immune response"			"HPA012122: AB_1848474, HPA015130: AB_1848475"	"unprognostic (2.19e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.58e-2)"	"unprognostic (3.87e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.64e-1)"	"unprognostic (3.67e-3)"	"unprognostic (3.40e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.18e-3)"	263.1	127.7	67.7	99.6	73.3	147.3	198.8	68.0	102.5	217.2	111.1	209.6	304.4	143.1	48.8	60.2	155.5	144.6	123.0	66.3	75.1	177.6	401.6	177.5	143.3	74.0	69.5	193.2	129.4	114.5	79.8	137.5	74.3	104.6	149.3	4.8	106.2	94.7	64.4	112.3	299.3	91.6	73.6	318.9	126.6	28.3	78.8	62.9	111.9	77.8	39.1	136.7	132.0	78.2	0.4	37.1	4.3	123.7	153.7	78.2	6.0	32.1	73.4	20.9	22.9	50.5	22.5	0.2	59.4	45.9	10.8	8.5	1.2	1.1	11.7	0.3	45.5	74.2	0.6	144.0	95.8	1.1	14.2	95.1	1.9	17.5	0.2	86.5	81.3	48.0	12.2	10.9	53.7	0.8	0.6	14.3	2.1	165.4	22.0	2.6	35.3	3.7	96.0	9.3	2.6	23.1	5.6	0.2	4.5	18.3	26.5	196.1	28.1	52.8	11.8	0.9	1.3	2.4	13.5	9.8	10.8	70.2	7.9	566.8	1364.4	1011.5	24.7	904.8	29.8	58.0	39.8	39.7	922.9	62.5	89.4	51.0	2346.7	28.6	630.2	536.4	28.2	1276.9	67.7	73.3	68.0	102.5	66.3	75.1	74.0	69.5	74.3	73.6	78.8	78.2	479.6	67.3	89.3	21.2	44.2	126.1	130.4	130.7	52.9	0.7	125.5	151.3	30.7	158.7	79.9	73.5	4.2	12.7	83.8	652.3	60.7	86.3	6.5	29.1	89.6	259.2	158.1	55.8	0.2	61.6	24.9	269.9	108.6	24.8	70.5	181.2	587.6	343.9	1362.6	0.0	0.2	349.0	57.0	877.7	438.1	21.8	362.2	608.6	186.7	24.4	190.6	13.4	11.3	10.1	0.2	90.6	883.9	183.6	63.2	87.9	1787.7	329.5	53.4	5.2	216.9	149.2	105.6	21.1	17.6	27.7	107.1	20.7	32.4	129.9	565.1	115.4
FCHO1	KIAA0290	ENSG00000130475	"FCH and mu domain containing endocytic adaptor 1"	O14526	19	17747718-17788568	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 59.5;lymphoid tissue: 24.3;skin 1: 22.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 16.8;dendritic cells: 19.1;Oligodendrocytes: 46.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 62.4;RPMI-8226: 43.3;U-937: 38.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041653, HPA062981"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Cytosol	"HPA041653: AB_10795641, HPA062981: AB_2684915"	"unprognostic (3.02e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.54e-3)"	"unprognostic (3.62e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.93e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.72e-9)"	"unprognostic (3.76e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.21e-1)"	"unprognostic (9.77e-3)"	2.2	1.8	24.9	14.7	33.7	20.2	1.5	21.7	32.6	1.0	8.6	2.5	3.2	1.3	1.4	1.1	1.5	4.2	0.8	24.1	25.6	1.4	2.2	3.7	24.3	27.5	28.6	1.7	0.7	1.1	3.9	1.1	29.7	1.0	2.2	3.4	1.3	0.8	0.6	22.2	8.1	1.7	19.9	15.5	3.4	4.4	29.2	17.6	1.0	0.8	17.4	3.0	1.0	59.5	0.9	11.9	7.5	5.2	0.2	0.2	7.5	1.1	0.3	0.3	0.5	1.5	1.4	62.4	17.1	0.5	1.4	2.3	3.7	2.3	0.2	27.6	2.1	4.9	1.4	6.4	0.6	15.7	10.2	0.1	0.3	0.0	0.4	0.4	1.6	30.2	24.9	28.9	0.0	17.4	36.2	27.8	3.6	14.7	28.7	30.2	0.2	43.3	0.2	1.2	1.3	2.5	0.3	5.9	0.9	0.9	6.0	15.4	1.3	0.1	4.1	0.9	0.4	18.2	9.0	33.4	0.9	38.5	0.5	13.2	9.6	10.1	7.0	14.3	6.0	12.4	7.9	6.3	14.5	12.3	7.4	6.1	37.8	6.4	11.5	15.3	7.6	7.4	24.9	33.7	21.7	32.6	24.1	25.6	27.5	28.6	29.7	19.9	29.2	59.5	0.4	0.0	1.5	0.7	16.8	0.0	0.4	0.2	0.6	7.8	2.0	4.3	0.9	2.8	0.4	1.8	0.0	2.9	19.1	2.0	0.0	0.5	1.5	0.8	0.2	2.4	1.2	2.5	15.0	0.0	4.6	2.5	1.5	1.0	9.5	2.9	2.5	0.0	6.8	0.0	13.0	1.7	0.0	8.7	14.3	0.7	2.5	11.0	1.8	6.5	12.3	0.1	13.4	3.0	46.9	2.1	0.5	8.6	4.5	0.3	0.1	0.1	0.7	0.8	0.0	0.2	0.6	0.9	5.5	0.2	0.6	0.8	9.8	12.2	1.8	0.3
FUCA1		ENSG00000179163	"Alpha-L-fucosidase 1"	P04066	1	23845077-23868290	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 181.7;Distal enterocytes: 226.6;Paneth cells: 221.0;Proximal enterocytes: 210.9;Syncytiotrophoblasts: 200.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 165.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046542, HPA056371"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	NA	NA		60000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"HPA046542: AB_2679691, HPA056371: AB_2683108"	"unprognostic (6.94e-3)"	"unprognostic (6.53e-2)"	"unprognostic (2.68e-3)"	"prognostic favorable (2.45e-4)"	"unprognostic (5.64e-3)"	"unprognostic (2.59e-3)"	"unprognostic (1.56e-2)"	"unprognostic (1.79e-3)"	"unprognostic (4.99e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.23e-2)"	"prognostic favorable (5.70e-13)"	"unprognostic (3.75e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.13e-3)"	34.2	34.4	8.3	49.8	8.2	7.7	26.3	8.3	11.2	54.5	23.8	124.2	90.3	20.7	113.0	17.0	51.1	46.6	20.6	8.3	10.5	78.2	104.8	55.1	168.2	9.5	8.8	23.8	23.9	56.9	17.6	72.6	9.6	50.2	140.7	5.7	40.8	60.4	15.8	14.9	81.3	26.7	9.3	71.8	63.9	27.7	10.8	26.8	70.6	17.7	94.1	74.9	13.2	12.8	15.9	10.6	2.2	31.9	4.2	0.3	11.0	16.6	34.4	17.1	31.6	14.5	165.1	23.9	40.9	21.3	18.8	9.4	15.3	35.4	22.4	16.9	25.6	19.7	9.2	32.7	14.2	2.0	62.7	15.3	19.7	6.2	8.1	55.2	6.9	13.3	9.3	0.5	20.6	17.5	5.0	17.7	5.4	48.1	16.9	26.9	0.2	26.2	63.5	40.5	10.9	10.6	47.9	18.5	26.2	17.9	13.6	7.8	1.8	5.8	9.0	38.9	5.6	28.5	31.0	8.5	14.5	58.9	9.5	54.8	100.4	51.9	27.2	99.9	23.1	23.8	19.5	22.9	44.0	14.1	18.9	22.0	12.8	44.6	91.1	25.4	21.4	64.8	8.3	8.2	8.3	11.2	8.3	10.5	9.5	8.8	9.6	9.3	10.8	12.8	12.9	25.6	28.6	4.2	10.5	3.6	27.4	99.3	6.8	4.4	22.2	10.4	5.6	40.0	77.8	84.6	0.0	181.7	13.9	226.6	15.6	64.1	61.0	31.5	2.8	11.6	10.8	20.6	5.8	50.3	24.2	16.7	33.1	13.3	8.2	11.1	25.7	42.7	156.4	0.0	6.3	44.4	44.7	121.0	13.5	24.4	23.3	85.4	8.8	2.8	29.6	13.0	10.3	4.0	4.7	34.9	221.0	19.5	8.7	23.6	210.9	40.2	53.7	5.0	6.6	16.7	13.2	109.0	24.8	8.5	2.8	200.6	11.2	34.6	79.5	40.3
GALNT6	GalNAc-T6	ENSG00000139629	"Polypeptide N-acetylgalactosaminyltransferase 6"	Q8NCL4	12	51351247-51392867	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 62.6"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 49.2;Gastric mucus-secreting cells: 130.5;granulocytes: 164.5;Oligodendrocytes: 57.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 31.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 29.1"	"Group enriched"	"Detected in all"	4	"granulocytes: 29.1;monocytes: 9.7;NK-cells: 15.5"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 107.0;CACO-2: 104.1;OE19: 97.6;SK-BR-3: 110.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA011762, HPA017086"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA		4800000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 4: Stomach - Digestion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 60: Granulocytes - Receptor signaling"	"Nucleoplasm, Golgi apparatus"		"HPA011762: AB_1849450, HPA017086: AB_1849452"	"unprognostic (2.03e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.26e-2)"	"prognostic favorable (9.85e-4)"	"unprognostic (1.35e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.15e-3)"	"unprognostic (2.05e-1)"	"unprognostic (2.27e-2)"	"prognostic favorable (5.40e-4)"	"unprognostic (1.88e-2)"	"unprognostic (5.25e-2)"	"unprognostic (7.13e-4)"	"unprognostic (5.65e-3)"	"unprognostic (3.18e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.18e-2)"	1.7	3.1	3.3	8.0	11.8	9.6	18.1	7.2	9.1	32.2	0.2	6.7	21.2	1.3	24.7	2.4	6.5	2.4	0.4	4.2	7.3	2.9	1.2	5.7	7.2	8.8	11.1	0.9	8.3	1.4	1.1	9.6	10.8	0.9	6.9	0.1	31.0	3.2	0.4	5.6	21.6	1.6	5.2	8.2	62.6	0.6	9.7	6.8	2.5	0.1	5.9	3.7	1.8	18.1	39.0	4.1	0.7	0.1	0.0	0.6	59.8	63.0	107.0	25.4	17.0	104.1	19.0	0.5	5.8	34.4	0.0	35.9	1.5	27.3	17.1	8.3	4.1	24.6	0.7	0.8	1.0	13.6	82.2	2.3	25.2	23.1	23.0	0.2	65.7	14.2	5.4	1.0	0.1	73.7	43.2	10.1	5.3	97.6	66.6	0.2	0.1	10.3	21.3	2.2	0.5	23.5	0.4	110.5	0.1	12.2	59.3	5.9	75.7	0.2	12.9	0.2	0.3	2.1	0.5	3.6	7.2	29.5	0.2	7.1	5.8	29.1	3.8	5.2	1.6	1.2	2.2	3.1	4.5	3.3	3.4	2.9	1.1	15.5	9.7	4.1	1.7	3.2	3.3	11.8	7.2	9.1	4.2	7.3	8.8	11.1	10.8	5.2	9.7	18.1	0.8	3.2	2.4	0.3	11.8	2.9	3.8	5.8	5.7	0.4	38.9	18.4	1.3	1.5	15.6	1.8	0.0	14.1	11.3	12.4	3.9	2.6	2.0	3.5	0.3	4.1	0.0	15.3	1.0	10.9	49.2	1.6	130.5	5.8	164.5	3.8	1.4	0.3	14.4	0.0	0.5	17.4	2.0	16.3	10.3	1.5	0.0	15.1	1.8	1.0	7.2	0.2	9.2	0.0	57.6	24.3	33.9	0.4	5.5	7.6	39.6	2.0	12.4	0.0	0.0	1.5	1.5	0.4	1.6	2.6	9.2	4.8	14.9	1.8	11.8	5.8
GLB1	"EBP, ELNR1"	ENSG00000170266	"Galactosidase beta 1"	P16278	3	32996609-33097202	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant, Gangliosidosis, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 857.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008382, HPA040610, HPA069503"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		2700000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	"Golgi apparatus"	"CAB008382: AB_590642, HPA040610: AB_2677039, HPA069503: AB_2686142"	"unprognostic (1.51e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.02e-3)"	"unprognostic (9.66e-3)"	"unprognostic (9.61e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.31e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.08e-1)"	"prognostic favorable (1.14e-5)"	"unprognostic (3.05e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.20e-1)"	"unprognostic (5.85e-2)"	22.0	36.1	12.1	27.8	13.0	21.9	20.5	12.5	14.8	33.4	16.0	43.5	43.0	21.9	103.6	15.4	28.2	32.0	15.5	12.5	14.8	46.0	48.2	42.7	25.8	14.3	12.9	21.4	30.8	59.4	18.5	53.8	15.4	23.2	45.6	14.9	25.3	29.3	7.7	15.8	31.0	30.6	12.4	24.4	35.5	13.5	13.5	17.5	52.8	10.8	23.0	31.8	16.2	15.1	37.4	63.6	39.8	48.3	241.9	123.7	857.2	59.1	157.6	73.7	95.1	91.3	86.5	17.9	50.9	120.9	53.9	35.1	38.1	75.5	53.7	104.9	33.0	69.9	35.3	47.4	124.3	50.5	69.9	144.9	70.2	67.0	39.2	144.1	116.5	24.7	64.3	67.0	81.8	44.6	29.6	31.6	26.4	78.0	27.0	24.7	26.4	86.6	78.4	54.4	12.0	40.3	75.0	120.2	74.4	69.3	80.3	130.2	67.7	46.8	32.2	65.2	50.1	53.2	87.9	5.9	99.6	71.2	36.7	43.9	146.2	86.4	29.2	125.8	40.4	37.9	34.3	31.8	166.5	35.6	17.9	21.8	56.6	26.0	92.1	35.1	77.1	91.9	12.1	13.0	12.5	14.8	12.5	14.8	14.3	12.9	15.4	12.4	13.5	15.1	8.7	19.2	25.3	39.2	18.6	6.0	13.6	60.1	10.8	11.3	11.5	7.5	9.1	34.3	43.3	27.6	6.2	100.1	14.1	41.9	27.4	53.5	24.8	18.7	16.0	17.4	16.9	20.6	46.7	35.4	55.3	29.2	26.0	27.1	26.6	20.6	19.6	39.7	79.5	5.0	46.0	23.5	40.7	43.9	13.9	5.0	15.2	41.7	14.2	23.4	64.6	16.5	10.3	27.2	24.2	28.1	43.4	21.1	19.8	9.9	36.2	33.1	31.0	16.2	13.1	12.9	16.3	1.0	6.6	10.1	3.4	49.1	18.7	51.0	32.0	12.1
GLIPR1	"GliPR, RTVP1"	ENSG00000139278	"GLI pathogenesis related 1"	P48060	12	75480753-75503863	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 216.3;Extravillous trophoblasts: 384.2;Hofbauer cells: 242.4;Kupffer cells: 273.9;Langerhans cells: 393.2;Macrophages: 259.6;monocytes: 220.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 189.3;U-138 MG: 363.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA011014	Approved				"Intracellular and membrane"	NA	NA		64000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 4: Macrophages - Innate immune response"			"HPA011014: AB_1849714"	"unprognostic (2.32e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.32e-3)"	"unprognostic (4.09e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (8.69e-9)"	"unprognostic (9.06e-3)"	"unprognostic (5.08e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.24e-1)"	17.2	16.9	2.0	47.0	1.7	18.3	11.5	1.5	5.6	15.6	3.8	11.4	6.6	32.6	6.0	7.9	17.9	33.5	9.2	2.3	2.8	5.6	12.5	22.1	32.7	4.0	3.3	13.7	3.7	2.3	3.9	25.8	3.9	9.2	12.6	1.7	9.7	17.1	3.1	3.4	14.1	39.9	3.4	36.4	10.8	4.8	4.2	19.8	5.4	7.3	32.3	35.0	6.7	8.4	7.2	7.0	5.9	0.6	22.0	46.2	0.9	93.0	97.5	76.8	55.7	3.8	2.7	23.9	19.1	101.7	67.6	1.2	0.2	38.6	124.7	38.0	1.6	1.2	8.4	6.1	25.1	8.4	1.3	43.0	14.1	189.3	41.4	123.1	62.0	1.7	1.7	29.0	144.7	0.1	4.0	20.2	0.6	0.2	2.8	1.0	4.5	0.8	8.1	1.6	0.2	0.2	38.5	0.3	0.2	12.5	0.9	6.7	102.6	363.8	35.4	39.2	144.1	5.1	0.8	2.1	144.4	9.9	5.6	25.3	352.7	40.9	115.0	232.6	77.2	73.9	80.5	90.7	240.2	90.2	24.3	50.4	462.1	20.4	265.6	202.1	91.2	265.0	2.0	1.7	1.5	5.6	2.3	2.8	4.0	3.3	3.9	3.4	4.2	8.4	6.5	12.8	16.0	2.0	121.6	13.6	189.2	23.0	4.0	2.9	15.5	19.9	0.9	5.7	10.0	3.7	4.2	4.8	216.3	0.3	0.0	102.8	14.3	11.3	119.4	7.0	3.5	11.8	13.3	83.9	384.2	46.1	2.0	16.4	10.1	0.8	10.4	4.4	242.4	6.7	14.6	0.4	4.1	273.9	393.2	5.9	14.3	259.6	16.0	28.1	220.9	1.4	123.6	2.5	1.5	90.9	2.5	53.8	66.8	106.5	0.1	1.5	10.6	3.2	13.1	8.1	50.2	7.9	1.0	4.6	9.8	16.8	161.9	26.7	0.6	42.8
GLMP	"C1orf85, MGC31963, NCU-G1"	ENSG00000198715	"Glycosylated lysosomal membrane protein"	Q8WWB7	1	156290089-156295689	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 197.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 224.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029121	Uncertain					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"			"HPA029121: AB_10600794"	"unprognostic (2.46e-2)"	"unprognostic (1.19e-2)"	"unprognostic (5.68e-2)"	"unprognostic (4.22e-3)"	"unprognostic (3.71e-2)"	"unprognostic (8.28e-2)"	"prognostic unfavorable (6.35e-5)"	"unprognostic (4.74e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.21e-3)"	"unprognostic (1.33e-1)"	"unprognostic (7.66e-3)"	"unprognostic (7.68e-3)"	"unprognostic (3.90e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.20e-3)"	33.9	68.3	11.8	17.1	12.8	19.4	25.6	12.9	15.4	38.1	21.1	24.6	30.3	24.4	23.2	29.8	21.1	44.7	18.1	11.7	13.9	52.2	59.8	28.9	22.6	13.6	13.6	22.0	27.0	29.4	19.7	48.0	15.0	57.3	21.1	2.7	35.2	20.4	7.4	29.2	26.9	24.5	12.4	32.3	28.8	6.4	16.0	12.2	23.6	9.6	15.4	36.0	26.8	14.4	22.7	40.8	3.9	27.0	224.8	121.7	27.5	40.8	172.0	58.1	79.0	50.9	68.7	0.0	83.2	59.0	1.9	14.6	0.6	30.0	18.4	4.6	41.8	7.0	22.9	60.6	101.4	19.7	58.1	119.9	36.0	55.9	17.9	85.1	89.0	17.6	32.8	3.1	34.6	28.5	10.1	0.1	46.5	56.9	20.9	17.4	0.0	74.3	53.7	24.5	12.9	42.2	27.1	76.4	120.6	45.6	38.3	54.2	45.7	25.7	5.0	46.2	26.9	24.9	45.9	11.3	44.0	15.7	36.3	35.0	71.3	12.2	23.4	74.5	21.7	13.1	23.0	20.5	31.8	7.7	22.7	21.7	19.4	18.0	55.6	21.3	43.4	36.9	11.8	12.8	12.9	15.4	11.7	13.9	13.6	13.6	15.0	12.4	16.0	14.4	11.7	3.2	19.1	3.3	7.3	0.0	16.4	0.0	10.8	2.0	12.3	11.6	5.8	31.5	5.0	31.3	0.0	70.3	7.6	13.8	27.4	51.3	0.6	8.5	19.1	17.5	10.9	18.5	1.6	38.3	68.5	33.4	18.8	14.2	8.8	14.9	42.8	69.8	197.7	1.7	1.9	19.4	0.0	66.8	0.0	1.4	16.4	41.1	0.0	1.0	29.8	21.0	13.4	2.0	3.9	29.8	22.2	13.9	23.0	28.9	44.9	67.3	5.8	1.5	13.1	11.9	17.1	0.9	1.9	17.8	0.0	69.6	9.3	17.6	11.8	18.7
GNS		ENSG00000135677	"Glucosamine (N-acetyl)-6-sulfatase"	P15586	12	64713445-64759431	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Kupffer cells: 198.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 228.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013695, CAB026011, HPA048508"	Enhanced				"Intracellular and membrane"	NA	NA		510000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"CAB026011: , HPA013695: AB_1849741, HPA048508: AB_2680423"	"unprognostic (8.07e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (7.76e-4)"	"unprognostic (9.33e-2)"	"prognostic unfavorable (1.94e-5)"	"unprognostic (1.26e-1)"	"unprognostic (4.03e-1)"	"unprognostic (2.62e-3)"	"unprognostic (3.04e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.28e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.04e-1)"	106.1	174.7	18.0	56.4	19.9	25.4	51.9	20.4	21.3	58.9	80.7	35.3	34.6	49.5	38.5	26.2	43.8	63.7	52.9	17.2	26.4	132.0	56.2	71.5	41.0	30.0	23.3	64.3	24.1	76.8	23.0	80.2	25.5	38.5	36.9	25.1	32.9	47.7	30.1	26.3	41.4	69.2	22.5	51.2	34.6	31.8	27.3	20.5	72.8	29.0	26.9	63.7	27.6	31.2	41.0	61.3	50.7	81.4	240.0	145.2	108.8	92.0	213.5	108.4	117.1	55.9	53.3	17.4	117.0	117.8	133.3	33.1	49.1	52.6	119.5	51.4	36.6	41.4	45.4	36.4	109.3	30.6	346.2	139.6	62.9	111.5	49.3	342.0	200.1	24.7	28.8	117.2	156.8	32.6	8.1	17.9	19.4	102.8	53.2	23.8	77.3	53.7	91.5	116.2	33.7	37.3	119.6	56.6	82.4	65.8	102.2	40.4	185.1	104.5	54.8	101.8	54.4	112.1	143.4	14.9	151.1	58.4	72.1	51.7	136.9	27.5	29.3	158.4	21.9	13.0	15.9	22.6	78.2	10.0	16.4	16.4	56.6	18.4	228.5	19.3	13.0	101.9	18.0	19.9	20.4	21.3	17.2	26.4	30.0	23.3	25.5	22.5	27.3	31.2	52.6	48.1	31.7	19.2	11.0	16.6	8.4	14.8	11.4	10.5	28.4	17.0	59.9	22.8	24.2	103.0	18.8	24.3	18.8	24.2	1.9	36.2	24.4	26.5	25.5	50.6	41.9	15.4	25.0	15.1	19.7	40.2	12.2	32.9	48.1	36.3	58.5	57.9	81.0	16.8	31.3	16.6	18.3	198.8	46.5	24.5	34.8	107.8	16.0	27.2	79.0	20.1	13.4	15.1	19.9	20.0	15.7	37.2	16.0	17.2	60.9	64.3	42.8	7.5	6.6	23.1	24.9	11.3	7.8	10.5	12.9	29.1	13.2	30.0	18.2	19.2
GPR137B	TM7SF1	ENSG00000077585	"G protein-coupled receptor 137B"	O60478	1	236142505-236221865	"Predicted membrane proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 135.6"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 139.0;Muller glia cells: 226.0;Proximal tubular cells: 115.1;Rod photoreceptor cells: 171.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 17.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 17.6;monocytes: 7.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 82.8;SK-MEL-30: 220.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026422	Approved					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 5: Muller glia cells - Visual perception"			"HPA026422: AB_1849338"	"unprognostic (1.59e-3)"	"unprognostic (6.89e-2)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (6.49e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.06e-2)"	"unprognostic (2.73e-2)"	"unprognostic (5.53e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.16e-1)"	"unprognostic (7.02e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.44e-1)"	15.8	6.9	33.4	15.4	39.4	6.4	13.7	35.6	39.8	25.2	18.8	11.4	9.7	19.1	39.9	9.1	6.1	20.3	22.2	32.8	35.4	68.1	22.1	16.7	18.4	36.9	38.3	12.2	3.7	13.1	3.3	30.0	37.3	10.4	10.8	135.6	6.2	14.7	1.4	18.8	8.7	15.9	34.2	16.4	11.0	3.5	37.3	6.3	15.1	5.0	16.9	28.7	13.2	38.1	5.6	7.8	6.4	5.7	82.8	46.6	2.0	12.3	27.5	7.4	10.3	1.8	6.7	0.9	19.1	13.0	16.7	4.3	8.4	7.6	7.2	5.4	15.8	3.2	1.0	1.4	11.7	4.3	29.7	30.5	25.4	5.7	2.8	23.3	12.0	7.6	0.5	0.1	12.6	6.7	3.6	1.7	3.1	2.4	2.9	6.1	10.0	2.4	10.8	20.1	4.6	9.3	4.2	16.9	220.5	4.9	22.1	7.5	10.7	11.2	7.8	26.2	12.1	1.0	7.2	0.8	6.7	3.1	17.3	17.6	0.9	9.6	0.9	4.1	0.4	0.5	0.6	2.7	1.1	0.3	0.3	0.8	0.1	0.1	7.3	0.3	1.7	0.4	33.4	39.4	35.6	39.8	32.8	35.4	36.9	38.3	37.3	34.2	37.3	38.1	7.3	0.0	1.7	17.6	10.3	25.7	22.2	8.0	14.2	31.9	8.2	4.8	23.0	7.2	5.1	12.9	35.5	46.7	9.7	1.1	17.6	14.4	0.1	1.9	10.2	7.1	8.5	4.0	14.8	10.4	9.9	19.3	6.6	2.1	20.3	2.8	11.7	4.1	88.0	52.2	15.4	2.7	0.0	81.4	139.0	0.9	9.0	55.0	69.4	8.4	83.8	226.0	4.1	30.2	14.9	11.1	2.7	6.0	8.4	21.4	2.2	115.1	6.1	171.2	0.0	7.1	10.5	0.1	1.1	9.4	19.9	40.8	19.9	3.5	2.7	29.8
GPR183	EBI2	ENSG00000169508	"G protein-coupled receptor 183"	P32249	13	99294539-99307399	"G-protein coupled receptors, Predicted membrane proteins"	"Adaptive immunity, Immunity"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 112.7;lymphoid tissue: 84.5"	"Group enriched"	"Detected in many"	4	"Langerhans cells: 2572.5;Macrophages: 809.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 1050.9"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	23	"HDLM-2: 157.7;HL-60: 108.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB033690, HPA075590"	Approved					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"CAB033690: AB_2114269, HPA075590: "	"unprognostic (3.28e-3)"	"prognostic favorable (9.77e-4)"	"unprognostic (6.03e-2)"	"unprognostic (4.61e-3)"	"unprognostic (3.45e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.29e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.50e-3)"	"unprognostic (4.49e-3)"	"unprognostic (1.97e-3)"	"unprognostic (9.31e-3)"	"unprognostic (9.86e-3)"	26.2	12.8	1.9	84.5	2.1	112.7	11.2	2.2	3.5	12.6	7.1	14.8	8.0	6.6	2.4	15.2	6.5	40.5	13.1	1.8	5.5	3.8	17.1	20.1	67.7	8.1	3.0	3.5	4.6	3.8	5.1	27.8	5.2	9.4	21.3	2.0	5.2	3.9	2.0	5.9	23.6	21.9	3.9	35.1	15.7	1.5	3.5	31.8	15.2	4.1	75.6	52.3	5.3	7.3	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.7	0.2	0.8	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.4	157.7	0.0	1.4	0.4	0.0	0.0	108.6	0.3	0.0	0.0	1.5	0.0	0.0	0.0	5.7	2.6	0.0	0.1	0.0	0.0	1.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.0	1.9	0.0	0.0	0.0	0.0	0.2	0.1	0.0	2.8	0.3	0.7	0.0	1050.9	10.4	391.6	43.7	3.8	264.5	364.1	463.0	240.9	77.9	172.1	286.1	39.8	9.9	487.0	3.9	255.2	401.6	255.9	1.9	2.1	2.2	3.5	1.8	5.5	8.1	3.0	5.2	3.9	3.5	7.3	6.0	16.0	26.3	0.0	413.9	61.6	0.8	0.5	2.2	0.3	2.5	3.9	4.6	1.5	6.3	0.0	6.2	1.0	168.8	0.5	1.9	0.2	0.7	0.6	1.3	17.1	0.0	4.4	0.2	2.9	1.5	12.8	11.2	0.9	60.9	0.1	0.7	1.2	113.4	0.0	0.2	0.0	18.3	119.1	2572.5	2.8	0.3	809.4	145.9	46.9	248.7	0.1	1.0	0.5	0.3	1.0	0.0	0.0	85.5	0.4	0.0	0.8	3.8	0.9	6.6	2.1	9.1	0.4	0.2	1.3	53.4	1.8	245.2	0.0	0.3	0.6
GPR34		ENSG00000171659	"G protein-coupled receptor 34"	Q9UPC5	X	41688973-41697275	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 42.7"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 251.4;Kupffer cells: 173.3;Macrophages: 100.6;Microglial cells: 54.4"	"Cancer enhanced"	"Detected in all"		"glioma: 26.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	16	"basophil: 339.6;eosinophil: 117.9"	"Lineage enriched"	"Detected in many"	24	"granulocytes: 339.6"	"Cell line enhanced"	"Detected in single"		"HMC-1: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010668, CAB025490"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Cytosol		"CAB025490: , HPA010668: AB_1849294"	"unprognostic (1.26e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.83e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.81e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.96e-1)"	"unprognostic (2.72e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.88e-3)"	"unprognostic (3.18e-2)"	28.2	17.1	5.2	15.1	5.2	0.9	21.5	6.1	5.8	14.0	5.6	12.0	6.5	6.7	2.7	8.2	7.8	17.0	8.3	5.0	7.6	5.0	8.5	10.9	20.0	10.6	7.9	7.3	5.4	5.3	1.4	42.7	11.4	3.2	13.1	0.6	3.6	8.8	0.8	1.0	14.6	16.3	9.9	15.6	7.8	2.7	9.7	6.9	3.7	4.6	16.7	13.3	1.7	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	339.6	9.7	117.9	0.0	12.9	0.4	1.5	0.4	0.1	2.0	1.2	0.1	0.3	1.1	14.3	7.0	0.3	0.6	2.8	5.2	5.2	6.1	5.8	5.0	7.6	10.6	7.9	11.4	9.9	9.7	18.8	0.9	0.0	2.8	1.0	2.0	0.6	0.2	0.0	0.0	0.0	0.5	2.3	1.2	0.0	0.0	0.0	0.0	1.4	0.4	0.0	0.0	0.0	0.6	0.1	0.1	5.0	1.2	0.4	0.7	0.0	1.6	1.0	0.5	0.0	37.3	0.0	2.9	0.8	251.4	0.0	0.9	0.0	0.0	173.3	13.6	1.9	0.9	100.6	1.8	54.4	7.1	0.1	1.0	3.5	0.0	0.0	0.0	0.4	0.6	0.1	0.0	0.1	0.0	0.8	19.7	0.6	0.3	0.0	0.2	0.4	1.0	2.5	7.2	0.1	0.1	0.0
HM13	"dJ324O17.1, H13, IMP1, IMPAS, PSENL3, PSL3, SPP, SPPL1"	ENSG00000101294	"Histocompatibility minor 13"	Q8TCT9	20	31514410-31577923	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 324.9;Plasma cells: 400.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045089, HPA056062"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"HPA045089: AB_10962054, HPA056062: AB_2683022"	"unprognostic (8.03e-2)"	"unprognostic (2.11e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.87e-3)"	"prognostic unfavorable (1.95e-5)"	"unprognostic (2.66e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.10e-2)"	"prognostic unfavorable (4.64e-12)"	"unprognostic (3.77e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.17e-2)"	78.6	102.9	10.5	60.9	13.5	61.7	63.4	13.6	15.7	100.0	42.4	54.5	52.6	72.9	111.4	128.6	70.4	46.7	55.9	12.5	17.1	61.4	136.1	83.7	40.7	17.8	17.9	59.2	241.1	68.8	90.0	64.6	17.4	66.0	44.4	20.8	217.7	80.3	44.6	51.6	52.1	49.1	14.2	70.2	92.5	21.9	23.9	30.5	74.7	14.1	54.2	64.9	72.2	20.9	143.8	147.6	56.6	87.7	260.2	163.5	197.6	239.0	221.3	159.7	162.8	287.3	166.8	90.4	312.8	262.7	209.7	253.8	74.9	162.0	97.7	46.2	112.0	201.3	99.7	179.3	287.0	118.1	78.1	152.5	103.5	133.7	182.7	159.0	124.5	56.0	90.2	364.0	148.8	170.3	100.0	84.0	67.8	234.9	248.5	63.6	272.6	436.5	154.4	75.6	76.3	90.4	243.5	234.9	199.2	56.4	182.0	109.5	153.3	243.1	129.8	246.3	136.2	225.5	145.5	71.7	328.7	413.0	219.4	117.7	380.9	190.8	116.7	372.6	159.7	91.9	108.0	112.9	260.8	74.4	70.6	84.1	282.8	117.5	363.7	271.9	104.1	374.1	10.5	13.5	13.6	15.7	12.5	17.1	17.8	17.9	17.4	14.2	23.9	20.9	67.4	51.3	55.4	23.8	78.2	33.4	59.0	127.8	31.3	45.4	65.6	49.1	13.6	71.4	102.2	53.3	123.0	154.0	70.7	115.2	13.7	145.6	15.5	55.0	111.5	60.9	61.5	38.9	40.5	169.7	139.0	93.2	80.0	128.4	42.4	55.5	53.2	86.4	324.9	43.7	39.2	134.5	63.1	81.2	83.1	15.9	60.6	106.1	65.8	28.1	77.4	52.2	53.5	33.7	23.8	144.3	81.2	43.6	400.6	92.4	54.8	51.0	49.3	44.8	32.9	49.2	79.2	26.1	26.4	60.0	35.4	213.6	60.1	97.2	70.8	69.3
HSPA6	HSP70B'	ENSG00000173110	"Heat shock protein family A (Hsp70) member 6"	P17066	1	161524540-161526894	"Plasma proteins, Predicted intracellular proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 242.2;lung: 94.4"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 335.3;Langerhans cells: 478.8;Macrophages: 213.7;Prostatic glandular cells: 180.1;Smooth muscle cells: 235.6;T-cells: 391.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	8	"cerebral cortex: 242.2"	"Immune cell enriched"	"Detected in many"	7	"neutrophil: 317.9"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 317.9"	"Cell line enriched"	"Detected in some"	7	"Karpas-707: 50.7"					"Low region specificity"	"Detected in all"			"CAB017452, HPA028549, HPA052504"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles	Nucleoplasm	"CAB017452: AB_10618032, HPA028549: AB_10601817, HPA052504: AB_2681854"	"unprognostic (3.90e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.36e-3)"	"prognostic unfavorable (7.26e-4)"	"unprognostic (4.61e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (1.98e-5)"	"unprognostic (2.33e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.04e-1)"	26.2	15.7	11.3	9.9	16.3	3.6	3.6	22.1	242.2	2.9	24.7	9.3	1.7	1.7	0.7	7.3	3.8	8.7	31.7	12.9	12.4	27.2	33.0	94.4	2.3	15.1	12.4	46.8	5.9	1.1	23.8	20.5	28.7	3.3	1.7	1.8	3.3	5.0	3.8	8.4	5.1	2.3	13.8	63.5	34.5	2.4	15.5	1.3	12.8	3.6	1.7	18.5	10.9	20.1	0.8	1.5	0.0	0.3	0.0	1.1	1.0	0.6	0.5	0.2	0.4	0.5	0.7	0.2	2.2	0.2	0.8	0.4	0.5	0.4	0.3	0.5	0.1	0.3	1.4	0.0	0.0	0.1	3.3	0.2	1.0	0.5	0.0	0.0	0.0	0.2	0.6	50.7	0.0	0.0	0.3	1.3	0.1	0.3	5.4	0.0	0.1	0.7	0.0	0.3	0.1	0.0	0.2	0.9	3.1	0.1	0.4	0.7	0.2	0.1	0.5	0.4	3.6	6.9	0.4	0.0	1.3	1.3	2.3	6.5	35.1	13.4	6.4	44.1	1.0	0.2	0.7	3.4	12.2	0.0	0.0	1.6	317.9	8.3	37.7	0.2	0.0	11.8	11.3	16.3	22.1	242.2	12.9	12.4	15.1	12.4	28.7	13.8	15.5	20.1	14.0	9.6	9.3	0.3	23.8	29.3	335.3	4.4	5.2	42.5	8.7	36.2	11.1	0.0	12.2	5.5	127.2	1.8	12.8	25.3	0.0	0.4	3.2	16.2	16.4	36.7	71.0	24.0	0.0	0.0	11.2	98.8	30.1	26.2	2.5	0.0	3.9	0.3	76.0	10.1	0.0	71.0	4.1	47.8	478.8	1.1	5.6	213.7	103.2	1.0	15.8	36.1	5.2	0.0	0.1	0.3	16.5	0.0	104.1	180.1	0.0	1.5	17.1	36.9	0.0	11.1	235.6	2.9	0.6	16.5	21.7	18.3	391.3	3.6	67.3	92.7
IGSF6	DORA	ENSG00000140749	"Immunoglobulin superfamily member 6"	O95976	16	21639550-21652608	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 29.8"	"Group enriched"	"Detected in many"	13	"Hofbauer cells: 216.2;Kupffer cells: 246.9;Langerhans cells: 132.6;Macrophages: 327.1;monocytes: 179.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 1213.7"	"Lineage enhanced"	"Detected in all"		"granulocytes: 1213.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA041023, HPA041072"	Uncertain					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 64: Macrophages - Immune response"		"Cluster 4: Macrophages - Innate immune response"			"HPA041023: AB_10794434, HPA041072: AB_10794262"	"unprognostic (7.94e-2)"	"prognostic favorable (4.92e-4)"	"unprognostic (1.18e-2)"	"prognostic favorable (1.54e-5)"	"unprognostic (3.27e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.28e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.02e-1)"	2.6	2.3	0.5	13.4	0.6	1.7	1.2	0.8	1.0	1.0	0.7	5.1	1.7	0.4	0.2	0.6	1.1	0.3	0.7	0.6	0.5	0.8	5.5	7.4	3.9	1.0	0.7	0.4	0.9	0.7	0.5	3.3	0.9	0.9	1.5	0.2	2.0	1.6	0.2	0.5	2.7	0.5	0.5	29.8	1.3	0.2	0.6	2.2	0.6	0.9	1.2	2.3	0.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.2	0.1	0.1	0.0	0.5	303.9	46.2	0.7	357.2	0.8	3.8	0.5	0.9	233.9	0.5	0.9	1.2	1213.7	2.7	263.5	55.5	1.0	210.7	0.5	0.6	0.8	1.0	0.6	0.5	1.0	0.7	0.9	0.5	0.6	1.4	1.7	3.2	12.2	0.7	7.1	3.2	0.7	0.0	0.0	1.3	1.4	3.7	4.0	2.8	5.0	1.8	10.4	0.7	15.2	0.0	0.0	0.2	0.4	1.0	1.2	4.0	0.0	6.5	1.1	0.0	1.4	3.2	0.0	2.5	10.1	0.4	2.9	1.8	216.2	0.0	0.8	0.3	0.0	246.9	132.6	0.1	0.9	327.1	8.8	16.9	179.9	0.7	3.1	1.0	0.4	0.0	1.2	0.0	1.3	0.6	0.1	0.4	4.4	2.1	0.0	0.9	1.1	0.1	0.2	0.6	2.0	1.4	5.4	0.2	0.0	0.5
IL10RA	"CD210, CD210a, CDW210A, HIL-10R, IL10R"	ENSG00000110324	"Interleukin 10 receptor subunit alpha"	Q13651	11	117986370-118003037	"CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins"		Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 63.6;lymphoid tissue: 73.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 87.5;Extravillous trophoblasts: 93.0;Kupffer cells: 190.7;Langerhans cells: 145.0;Macrophages: 128.6;monocytes: 175.7;NK-cells: 110.2;Plasma cells: 129.5;T-cells: 105.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 30.5;HDLM-2: 76.6;Karpas-707: 27.7;RPMI-8226: 35.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065647, HPA069086"			Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 2: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	Cytosol	"HPA065647: , HPA069086: "	"unprognostic (1.01e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.58e-2)"	"unprognostic (7.08e-2)"	"unprognostic (8.27e-2)"	"prognostic favorable (4.47e-4)"	"unprognostic (5.27e-2)"	"unprognostic (4.84e-2)"	"unprognostic (7.70e-3)"	"unprognostic (5.94e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.83e-1)"	"prognostic unfavorable (1.45e-5)"	"unprognostic (1.82e-1)"	"unprognostic (8.43e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.27e-1)"	13.9	8.9	4.7	39.8	4.9	63.6	6.1	4.4	7.0	5.6	4.9	12.0	8.0	3.5	2.7	6.4	5.2	17.9	5.3	4.2	5.9	4.1	13.1	23.8	51.7	6.9	5.1	3.1	2.4	2.6	3.6	14.2	5.5	4.7	14.5	0.5	5.2	3.2	1.7	3.2	24.8	10.4	6.0	73.7	9.2	1.9	5.3	16.9	4.2	3.3	32.4	20.7	3.7	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.5	0.2	0.0	0.7	0.0	0.5	0.0	0.0	76.6	0.0	0.2	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	5.6	27.7	0.0	0.0	0.4	6.0	0.1	0.0	0.0	0.0	0.0	35.5	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.1	0.0	5.6	1.0	8.0	0.0	11.4	0.0	3.3	48.9	2.4	52.8	68.6	38.3	12.6	51.0	62.1	44.7	6.2	17.9	33.3	3.4	70.2	58.6	17.3	88.7	84.1	4.7	4.9	4.4	7.0	4.2	5.9	6.9	5.1	5.5	6.0	5.3	7.5	2.2	6.4	16.0	0.3	52.8	5.7	0.4	0.0	5.7	0.1	1.0	1.9	2.7	0.0	1.3	0.0	0.0	1.3	87.5	0.5	0.0	0.2	0.1	0.4	0.5	4.9	0.0	9.3	0.8	0.8	93.0	2.3	6.6	0.7	12.6	0.0	3.6	1.4	60.4	0.0	1.2	0.0	0.0	190.7	145.0	0.5	0.3	128.6	17.8	22.5	175.7	0.4	110.2	0.0	0.6	0.1	0.1	0.0	129.5	0.0	0.0	1.0	1.5	0.1	0.0	1.6	2.7	0.1	0.3	1.2	4.1	3.3	105.5	0.0	0.7	0.4
IL10RB	"CDW210B, CRF2-4, CRFB4, D21S58, D21S66, IL-10R2"	ENSG00000243646	"Interleukin 10 receptor subunit beta"	Q08334	21	33266367-33310187	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Antiviral defense"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 198.4;Extravillous trophoblasts: 164.9;Syncytiotrophoblasts: 315.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB020670, HPA047550"	Approved		Approved	Cytosol		NA	NA		1600000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"CAB020670: , HPA047550: AB_2680086"	"unprognostic (8.43e-2)"	"unprognostic (6.50e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.97e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.69e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.93e-2)"	"prognostic unfavorable (5.62e-9)"	"unprognostic (3.09e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.05e-1)"	24.6	14.5	8.2	30.3	8.2	19.8	18.1	8.1	11.3	20.2	8.6	40.6	36.5	14.7	9.9	27.6	23.9	23.9	13.8	8.1	7.8	16.8	27.5	25.8	27.6	9.0	8.1	20.4	25.4	10.7	11.3	62.5	8.9	18.6	38.0	4.8	23.6	12.3	12.4	20.2	45.7	19.8	8.6	43.1	33.8	5.0	9.5	30.5	14.0	9.8	26.0	29.3	19.3	9.8	28.8	21.6	4.9	19.1	82.7	61.3	30.0	22.9	62.3	23.5	33.6	20.6	36.1	10.9	25.0	37.8	48.3	34.5	13.2	14.8	17.3	28.5	15.5	30.8	15.1	15.2	58.3	29.5	54.6	62.5	26.8	41.2	23.5	36.8	34.6	25.6	20.6	79.7	32.5	29.1	22.6	27.4	4.2	59.1	11.4	18.5	14.4	33.9	22.6	16.6	7.5	8.0	45.4	35.3	37.5	9.7	21.3	104.5	31.0	24.1	22.7	40.0	12.4	49.9	48.3	6.8	40.5	44.5	19.4	103.8	115.0	98.9	32.0	134.9	35.2	51.6	39.3	38.1	67.9	54.1	36.8	36.3	219.4	56.9	141.6	73.6	77.6	87.5	8.2	8.2	8.1	11.3	8.1	7.8	9.0	8.1	8.9	8.6	9.5	9.8	3.1	35.3	20.5	11.8	26.5	14.5	38.0	54.0	19.4	5.8	3.3	2.8	12.3	32.9	32.3	3.7	14.6	198.4	33.6	102.1	0.0	20.1	1.1	2.3	3.5	23.5	10.2	17.7	14.5	30.1	164.9	24.2	29.6	2.4	35.5	2.1	31.8	23.2	116.6	8.4	12.7	64.4	30.5	111.3	25.3	1.6	31.7	54.3	14.2	23.4	80.6	6.7	49.4	14.6	18.5	23.4	86.8	23.7	39.9	44.3	103.1	1.1	15.8	6.4	19.7	16.9	9.1	2.9	5.0	21.7	14.6	315.6	21.0	0.2	41.4	67.6
IQGAP2		ENSG00000145703	"IQ motif containing GTPase activating protein 2"	Q13576	5	76403285-76708132	"Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 113.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 1011.9;Late spermatids: 351.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 21.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 74.2;Hep G2: 61.7;HMC-1: 211.8;RPMI-8226: 81.6;U-937: 57.0"	"Region enhanced"	"Detected in many"		"hippocampal formation: 30.5"	"Low region specificity"	"Detected in all"			"CAB004241, HPA037403, HPA037404"	Uncertain		Approved	"Vesicles,Plasma membrane"		NA	NA		3700000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Vesicles, Plasma membrane"		"CAB004241: AB_2125909, HPA037403: AB_2675459, HPA037404: AB_2675460"	"unprognostic (9.46e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.03e-3)"	"unprognostic (8.85e-2)"	"prognostic favorable (5.65e-4)"	"unprognostic (5.96e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.41e-1)"	"prognostic favorable (9.44e-12)"	"unprognostic (3.29e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.27e-2)"	7.9	12.2	0.8	11.7	0.6	25.0	27.1	0.5	0.7	19.6	2.4	25.7	56.5	3.3	9.5	2.8	3.4	18.6	2.9	0.4	0.9	35.2	113.1	9.9	14.4	2.2	2.5	8.9	25.7	44.3	1.1	30.7	1.9	15.2	23.0	23.9	34.6	15.4	0.3	2.7	31.4	4.3	1.4	13.2	39.1	51.1	2.4	7.3	28.6	1.3	8.2	6.5	1.5	2.4	0.0	9.6	31.5	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	74.2	0.1	0.7	2.7	0.0	2.7	0.2	12.1	0.0	0.1	8.6	12.0	27.6	6.8	61.7	0.2	15.7	211.8	0.0	0.0	0.0	0.0	0.0	1.2	14.9	24.6	21.4	0.0	0.0	13.5	42.4	14.8	25.4	0.3	4.9	0.1	81.6	0.0	0.1	0.6	3.2	17.3	0.9	0.1	31.4	0.0	9.3	0.4	0.0	0.5	0.0	0.3	19.8	0.0	18.7	0.1	57.0	3.0	21.3	3.1	1.9	4.5	2.5	3.7	0.5	4.7	3.9	2.9	0.2	1.8	3.3	6.0	4.3	3.4	7.7	6.2	1.4	0.8	0.6	0.5	0.7	0.4	0.9	2.2	2.5	1.9	1.4	2.4	2.4	9.1	12.8	12.2	0.7	27.3	4.7	21.5	2.4	0.0	6.7	68.9	34.5	3.5	107.2	9.1	35.0	108.4	14.2	230.3	96.2	7.9	44.5	1011.9	43.8	3.3	7.7	9.1	76.3	2.3	66.7	1.2	22.0	99.4	37.5	94.9	8.7	18.5	235.7	65.9	1.7	19.0	52.9	61.1	132.6	63.3	351.0	7.5	141.3	16.0	47.8	63.4	14.0	114.4	0.5	1.1	18.7	37.5	5.3	148.3	21.5	87.1	65.2	16.1	121.8	0.0	3.9	3.5	25.5	11.4	1.2	3.8	7.3	112.1	82.7	43.7	6.5
JPT1	"ARM2, HN1, HN1A"	ENSG00000189159	"Jupiter microtubule associated homolog 1"	Q9UK76	17	75135248-75168281	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 406.9"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 371.3;Exocrine glandular cells: 437.2;Extravillous trophoblasts: 1344.2;monocytes: 375.7;Pancreatic endocrine cells: 1434.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 767.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA059729	Approved		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli"		NA	NA		40000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nuclear membrane, Nucleoli"	"HPA059729: AB_2684114"	"unprognostic (1.13e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.31e-3)"	"unprognostic (3.57e-3)"	"unprognostic (6.71e-2)"	"unprognostic (2.51e-3)"	"prognostic unfavorable (1.58e-7)"	"unprognostic (3.58e-2)"	"unprognostic (1.37e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (1.25e-3)"	"unprognostic (8.24e-2)"	"prognostic unfavorable (1.77e-7)"	"unprognostic (1.83e-1)"	"unprognostic (8.99e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.51e-1)"	26.1	74.9	44.0	87.5	43.7	83.5	21.3	49.4	54.7	44.1	31.0	140.1	119.2	18.0	7.3	225.1	15.5	63.7	23.3	44.3	54.4	72.2	49.1	49.3	87.6	38.6	42.8	13.4	22.6	6.7	24.3	66.3	49.3	28.3	70.4	17.0	62.1	27.8	96.1	40.7	141.6	23.4	34.3	100.5	134.2	406.9	53.1	88.0	16.1	24.3	91.5	93.9	75.7	36.3	775.3	743.0	371.8	384.7	75.5	75.2	309.5	391.8	111.5	364.6	278.0	614.8	449.1	210.1	247.4	303.0	401.7	446.5	344.3	481.9	278.5	215.7	438.3	336.1	275.2	624.8	177.5	256.3	318.3	117.1	218.4	307.3	308.7	107.1	672.2	388.7	197.3	431.3	335.4	561.4	845.0	248.7	216.9	627.8	979.0	520.8	447.5	326.8	392.7	479.1	465.4	373.8	553.8	293.3	213.4	393.8	786.0	154.9	395.1	214.3	615.7	305.0	469.0	165.9	298.1	332.5	186.9	233.4	254.4	241.7	127.0	372.6	79.6	187.8	57.2	102.3	109.3	96.8	100.7	57.2	51.6	76.1	767.6	74.5	206.7	67.4	202.6	118.4	44.0	43.7	49.4	54.7	44.3	54.4	38.6	42.8	49.3	34.3	53.1	36.3	61.6	25.6	18.1	0.0	36.2	0.0	0.0	0.0	0.0	0.0	81.8	133.2	0.0	0.0	18.0	246.5	0.0	137.6	171.2	0.0	99.7	371.3	0.0	113.2	79.7	32.9	0.0	0.0	0.0	437.2	1344.2	40.4	0.0	194.0	7.6	179.6	0.0	0.0	319.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	102.5	0.0	0.0	375.7	0.0	0.0	0.0	0.0	1434.1	0.0	0.0	13.9	0.0	0.0	203.3	16.8	0.0	0.0	0.0	76.2	0.0	0.0	0.0	0.0	96.9	73.9	95.0	0.0	0.0
KCNAB2	"AKR6A5, HKvbeta2.1, HKvbeta2.2, KCNA2B"	ENSG00000069424	"Potassium voltage-gated channel subfamily A regulatory beta subunit 2"	Q13303	1	5990927-6101193	"Plasma proteins, Predicted intracellular proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Oxidoreductase, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 188.3"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 50.3;Excitatory neurons: 67.8;Hofbauer cells: 63.6;Inhibitory neurons: 49.2;Kupffer cells: 86.2;Macrophages: 51.3;Melanocytes: 64.0;NK-cells: 51.5"	"Cancer enriched"	"Detected in all"	7	"melanoma: 29.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 278.8;JURKAT: 142.7;U-937: 289.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB001975	Enhanced					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB001975: "	"unprognostic (6.60e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.97e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.76e-2)"	"unprognostic (8.18e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.71e-3)"	"unprognostic (8.83e-3)"	"prognostic unfavorable (3.50e-5)"	"unprognostic (2.88e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.24e-2)"	12.8	7.7	69.2	28.6	94.1	63.8	8.0	7.4	188.3	5.6	0.0	8.8	5.4	7.2	2.3	5.0	8.6	11.2	22.1	141.6	12.8	26.0	10.1	31.1	43.6	78.7	5.3	5.6	4.0	1.5	20.3	5.9	77.5	6.2	4.6	17.8	6.4	3.4	12.6	12.3	23.9	6.3	1.5	65.8	6.5	5.6	18.9	27.0	6.2	15.8	24.7	8.8	5.1	89.7	11.3	27.0	2.5	4.5	1.5	5.0	10.3	6.3	40.0	6.3	7.8	10.6	4.1	62.0	23.3	6.1	7.7	5.4	2.7	1.0	3.2	84.6	9.6	71.1	25.3	21.1	6.0	278.8	1.9	6.5	1.3	3.4	7.5	6.3	3.6	142.7	2.7	114.2	3.1	9.8	61.9	115.9	1.1	3.9	15.4	13.8	9.7	78.9	0.1	0.2	20.6	6.2	5.3	6.4	101.0	2.7	5.4	117.3	1.1	1.3	9.4	14.4	7.5	84.4	122.4	100.4	12.7	289.2	1.9	4.4	34.3	18.6	29.8	27.2	26.8	7.5	18.2	28.0	31.0	8.7	18.7	20.6	14.4	19.4	25.0	12.7	19.1	43.2	69.2	94.1	7.4	188.3	141.6	12.8	78.7	5.3	77.5	1.5	18.9	89.7	3.0	0.0	6.6	7.5	23.0	4.8	1.7	1.8	1.8	24.0	1.2	2.3	15.7	7.2	1.5	1.8	6.2	0.5	50.3	0.3	0.0	0.3	5.8	3.4	1.9	3.1	0.0	11.1	67.8	1.4	2.3	3.5	2.0	0.6	8.8	2.9	3.9	1.0	63.6	6.7	49.2	0.5	2.0	86.2	19.0	5.2	3.7	51.3	64.0	5.6	26.6	4.9	51.5	8.5	6.1	0.6	0.1	2.6	23.4	0.4	0.1	40.8	8.7	11.8	0.0	2.1	3.1	3.2	2.9	0.7	2.8	0.8	44.3	2.5	0.3	0.6
KCNE3	"HOKPP, MiRP2"	ENSG00000175538	"Potassium voltage-gated channel subfamily E regulatory subunit 3"	Q9Y6H6	11	74454841-74467729	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Brugada syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 70.5;stomach 1: 56.2"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 41.8;granulocytes: 33.7;Hofbauer cells: 40.6;Kupffer cells: 104.0;Macrophages: 37.8;monocytes: 59.0;Undifferentiated cells: 44.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	48	"basophil: 51.4;classical monocyte: 38.5;eosinophil: 23.4;intermediate monocyte: 41.8;myeloid DC: 18.3;neutrophil: 53.1;non-classical monocyte: 36.6"	"Group enriched"	"Detected in many"	115	"dendritic cells: 18.3;granulocytes: 53.1;monocytes: 41.8"	"Cell line enhanced"	"Detected in some"		"HEL: 70.3;NB-4: 44.7;OE19: 155.3;THP-1: 32.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA014849	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"		"HPA014849: AB_1852112"	"unprognostic (1.61e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.69e-2)"	"unprognostic (3.58e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (4.67e-3)"	"unprognostic (4.89e-4)"	"unprognostic (4.12e-3)"	"unprognostic (2.56e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.45e-3)"	"unprognostic (7.86e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.00e-1)"	7.3	2.8	2.8	20.7	2.9	8.2	5.2	2.5	3.6	9.9	7.0	34.9	70.5	8.8	1.9	4.6	9.4	24.6	5.0	3.0	3.0	20.1	5.0	13.8	5.0	3.8	3.6	14.0	10.8	3.6	3.1	12.7	3.6	8.0	47.3	8.1	15.4	3.4	1.3	1.3	40.0	11.1	3.3	12.6	56.2	1.8	4.1	1.9	33.5	3.0	3.2	6.2	4.5	4.9	0.1	0.1	0.1	0.2	8.1	2.1	7.1	0.1	0.0	1.0	0.8	23.0	2.0	0.3	21.3	0.1	0.1	0.3	1.8	0.0	0.7	0.0	0.2	70.3	0.4	4.7	2.9	0.6	12.0	7.1	0.0	0.6	0.0	0.3	0.3	0.1	1.9	0.3	0.8	0.1	0.1	44.7	0.9	155.3	0.1	7.6	0.3	0.5	1.7	0.0	0.0	0.4	0.1	0.0	0.0	5.4	0.1	32.7	0.1	0.1	0.2	0.2	0.1	0.3	0.3	0.4	0.1	12.9	0.1	51.4	38.5	23.4	0.1	41.8	0.2	0.2	0.1	0.1	18.3	0.3	0.1	0.1	53.1	0.2	36.6	0.7	0.0	13.2	2.8	2.9	2.5	3.6	3.0	3.0	3.8	3.6	3.6	3.3	4.1	4.9	4.4	0.0	6.8	0.3	0.7	0.3	0.6	1.1	3.4	0.2	0.2	0.3	0.7	8.6	5.6	1.8	0.0	0.4	0.0	8.6	3.9	0.5	0.1	3.1	3.4	8.9	2.4	2.1	0.2	7.3	7.4	4.5	41.8	5.0	33.7	0.2	5.7	2.0	40.6	0.0	0.3	27.9	4.1	104.0	2.9	0.3	3.7	37.8	0.0	8.4	59.0	22.7	1.0	0.0	0.0	3.3	8.9	2.6	0.2	0.4	8.6	23.4	4.6	1.2	0.0	4.7	0.7	0.0	0.4	2.7	0.1	2.1	1.0	8.8	44.3	0.6
LAT2	"HSPC046, LAB, NTAL, WBSCR15, WBSCR5, WSCR5"	ENSG00000086730	"Linker for activation of T cells family member 2"	Q9GZY6	7	74199652-74229834	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Mast cell degranulation"		"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 61.3;lymphoid tissue: 56.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 90.6;granulocytes: 171.6;Hofbauer cells: 82.7;Kupffer cells: 71.1;Langerhans cells: 81.9;Macrophages: 89.1;monocytes: 89.6;NK-cells: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 871.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 192.2;REH: 205.7;RPMI-8226: 73.3;THP-1: 186.5;U-937: 177.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003462	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"		"HPA003462: AB_1079238"	"unprognostic (1.24e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.30e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.33e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.34e-3)"	"unprognostic (6.91e-2)"	"prognostic unfavorable (4.10e-4)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (6.10e-4)"	"unprognostic (7.44e-2)"	"unprognostic (2.03e-1)"	6.8	5.4	9.7	37.7	11.1	61.3	3.8	11.8	12.8	3.7	9.1	6.5	6.3	2.9	2.5	3.6	4.2	9.1	2.3	10.3	12.2	3.3	4.8	19.2	51.6	18.4	13.6	1.7	3.0	2.2	3.0	7.4	17.7	7.1	7.7	1.2	4.5	3.5	3.3	3.0	13.6	8.8	16.5	47.0	6.5	2.0	15.3	12.2	2.8	2.4	56.6	10.1	2.5	20.1	1.7	1.1	1.1	3.1	0.3	0.0	1.1	1.4	1.2	0.6	0.7	2.3	28.9	19.6	0.4	0.5	6.1	1.2	0.4	1.1	0.6	31.4	1.2	8.6	1.8	1.8	0.1	56.1	55.6	0.4	0.8	2.1	0.6	1.2	0.3	1.1	1.6	9.3	0.5	1.7	1.3	192.2	0.9	5.5	2.0	205.7	1.1	73.3	0.2	1.7	0.9	0.8	0.6	1.2	1.2	0.9	1.1	186.5	2.1	2.1	19.9	0.8	1.8	0.9	6.2	32.2	9.4	177.6	1.5	871.6	276.6	46.0	8.8	159.0	0.9	169.3	2.3	1.4	225.2	191.1	1.0	2.9	491.0	73.9	93.9	8.9	4.9	214.7	9.7	11.1	11.8	12.8	10.3	12.2	18.4	13.6	17.7	16.5	15.3	20.1	1.3	3.2	16.2	0.7	90.6	3.4	0.7	0.0	0.6	0.3	1.0	1.9	1.1	5.7	3.1	3.7	0.0	0.6	47.8	0.2	0.0	0.3	2.4	1.3	0.6	3.9	7.8	16.6	1.7	0.2	1.1	1.7	1.1	2.1	171.6	0.4	3.9	4.5	82.7	0.0	1.4	0.8	0.0	71.1	81.9	3.4	0.0	89.1	1.8	20.6	89.6	0.2	70.0	0.5	0.9	0.6	0.1	0.7	18.7	1.2	0.1	0.2	5.9	1.3	0.0	1.9	0.9	0.4	1.4	0.1	2.6	1.2	27.7	0.3	0.8	0.4
LILRB1	"CD85, CD85j, ILT2, LIR-1, LIR1, MIR-7, PIR-B, PIRB"	ENSG00000104972	"Leukocyte immunoglobulin like receptor B1"		19	54617158-54637528	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 36.1"	"Cell type enhanced"	"Detected in some"		"B-cells: 32.3;dendritic cells: 37.4;Kupffer cells: 87.3;Macrophages: 73.8;Microglial cells: 30.9;monocytes: 39.6;Plasma cells: 34.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	6	"intermediate monocyte: 39.3;non-classical monocyte: 63.7"	"Lineage enriched"	"Detected in many"	11	"monocytes: 63.7"	"Group enriched"	"Detected in some"	19	"Daudi: 5.6;THP-1: 2.9"														"Intracellular and membrane"	NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"				"unprognostic (9.23e-2)"	"unprognostic (4.20e-2)"	"unprognostic (4.95e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.89e-2)"	"unprognostic (3.58e-1)"	"unprognostic (9.64e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (3.08e-6)"	"unprognostic (6.57e-2)"	"unprognostic (1.62e-2)"	"unprognostic (7.06e-2)"	"unprognostic (8.03e-2)"	2.5	1.6	0.2	7.0	0.2	1.2	1.0	0.2	0.3	0.6	0.2	2.1	0.1	0.4	0.0	0.7	1.5	0.0	0.9	0.2	0.3	1.2	2.2	7.6	5.6	0.6	0.5	0.6	0.7	0.0	0.9	0.1	0.8	1.1	0.4	0.0	1.2	0.2	0.2	0.1	6.0	2.7	0.7	36.1	1.1	0.2	0.7	0.0	0.8	0.0	0.3	2.1	0.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	8.1	0.0	1.4	39.3	0.0	2.3	0.0	1.2	5.6	2.4	0.0	0.8	0.2	0.0	63.7	2.2	0.0	5.5	0.2	0.2	0.2	0.3	0.2	0.3	0.6	0.5	0.8	0.7	0.7	1.4	0.9	0.0	2.2	0.0	32.3	0.3	0.3	0.0	0.0	0.0	0.3	0.8	1.0	1.5	2.5	0.0	0.0	0.0	37.4	0.0	0.0	0.0	0.3	0.0	0.0	2.0	0.0	1.3	0.0	0.0	0.1	0.2	0.5	0.0	2.5	0.0	2.5	0.7	15.9	0.0	0.1	0.0	0.0	87.3	2.2	0.0	0.0	73.8	0.0	30.9	39.6	0.3	9.2	0.0	0.1	0.0	0.0	0.0	34.0	0.3	0.0	0.3	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.3	9.5	0.0	0.1	2.2
LILRB2	"CD85d, ILT4, LIR-2, LIR2, MIR-10, MIR10"	ENSG00000131042	"Leukocyte immunoglobulin like receptor B2"	Q8N423	19	54273812-54281184	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 35.0;lung: 15.0;lymphoid tissue: 51.2"	"Cell type enhanced"	"Detected in some"		"Kupffer cells: 150.7;Langerhans cells: 61.8;Macrophages: 147.3;monocytes: 75.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"classical monocyte: 61.6;intermediate monocyte: 132.3;neutrophil: 62.9;non-classical monocyte: 153.4"	"Group enriched"	"Detected in many"	6	"granulocytes: 62.9;monocytes: 153.4"	"Not detected"	"Not detected"																	NA	NA		65000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"		"Cluster 19: Monocytes & Neutrophils - Innate immune response"				"unprognostic (1.23e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.21e-2)"	"unprognostic (3.51e-2)"	"unprognostic (6.21e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (5.45e-7)"	"unprognostic (1.90e-2)"	"unprognostic (4.68e-3)"	"unprognostic (3.72e-1)"	"unprognostic (9.73e-2)"	6.5	2.6	0.0	12.2	0.0	35.0	2.2	0.0	0.5	1.1	0.6	2.3	3.2	1.2	0.1	1.0	3.7	0.0	2.5	0.1	0.1	2.2	3.9	15.0	0.8	0.9	0.5	0.8	1.3	0.0	1.3	0.5	0.6	1.7	0.8	0.0	1.6	0.4	0.6	0.6	3.0	0.4	0.0	51.2	1.8	0.3	1.0	0.2	1.1	0.1	0.0	2.3	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.0	61.6	16.2	0.1	132.3	0.3	0.0	0.0	0.0	18.8	0.1	0.1	0.0	62.9	0.0	153.4	8.0	0.3	29.7	0.0	0.0	0.0	0.5	0.1	0.1	0.9	0.5	0.6	0.0	1.0	0.2	0.5	3.2	10.9	0.0	5.5	1.5	0.0	0.0	0.0	0.0	0.1	0.1	0.8	1.5	3.1	0.0	0.0	0.1	10.3	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.8	0.0	0.0	0.3	1.0	1.1	0.0	5.1	0.0	2.2	1.5	27.2	0.0	0.0	0.0	0.0	150.7	61.8	0.1	0.0	147.3	3.6	1.0	75.3	0.0	2.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.3	2.2	0.0	6.6	0.4	0.2	0.0	0.0	0.0	0.6	0.1	2.9	0.0	0.0	0.1
LPAR5	"GPR92, GPR93, KPG_010, LPA5"	ENSG00000184574	"Lysophosphatidic acid receptor 5"	Q9H1C0	12	6618835-6635960	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 20.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 26.5;Hofbauer cells: 38.0;Microglial cells: 33.7;Proximal enterocytes: 18.4"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 18.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"B-cells: 83.8;T-cells: 66.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 10.5;HEL: 19.6;HMC-1: 26.0;K-562: 14.8;OE19: 9.4;U-698: 13.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA013170	Approved					NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"			"HPA013170: AB_1849314"	"unprognostic (1.94e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.95e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.62e-3)"	"unprognostic (2.07e-1)"	"unprognostic (6.27e-2)"	"unprognostic (7.99e-3)"	"unprognostic (5.43e-1)"	"prognostic favorable (6.56e-5)"	"unprognostic (7.43e-2)"	1.9	2.5	6.0	5.3	6.1	1.0	1.3	6.1	5.9	5.8	3.4	8.9	9.7	0.5	2.7	20.9	1.6	1.7	4.1	5.4	6.8	0.7	1.3	1.9	8.9	10.3	8.9	0.7	0.5	0.8	1.0	5.4	9.4	1.0	8.3	0.2	5.5	1.3	0.2	6.9	8.9	1.0	10.2	9.3	7.2	1.6	11.8	2.6	1.6	0.1	12.4	2.1	9.6	14.4	5.8	0.7	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.3	10.5	4.3	1.3	0.0	0.1	7.0	0.0	3.2	0.0	0.0	0.0	19.6	0.6	0.4	0.0	0.0	26.0	0.0	3.5	0.1	1.5	0.0	0.0	4.0	14.8	0.0	0.0	0.5	0.6	6.1	0.1	9.4	1.0	4.8	0.0	0.0	0.0	3.3	0.1	0.1	3.0	0.0	0.0	1.1	0.0	2.2	0.1	0.0	3.9	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	10.4	0.3	0.1	66.8	3.4	51.2	83.8	11.2	40.2	17.3	82.7	10.8	24.6	0.8	4.6	6.1	1.1	18.0	20.1	6.0	6.1	6.1	5.9	5.4	6.8	10.3	8.9	9.4	10.2	11.8	14.4	0.2	0.0	0.0	0.0	26.5	1.5	0.4	3.9	1.8	0.0	0.6	0.5	2.8	1.5	4.4	1.8	0.0	0.3	2.8	16.9	0.0	0.3	4.9	0.4	0.1	1.5	1.2	0.8	0.2	0.9	0.2	0.6	3.6	0.7	16.5	0.0	1.1	0.2	38.0	0.0	0.3	11.1	2.0	15.6	7.0	14.5	0.0	13.9	0.0	33.7	4.6	0.1	17.5	0.5	0.1	9.4	16.8	0.0	2.7	0.7	18.4	0.1	0.6	0.1	0.0	0.1	0.2	0.6	1.4	10.3	1.3	0.5	6.9	0.0	13.0	2.2
LY86	"dJ80N2.1, MD-1"	ENSG00000112799	"Lymphocyte antigen 86"	O95711	6	6588108-6654983	"Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 78.4"	"Group enriched"	"Detected in many"	9	"B-cells: 124.9;Hofbauer cells: 191.7;Kupffer cells: 199.1;Langerhans cells: 118.6;Macrophages: 149.8;Microglial cells: 105.9;monocytes: 155.6"	"Cancer enhanced"	"Detected in all"		"glioma: 22.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 426.6;myeloid DC: 426.1"	"Group enriched"	"Detected in all"	43	"B-cells: 335.1;dendritic cells: 426.1;monocytes: 426.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 69.5;NB-4: 44.7;RPMI-8226: 245.0;THP-1: 103.8;U-937: 45.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB025000, HPA044895"	Approved				"Secreted to blood"	NA	NA		77000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 57: B-cells - Immune response"			"CAB025000: , HPA044895: AB_2679138"	"unprognostic (1.82e-1)"	"unprognostic (2.49e-3)"	"unprognostic (2.01e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.46e-3)"	"unprognostic (3.52e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (5.61e-4)"	"unprognostic (1.11e-1)"	"unprognostic (4.20e-2)"	9.7	10.3	14.0	30.9	13.5	29.2	7.4	14.7	22.0	8.2	14.2	7.6	4.9	3.8	2.8	3.1	4.3	14.6	2.9	13.5	15.8	3.1	13.3	29.7	72.1	17.8	15.4	3.3	3.0	3.4	2.3	14.5	18.7	3.8	11.1	1.2	5.5	6.2	0.7	3.4	16.8	11.1	17.8	52.7	6.2	1.8	18.0	15.1	1.5	1.1	78.4	15.6	1.1	24.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	44.7	0.0	0.0	0.0	8.0	0.0	245.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	103.8	0.2	0.0	0.1	0.0	0.0	0.0	0.0	30.3	0.0	45.8	0.0	4.1	426.6	3.5	1.0	234.9	0.7	335.1	1.1	1.1	426.1	248.8	4.7	2.7	9.1	5.3	88.3	16.3	1.8	221.1	14.0	13.5	14.7	22.0	13.5	15.8	17.8	15.4	18.7	17.8	18.0	24.8	1.2	0.0	15.0	1.6	124.9	2.0	0.0	0.0	0.0	0.0	0.9	3.7	1.5	1.5	1.3	0.0	0.0	1.4	9.8	0.0	0.0	0.0	3.4	0.4	0.1	5.4	0.0	3.8	3.8	0.0	1.8	2.1	0.0	0.0	1.3	0.0	4.2	1.3	191.7	0.0	0.6	0.3	0.0	199.1	118.6	15.4	0.3	149.8	0.0	105.9	155.6	0.0	4.1	0.5	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.7	0.4	6.6	0.4	0.2	5.3	0.2	0.3	2.4	1.9	3.6	0.0	0.2	0.2
M6PR	"CD-M6PR, CD-MPR"	ENSG00000003056	"Mannose-6-phosphate receptor, cation dependent"	P20645	12	8940361-8949761	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 242.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 859.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034464, HPA040445"	Approved					NA	NA		100000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 4: Macrophages - Innate immune response"			"CAB034464: AB_2139108, HPA040445: AB_2676989"	"unprognostic (2.43e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (3.89e-4)"	"unprognostic (1.76e-1)"	"unprognostic (2.84e-1)"	"unprognostic (5.82e-3)"	"unprognostic (1.44e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.53e-3)"	"unprognostic (3.79e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.64e-1)"	"unprognostic (3.98e-1)"	76.6	64.8	79.5	113.9	83.3	104.1	81.5	80.7	95.5	61.5	79.2	78.4	61.1	73.7	63.1	63.3	70.4	74.0	82.0	83.5	85.9	79.1	78.9	97.5	138.8	85.7	83.8	62.8	59.6	95.0	34.0	78.6	86.2	64.9	91.8	73.7	79.2	74.5	51.9	60.4	64.5	81.1	84.0	132.5	74.8	59.7	90.8	105.4	96.4	56.0	125.4	98.0	37.5	96.4	103.6	159.7	103.0	122.0	187.7	86.8	306.2	129.7	159.4	186.2	210.7	176.4	268.4	188.9	48.9	133.0	374.4	160.0	142.7	131.2	218.8	859.9	86.6	331.3	125.0	122.4	213.7	355.6	566.6	126.0	166.3	184.4	232.5	179.2	105.5	123.3	93.0	114.6	165.2	103.7	120.7	142.3	412.8	189.0	72.4	118.0	248.0	108.4	151.9	241.2	26.5	109.9	159.8	159.4	223.9	363.8	39.0	251.3	106.0	156.3	175.1	186.6	193.2	139.3	253.5	201.4	183.2	226.4	120.5	706.9	292.0	319.1	177.4	477.6	201.5	123.2	210.7	195.5	334.0	111.4	152.7	170.6	44.5	186.3	567.4	205.0	182.3	497.3	79.5	83.3	80.7	95.5	83.5	85.9	85.7	83.8	86.2	84.0	90.8	96.4	49.9	57.7	57.0	13.4	75.2	44.1	73.0	73.1	43.9	46.1	50.1	40.8	10.7	44.3	68.0	31.3	22.9	64.4	107.0	23.4	19.6	91.8	7.9	31.3	36.7	39.6	38.3	60.1	25.9	66.9	71.4	37.2	30.5	33.7	132.3	39.9	37.1	28.3	242.8	55.5	29.0	30.5	40.7	138.9	95.4	7.9	35.1	166.4	67.6	21.5	212.2	35.8	159.6	17.1	22.7	56.1	29.5	32.0	73.7	65.4	25.7	41.8	53.1	37.4	26.3	52.5	43.7	117.5	54.4	51.6	40.5	53.1	96.4	55.8	43.8	68.2
MARCHF1	"FLJ20668, MARCH-I, MARCH1, RNF171"	ENSG00000145416	"Membrane associated ring-CH-type finger 1"	Q8TCQ1	4	163524298-164384050	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 31.6;retina: 27.5"	"Group enriched"	"Detected in some"	4	"B-cells: 21.4;Hofbauer cells: 46.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	94	"classical monocyte: 41.8;eosinophil: 25.5;intermediate monocyte: 41.0;memory B-cell: 42.3;myeloid DC: 44.2;naive B-cell: 35.8;non-classical monocyte: 45.4;plasmacytoid DC: 16.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 7.1;U-266/70: 7.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014600, HPA048024"	Uncertain		Supported	"Endoplasmic reticulum,Golgi apparatus,Vesicles"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles	"Endoplasmic reticulum, Golgi apparatus"	"HPA014600: AB_1853573, HPA048024: "	"unprognostic (7.29e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.09e-2)"	"unprognostic (8.25e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.79e-3)"	"unprognostic (9.00e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.00e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.91e-2)"	6.4	3.5	7.8	21.5	8.1	3.9	2.7	3.6	7.7	3.1	1.8	3.5	3.9	2.5	0.7	3.0	2.8	5.3	1.7	6.6	10.1	1.8	4.1	8.0	31.6	8.0	8.2	2.7	2.8	0.8	2.5	9.9	6.9	2.3	4.5	27.5	3.2	1.2	1.0	4.5	7.0	6.2	7.0	25.8	3.9	1.7	12.1	5.6	2.1	1.0	25.5	7.7	2.9	14.4	0.6	0.5	2.1	1.2	0.0	0.0	1.3	0.9	0.0	0.0	0.0	1.2	2.4	7.1	2.5	0.0	0.2	1.0	0.0	0.0	0.0	0.8	0.7	5.0	3.0	0.5	0.0	3.1	1.6	0.0	0.0	0.0	0.1	2.8	0.0	1.3	1.9	3.6	2.4	0.7	1.8	1.9	2.6	0.2	0.9	2.0	0.3	0.5	0.1	1.1	1.0	0.9	0.6	1.0	0.4	1.4	2.9	0.5	2.3	0.8	1.4	0.5	1.7	7.0	2.5	1.9	0.9	1.5	1.1	0.0	41.8	25.5	0.1	41.0	0.0	42.3	0.1	0.0	44.2	35.8	0.0	0.0	0.3	0.3	45.4	16.5	0.0	18.4	7.8	8.1	3.6	7.7	6.6	10.1	8.0	8.2	6.9	7.0	12.1	14.4	0.1	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	46.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0
MPEG1	MPG1	ENSG00000197629	"Macrophage expressed 1"	Q2M385	11	59208510-59212927	"Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Immunity, Innate immunity"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 207.4"	"Group enriched"	"Detected in some"	4	"dendritic cells: 156.0;Kupffer cells: 409.8;Macrophages: 174.6;monocytes: 218.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 290.5;intermediate monocyte: 209.9;myeloid DC: 144.7;non-classical monocyte: 245.2;plasmacytoid DC: 204.9"	"Group enriched"	"Detected in many"	6	"dendritic cells: 204.9;monocytes: 290.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA046801	Approved				"Secreted to blood"	NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"		"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA046801: AB_2679814"	"unprognostic (1.24e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.79e-3)"	"unprognostic (7.82e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.76e-1)"	"unprognostic (5.48e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.86e-2)"	29.2	15.8	1.5	112.4	1.6	21.3	13.5	1.7	2.4	11.6	3.2	32.9	40.9	10.9	3.7	12.6	6.9	36.2	10.3	1.4	2.1	6.0	41.1	35.4	96.3	3.3	1.9	4.9	4.6	4.6	1.6	35.8	2.5	8.0	43.4	0.3	7.3	9.3	3.9	7.1	52.8	28.2	2.9	207.4	19.2	4.5	4.0	42.8	5.9	8.3	75.2	42.7	2.1	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	290.5	8.4	0.5	209.9	0.5	12.6	0.3	0.2	144.7	14.0	0.2	0.1	38.5	1.2	245.2	204.9	0.6	214.5	1.5	1.6	1.7	2.4	1.4	2.1	3.3	1.9	2.5	2.9	4.0	4.0	0.7	0.0	7.9	0.0	33.8	1.1	0.0	0.0	1.2	0.0	0.3	0.9	1.7	1.5	0.6	0.0	0.0	0.3	156.0	0.1	0.0	0.0	0.2	0.0	0.1	1.7	0.0	4.4	0.0	0.0	0.6	0.8	0.5	0.1	2.5	0.0	4.6	3.7	52.4	0.0	0.0	0.0	0.0	409.8	48.0	0.6	0.0	174.6	1.8	10.3	218.2	0.2	7.2	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.7	0.7	0.1	6.6	0.7	0.4	0.0	0.0	0.3	1.6	0.3	2.7	0.0	0.0	0.1
MS4A14	"DKFZp434H092, FLJ32856, MS4A16, NYD-SP21"	ENSG00000166928	"Membrane spanning 4-domains A14"	Q96JA4	11	60378530-60417756	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 73.0"	"Group enriched"	"Detected in some"	44	"Early spermatids: 262.3;Late spermatids: 672.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 5.5;non-classical monocyte: 8.0"	"Lineage enriched"	"Detected in many"	5	"monocytes: 8.0"	"Cell line enriched"	"Detected in single"	23	"THP-1: 9.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA058973	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Plasma membrane"	"HPA058973: "	"unprognostic (1.78e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.45e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.50e-6)"	"unprognostic (3.73e-2)"	"unprognostic (7.16e-3)"	"unprognostic (8.40e-2)"	"unprognostic (7.11e-2)"	5.1	3.7	6.2	3.5	5.6	0.6	3.6	5.8	8.8	1.2	7.5	2.7	0.7	0.9	0.6	0.9	1.3	0.9	2.6	5.8	6.3	1.8	2.0	11.9	1.3	7.7	6.8	0.7	1.3	0.3	1.5	2.4	7.2	1.8	1.1	0.4	1.9	0.5	0.9	0.9	2.7	1.2	6.0	10.4	1.2	73.0	8.5	0.3	1.5	0.3	1.9	2.0	1.2	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	3.4	0.0	0.0	5.5	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.9	6.2	5.6	5.8	8.8	5.8	6.3	7.7	6.8	7.2	6.0	8.5	8.0	0.2	0.0	1.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	262.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	7.3	5.5	672.0	4.1	10.4	0.0	3.7	5.7	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.1	0.0	0.0	0.0	0.7	0.0	6.6	0.1	0.0	6.5	3.4	0.0	0.3	0.1	0.1	0.0	0.0	0.0
MYO1F		ENSG00000142347	"Myosin IF"	O00160	19	8520778-8577577	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 96.0;lung: 24.4;lymphoid tissue: 78.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 110.2;Kupffer cells: 235.4;Macrophages: 122.7;monocytes: 195.5;NK-cells: 616.9;T-cells: 100.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 263.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 52.4;HL-60: 52.3;HMC-1: 87.9;NB-4: 210.2;THP-1: 154.3;U-937: 84.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA055242, HPA056036"	Enhanced		Enhanced	Cytosol		NA	NA		46000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"HPA055242: AB_2682754, HPA056036: "	"unprognostic (4.86e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.47e-3)"	"unprognostic (2.86e-1)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (3.23e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.35e-2)"	9.6	4.5	5.1	38.9	5.2	96.0	3.5	5.7	7.2	2.7	6.3	5.0	7.4	2.0	0.7	3.3	6.5	10.5	4.6	4.7	5.9	3.8	7.8	24.4	20.7	9.2	7.6	1.2	2.4	1.2	2.2	7.1	8.7	3.7	3.4	0.2	3.7	1.8	1.5	2.7	12.2	6.4	7.5	78.1	6.5	1.4	8.6	5.4	3.0	4.2	8.5	10.2	2.8	10.1	0.1	0.2	0.0	0.2	0.2	0.3	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.2	6.1	0.4	0.0	0.4	0.0	0.0	0.0	52.4	0.2	38.1	0.0	0.0	0.1	52.3	87.9	0.6	0.1	0.0	0.0	0.1	0.0	0.1	0.5	23.8	0.1	0.3	0.1	210.2	0.0	0.1	0.3	1.0	0.0	5.6	0.1	0.0	0.1	0.3	0.0	0.1	0.3	0.1	0.8	154.3	12.3	0.1	0.2	0.2	0.1	0.1	1.9	0.3	0.3	84.3	0.0	64.5	107.6	105.7	56.6	78.7	44.5	5.9	22.3	39.7	62.8	2.8	1.6	17.0	263.2	32.3	98.8	8.1	34.0	101.3	5.1	5.2	5.7	7.2	4.7	5.9	9.2	7.6	8.7	7.5	8.6	10.1	1.9	3.2	12.3	2.0	26.5	3.3	2.4	0.8	1.2	0.7	3.1	4.3	2.6	5.7	2.9	1.8	2.1	5.0	110.2	2.0	1.9	1.7	6.0	0.6	2.9	4.1	1.2	14.3	2.3	0.9	8.2	2.7	3.6	1.2	31.6	2.2	10.8	6.7	75.8	6.7	1.5	2.1	0.0	235.4	49.3	6.8	2.5	122.7	7.2	64.6	195.5	1.5	616.9	1.5	3.4	1.3	3.2	1.2	30.0	1.8	3.0	2.9	0.2	0.8	0.0	3.4	2.2	6.0	3.4	3.6	5.4	5.1	100.1	3.9	2.7	1.9
MYO5A	"GS1, MYH12, MYO5, MYR12"	ENSG00000197535	"Myosin VA"	Q9Y4I1	15	52307283-52529050	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.1;parathyroid gland: 47.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 353.0;Inhibitory neurons: 241.0;Oligodendrocyte precursor cells: 330.8;Oligodendrocytes: 404.2"	"Cancer enhanced"	"Detected in all"		"melanoma: 25.2"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 201.0;RPMI-8226: 140.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001356	Enhanced		Approved	"Focal adhesion sites,Centriolar satellite"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Focal adhesion sites, Centriolar satellite"		"HPA001356: AB_1079441"	"unprognostic (1.54e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.30e-2)"	"unprognostic (6.65e-2)"	"unprognostic (7.89e-2)"	"unprognostic (4.74e-2)"	"unprognostic (9.36e-3)"	"unprognostic (1.71e-1)"	"unprognostic (5.63e-3)"	"unprognostic (3.79e-3)"	"unprognostic (1.24e-1)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (4.22e-4)"	10.3	8.3	17.0	12.1	20.8	21.8	6.5	3.0	39.1	6.8	0.0	6.1	3.8	5.0	3.7	5.3	4.0	8.5	5.8	19.0	3.6	5.3	2.9	8.8	15.0	9.6	4.2	5.7	5.2	47.4	8.9	6.3	9.8	5.1	5.9	26.1	5.2	3.5	5.4	11.8	5.0	9.4	0.0	9.5	4.7	5.9	6.6	11.0	8.4	5.0	13.1	9.7	5.3	20.8	19.5	33.7	17.6	21.3	16.2	19.3	19.0	34.7	31.1	18.1	14.0	3.2	7.8	18.7	8.9	41.8	26.5	15.7	40.7	35.6	22.3	105.5	9.6	16.7	8.8	4.2	8.3	9.0	16.3	13.0	21.9	26.6	52.4	17.6	106.8	12.0	0.7	201.0	34.8	34.4	8.2	1.2	8.1	0.5	26.6	14.5	27.8	140.8	15.1	14.0	12.7	7.8	32.3	26.2	59.4	13.1	14.0	9.1	52.0	36.4	15.7	17.1	34.1	20.9	49.9	22.0	39.4	25.1	53.5	0.4	2.4	3.1	1.4	1.7	2.1	1.1	1.3	0.9	2.7	0.7	0.2	0.4	3.0	0.3	1.4	1.5	2.2	1.1	17.0	20.8	3.0	39.1	19.0	3.6	9.6	4.2	9.8	0.0	6.6	20.8	11.2	12.8	11.4	68.2	19.8	20.8	9.3	10.5	7.4	75.1	6.7	5.5	12.1	2.8	19.8	14.7	39.6	0.6	18.4	0.3	0.0	5.4	18.0	9.3	8.0	12.7	1.2	2.5	353.0	6.3	0.4	7.5	3.1	6.7	22.8	5.0	2.5	1.3	24.4	26.9	241.0	0.2	2.0	27.1	28.0	10.8	3.7	50.2	97.8	52.5	36.7	6.0	15.5	330.8	404.2	6.1	2.5	1.9	32.4	10.2	0.0	2.8	11.1	28.7	6.6	16.7	10.8	14.0	9.4	3.9	11.6	1.1	23.7	2.1	0.3	7.3
NAGPA	"APAA, UCE"	ENSG00000103174	"N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase"	Q9UK23	16	5024844-5034141	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 44.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 53.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064055	Approved					NA	NA		7800000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 52: Non-specific - Transcription"			"HPA064055: AB_2685183"	"unprognostic (9.93e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.12e-3)"	"unprognostic (3.30e-3)"	"prognostic unfavorable (4.67e-4)"	"unprognostic (1.05e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.51e-3)"	"unprognostic (9.41e-2)"	"prognostic unfavorable (2.67e-5)"	"unprognostic (1.26e-1)"	"unprognostic (6.09e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.02e-1)"	6.3	7.0	20.3	5.7	21.6	6.2	5.5	17.9	29.6	5.5	17.6	8.8	6.5	6.6	2.6	6.4	4.8	3.4	5.4	23.6	18.3	8.2	9.0	5.7	6.4	19.2	18.0	3.6	6.2	4.8	5.4	4.1	18.5	5.7	3.0	0.6	5.4	3.3	6.1	6.7	9.8	3.4	17.8	11.8	9.4	3.3	19.6	3.5	5.7	2.4	2.8	6.4	5.1	20.9	2.5	9.7	1.6	10.4	4.0	5.0	10.8	7.1	12.7	9.3	11.2	8.0	19.9	1.0	8.8	9.6	15.8	7.3	4.4	7.8	2.6	11.8	13.3	3.6	5.7	53.1	12.7	8.8	14.6	7.7	8.1	6.0	2.7	11.0	14.6	8.8	11.5	14.1	5.5	11.3	4.0	23.6	5.0	6.3	10.2	10.4	3.7	19.3	5.8	3.9	4.0	5.6	5.6	14.2	15.1	1.4	9.7	10.5	11.0	9.9	7.2	24.0	5.3	6.9	6.3	2.3	4.6	13.1	8.3	3.9	39.3	10.4	17.9	35.0	14.2	17.3	17.1	15.4	50.5	14.2	14.0	13.2	1.2	10.6	23.6	12.9	16.3	20.1	20.3	21.6	17.9	29.6	23.6	18.3	19.2	18.0	18.5	17.8	19.6	20.9	8.1	0.0	2.7	7.8	15.0	2.9	4.7	4.5	7.4	14.7	5.2	5.1	3.1	8.6	4.7	5.5	31.3	13.3	10.2	21.8	1.9	11.3	0.4	3.0	3.7	8.4	1.2	9.1	44.5	8.5	14.9	4.6	28.1	4.1	1.3	8.9	9.7	7.7	27.2	16.8	21.5	13.6	2.0	24.9	8.6	1.0	8.1	20.6	3.6	2.8	24.0	4.5	18.6	4.0	6.9	9.5	18.4	6.4	13.2	4.1	28.9	9.0	3.2	13.8	0.0	4.3	4.8	4.4	8.4	8.8	2.4	9.4	12.1	5.8	12.4	3.2
NAIP	"BIRC1, NLRB1"	ENSG00000249437	"NLR family apoptosis inhibitory protein"	Q13075	5	70968166-71025339	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Immunity, Inflammatory response, Innate immunity"	"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 31.6"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 138.4;Macrophages: 97.4;Microglial cells: 113.4;Oligodendrocytes: 177.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 8.4;myeloid DC: 5.3"	"Group enriched"	"Detected in many"	16	"dendritic cells: 5.3;granulocytes: 4.4;monocytes: 8.4"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 3.9;SiHa: 2.1;T-47d: 2.3"									HPA042438	Approved					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA042438: AB_10796578"	"unprognostic (9.03e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.50e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.23e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.54e-2)"	"unprognostic (5.13e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.38e-1)"	"unprognostic (9.96e-2)"	5.5	2.7	1.1	2.7	0.8	1.6	3.4	1.8	1.7	3.0	1.0	3.2	0.3	2.1	0.8	1.4	4.5	1.1	2.9	1.0	0.8	2.7	3.4	6.8	2.4	0.8	0.5	2.9	3.3	0.2	1.4	0.6	1.0	2.2	0.5	2.1	1.8	0.5	1.0	2.2	4.6	0.8	0.5	31.6	2.8	4.1	1.2	0.4	3.6	0.0	0.2	3.0	2.7	1.0	0.0	0.0	0.6	0.3	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.5	0.4	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.5	0.4	0.5	0.7	0.1	0.8	0.4	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.3	0.4	0.0	0.0	3.9	0.0	0.1	0.0	0.0	0.1	0.0	0.8	0.2	0.1	0.4	0.0	2.1	0.0	0.1	0.4	2.3	0.0	0.0	0.6	0.2	0.1	0.0	0.5	0.0	0.3	0.1	0.1	0.4	0.2	8.4	0.0	0.2	2.0	0.1	0.0	0.0	0.1	5.3	0.2	0.2	0.1	4.4	0.3	0.4	0.3	0.1	2.5	1.1	0.8	1.8	1.7	1.0	0.8	0.8	0.5	1.0	0.5	1.2	1.0	8.5	19.2	9.7	60.7	9.4	3.6	2.4	2.2	2.8	16.2	10.2	4.6	3.2	11.5	8.2	5.5	22.9	3.7	7.3	4.1	0.0	1.9	44.0	10.0	15.1	11.1	10.7	18.3	50.2	2.3	2.4	8.2	14.3	10.9	5.1	15.8	9.3	7.3	69.3	16.8	46.4	5.6	2.0	138.4	16.4	11.6	10.8	97.4	1.8	113.4	44.2	6.7	4.1	67.8	177.5	1.6	2.5	7.2	9.8	2.3	1.6	1.3	6.9	38.4	6.6	12.8	5.5	13.7	4.4	3.6	3.8	2.9	8.5	6.0	4.0	1.5
NANS	SAS	ENSG00000095380	"N-acetylneuraminate synthase"	Q9NR45	9	98056732-98083077	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Intestinal goblet cells: 362.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019223	Approved		Enhanced	Nucleoplasm		No	No		410000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 4: Stomach - Digestion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA019223: AB_1854298"	"unprognostic (2.95e-1)"	"unprognostic (5.10e-3)"	"unprognostic (2.24e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (7.31e-3)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (2.08e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.36e-2)"	"unprognostic (3.62e-3)"	"unprognostic (1.79e-1)"	39.4	28.9	16.2	49.3	15.0	67.8	36.5	13.8	18.2	49.9	29.8	133.5	52.2	28.5	33.5	51.4	29.4	34.2	46.3	15.1	17.0	32.8	67.0	45.9	59.5	16.2	17.2	26.2	67.6	20.4	42.5	31.7	18.4	106.4	129.2	8.3	120.0	19.7	34.2	29.2	47.8	29.0	15.1	53.3	76.1	27.2	17.2	18.8	27.3	17.4	60.5	47.5	41.5	17.2	387.9	111.8	32.5	94.5	64.0	68.8	70.5	120.9	93.7	96.3	78.3	134.8	53.6	118.1	57.2	133.3	101.9	134.1	61.0	103.6	80.0	95.7	91.0	70.3	128.4	271.9	176.3	80.3	55.3	58.4	69.1	102.9	116.4	111.8	104.3	57.9	129.9	119.8	71.2	265.0	54.1	114.9	56.2	277.5	143.3	103.4	89.0	121.5	78.2	116.6	65.7	34.4	77.8	414.4	107.2	35.8	137.6	85.3	274.2	74.8	72.5	193.4	125.8	110.7	99.3	45.7	88.4	95.9	59.6	30.9	190.9	29.5	34.9	237.6	53.4	55.6	45.5	36.8	194.7	54.9	48.8	33.7	77.4	38.9	217.0	178.8	58.3	91.4	16.2	15.0	13.8	18.2	15.1	17.0	16.2	17.2	18.4	15.1	17.2	17.2	46.7	28.9	54.9	3.6	57.0	70.1	134.0	183.0	30.7	11.4	61.6	45.5	25.3	42.9	206.3	22.0	18.8	86.7	50.2	234.3	70.5	49.4	42.8	63.4	37.9	63.4	64.9	18.7	6.7	100.7	159.2	50.6	99.4	55.8	43.8	29.5	34.2	33.6	160.0	10.1	7.2	362.7	95.6	67.7	107.6	71.5	32.3	89.8	129.9	6.5	53.1	14.1	14.4	2.0	3.1	70.9	181.0	26.4	141.1	213.6	66.5	68.3	204.5	8.0	13.1	32.9	91.3	10.5	21.9	42.0	61.7	150.8	50.6	44.6	260.1	223.3
NCSTN	"APH2, KIAA0253"	ENSG00000162736	Nicastrin	Q92542	1	160343316-160358952	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Notch signaling pathway"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 147.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021982, HPA054846, HPA070642"	Approved		Approved	Cytosol		NA	NA		130000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"CAB021982: , HPA054846: AB_2682624, HPA070642: AB_2686289"	"unprognostic (1.08e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.89e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.62e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.06e-2)"	"prognostic unfavorable (7.75e-9)"	"unprognostic (1.36e-3)"	"unprognostic (3.15e-1)"	"unprognostic (3.14e-2)"	"unprognostic (4.89e-2)"	51.0	36.6	30.6	42.1	36.1	38.1	43.9	38.5	32.5	52.4	42.0	58.4	80.4	40.3	56.4	35.1	49.7	42.9	50.6	29.9	35.8	59.7	59.3	56.0	38.3	40.0	34.0	51.7	63.8	86.0	30.1	98.7	41.6	45.2	60.9	48.1	60.5	47.3	37.6	38.9	63.5	52.1	37.3	46.2	45.7	41.8	36.4	40.0	63.8	38.4	43.0	45.6	31.5	48.9	52.1	57.4	100.4	82.8	301.0	153.4	108.3	104.0	177.0	95.4	109.9	47.9	140.0	36.6	208.6	209.3	67.1	81.5	47.3	95.9	82.4	56.5	42.3	36.6	70.9	70.0	118.6	82.8	152.0	155.7	92.3	94.3	93.6	207.2	139.9	54.3	66.9	100.2	142.2	34.3	26.8	39.8	82.2	130.6	33.8	35.1	59.9	103.6	130.5	69.9	34.2	75.6	109.1	118.5	70.9	158.0	108.2	186.3	125.5	70.3	46.4	48.8	79.9	130.8	194.4	38.6	106.6	49.8	129.4	71.4	79.0	67.8	27.4	79.0	26.2	31.1	23.5	24.0	75.1	27.8	23.9	23.3	69.2	36.6	79.6	45.1	26.5	52.2	30.6	36.1	38.5	32.5	29.9	35.8	40.0	34.0	41.6	37.3	36.4	48.9	28.0	6.4	9.3	0.0	23.0	10.5	23.8	59.5	15.9	20.0	27.9	23.1	14.6	45.8	42.6	53.3	52.1	107.7	27.8	53.3	7.9	38.9	2.6	19.2	19.7	23.9	20.3	17.2	0.0	27.0	95.7	33.7	17.9	30.2	13.3	25.8	29.6	31.4	58.0	18.5	0.0	31.8	46.8	47.1	18.8	4.7	27.1	33.4	17.8	0.0	31.7	35.0	20.6	0.0	0.0	34.8	33.4	21.1	33.2	15.6	66.1	24.7	28.7	26.3	26.3	23.8	19.6	44.6	35.9	15.5	11.4	147.4	16.5	32.5	29.6	20.5
NPC2	"EDDM1, HE1, NP-C2"	ENSG00000119655	"NPC intracellular cholesterol transporter 2"	P61916	14	74476192-74494177	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"		"Disease variant, Niemann-Pick disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	21	"epididymis: 16783.1"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 2034.2;Hofbauer cells: 2898.5;Kupffer cells: 2035.4"	"Cancer enriched"	"Detected in all"	5	"thyroid cancer: 769.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 668.7;classical monocyte: 1300.7;intermediate monocyte: 1772.7;myeloid DC: 587.8;neutrophil: 674.2;non-classical monocyte: 1252.1;plasmacytoid DC: 2113.2"	"Group enriched"	"Detected in all"	5	"dendritic cells: 2113.2;granulocytes: 674.2;monocytes: 1772.7"	"Cell line enhanced"	"Detected in all"		"ASC diff: 1619.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000835, CAB032888"	Enhanced				"Secreted to blood"	NA	NA		53000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"			"CAB032888: AB_2157036, HPA000835: AB_1079499"	"unprognostic (1.27e-3)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (4.83e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.82e-2)"	"unprognostic (3.72e-2)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (6.67e-3)"	"unprognostic (3.26e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.11e-3)"	"prognostic unfavorable (2.66e-4)"	"unprognostic (1.97e-1)"	"prognostic favorable (6.55e-4)"	"unprognostic (1.42e-1)"	260.1	297.0	127.1	261.3	145.4	305.3	221.3	152.2	190.6	284.5	434.0	259.7	201.7	196.7	16783.1	185.0	170.0	356.0	215.1	118.1	156.9	322.4	202.4	786.0	360.3	185.7	145.6	283.1	219.9	241.3	197.5	263.1	179.2	164.2	220.8	48.6	221.9	261.3	58.7	181.6	193.3	180.5	151.1	305.6	206.8	156.8	172.1	134.4	444.7	114.7	241.9	347.4	187.9	195.5	297.2	199.3	124.8	179.4	1619.3	498.6	404.8	194.1	707.1	200.9	398.9	351.7	420.3	78.6	141.6	181.9	372.6	595.9	170.0	405.5	188.6	120.4	126.3	29.6	96.7	296.2	348.6	51.0	548.4	467.7	388.9	173.7	336.9	930.2	298.1	87.0	32.9	601.4	224.0	106.9	70.1	75.9	52.9	489.0	307.9	39.5	219.1	281.6	511.1	735.0	5.5	91.3	296.3	120.3	298.0	359.6	205.2	225.7	268.9	291.9	342.0	396.1	188.2	253.7	452.5	24.2	292.1	168.4	163.4	668.7	1300.7	274.1	92.2	1772.7	87.9	295.2	126.5	92.3	587.8	241.8	120.9	100.5	674.2	99.5	1252.1	2113.2	187.8	1304.5	127.1	145.4	152.2	190.6	118.1	156.9	185.7	145.6	179.2	151.1	172.1	195.5	154.9	381.4	2034.2	11.1	160.2	374.9	557.8	1074.2	170.2	9.9	138.6	220.5	55.4	163.0	626.9	331.1	22.9	228.3	664.0	301.0	305.2	500.4	90.9	123.8	168.5	276.5	119.7	65.4	2.1	279.4	803.3	318.1	61.7	161.0	341.4	104.2	447.3	195.6	2898.5	8.4	3.8	264.8	832.1	2035.4	750.9	69.6	566.7	1462.6	602.9	6.5	790.5	167.4	117.4	7.5	24.4	368.3	405.1	291.9	287.4	357.9	298.1	969.0	393.3	25.1	131.5	118.3	155.9	268.1	166.7	182.6	320.7	210.4	109.9	330.0	298.5	521.6
NUCB1	"Calnuc, NUC"	ENSG00000104805	"Nucleobindin 1"	Q02818	19	48900312-48923372	"Plasma proteins, Predicted secreted proteins"		"DNA-binding, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 453.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008176	Supported		Supported	"Golgi apparatus,Microtubules"	"Secreted to blood"	NA	NA		27000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 16: U-266 - Nucleosome"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus"	Microtubules	"HPA008176: AB_1845923"	"unprognostic (2.13e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.36e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.95e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.51e-2)"	"unprognostic (8.14e-3)"	"unprognostic (2.34e-3)"	"unprognostic (9.89e-2)"	"unprognostic (5.04e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.90e-3)"	"unprognostic (3.41e-1)"	181.3	103.5	55.8	106.8	60.4	82.3	141.6	65.5	68.1	115.0	79.4	122.1	179.9	127.6	61.3	111.2	116.9	108.3	204.0	58.2	63.0	154.6	264.5	157.1	82.1	65.9	62.9	125.6	130.1	173.5	69.5	114.8	67.5	109.2	54.8	30.2	117.8	103.0	180.1	96.6	163.6	106.0	57.7	111.1	118.8	34.7	73.1	49.5	122.2	110.7	53.1	130.1	108.9	61.6	54.8	182.1	84.2	188.5	304.6	249.2	97.6	208.1	189.9	103.3	144.2	92.9	203.1	54.7	151.8	250.6	98.9	132.0	48.6	107.0	43.3	194.6	90.3	141.6	119.0	131.6	156.6	85.1	183.6	288.0	52.1	96.8	62.9	275.2	167.2	60.7	173.1	278.8	107.0	71.6	42.3	68.6	42.2	132.1	93.5	78.7	125.3	114.9	90.2	134.6	61.2	123.2	247.1	152.2	88.1	79.7	78.8	112.1	234.6	172.3	114.3	107.0	99.3	210.8	501.1	37.1	132.5	54.3	207.3	102.9	108.5	105.7	100.6	128.5	75.3	46.8	67.5	77.2	79.0	37.3	55.3	56.7	104.7	69.2	114.2	113.9	74.6	129.5	55.8	60.4	65.5	68.1	58.2	63.0	65.9	62.9	67.5	57.7	73.1	61.6	154.5	41.7	72.1	17.6	51.0	48.3	67.2	81.3	66.0	21.7	57.6	57.5	58.0	78.6	51.5	69.9	14.6	101.5	69.6	153.0	41.1	148.0	10.8	27.4	65.5	116.0	74.4	54.5	14.5	118.3	150.9	126.7	76.0	50.2	95.2	64.1	122.0	149.2	213.7	20.2	18.9	109.9	69.2	138.3	74.6	9.3	110.3	101.9	101.4	17.8	120.3	52.6	74.2	8.5	11.8	100.0	149.2	124.1	126.3	63.8	453.3	135.4	24.4	20.5	92.1	51.0	79.0	21.9	37.6	65.6	49.9	102.1	73.0	103.9	123.3	68.1
OTOA	"CT108, DFNB22"	ENSG00000155719	Otoancorin	Q7RTW8	16	21663968-21761935	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	Hearing		"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"lymphoid tissue: 1.8;testis: 4.0"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 111.8;Kupffer cells: 60.5;Late spermatids: 18.7;Macrophages: 34.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Lineage enriched"	"Detected in single"	13	"dendritic cells: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041405	Enhanced				"Secreted in other tissues"	NA	NA		51000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 78: Testis - Spermatogenesis"		"Cluster 4: Macrophages - Innate immune response"			"HPA041405: AB_10796344"	"unprognostic (7.96e-2)"	"unprognostic (2.44e-4)"	"unprognostic (1.66e-2)"	"unprognostic (9.69e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.11e-1)"	"unprognostic (4.71e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.08e-4)"	"unprognostic (1.83e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.18e-2)"	0.1	0.2	0.2	0.0	0.2	0.2	0.1	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.2	0.2	0.2	0.1	0.0	0.0	0.0	0.4	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	4.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.2	0.1	0.3	0.2	0.1	0.2	0.1	0.2	0.1	0.2	0.3	8.4	0.0	0.5	0.3	0.7	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.9	0.0	0.0	1.8	0.0	0.4	0.1	0.3	0.0	0.2	11.6	0.3	0.2	1.0	1.2	0.0	2.6	0.4	0.8	0.3	0.0	0.5	5.7	0.1	0.7	0.4	111.8	0.0	1.8	0.1	0.0	60.5	3.7	18.7	0.3	34.4	1.8	0.0	1.9	0.0	0.0	0.5	0.2	0.1	1.4	0.0	0.1	0.2	0.0	0.7	0.0	0.0	6.6	0.2	0.7	9.4	7.4	0.0	0.1	0.5	0.2	0.1	0.2	0.2
OTULINL	"FAM105A, FLJ11127, NET20"	ENSG00000145569	"OTU deubiquitinase with linear linkage specificity like"	Q9NUU6	5	14581792-14616180	"Enzymes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 30.3"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 29.5;dendritic cells: 36.7;Endometrial stromal cells: 16.6;Hofbauer cells: 100.7;Macrophages: 28.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 17.7;HMC-1: 55.6;OE19: 16.1;THP-1: 16.9;U-937: 27.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046638	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoli, Cytosol"		"HPA046638: AB_2679731"	"unprognostic (1.47e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.15e-3)"	"unprognostic (6.26e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.27e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.42e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (7.62e-4)"	"unprognostic (3.14e-1)"	"unprognostic (8.79e-3)"	3.1	2.7	1.2	6.8	1.1	30.3	4.1	1.3	1.6	3.8	4.8	12.3	6.6	1.5	1.4	1.7	1.4	2.7	0.9	1.1	1.8	3.6	1.4	13.1	5.4	2.3	1.5	2.0	7.6	1.2	2.5	4.2	2.1	8.3	13.3	0.5	1.4	10.0	0.4	1.7	9.4	2.5	2.4	7.9	3.3	2.5	1.9	3.4	2.8	0.8	3.6	5.2	3.1	3.6	0.0	0.8	1.6	0.0	0.3	0.0	6.9	2.0	1.8	0.5	1.0	2.8	1.7	0.1	1.1	0.9	2.8	0.1	3.7	1.6	0.7	1.1	4.9	4.6	17.7	0.4	1.7	0.1	55.6	0.1	0.3	0.2	0.0	0.0	0.1	2.9	0.0	7.1	0.2	1.4	0.0	1.7	2.5	16.1	11.9	0.5	0.7	2.0	0.0	13.9	6.0	7.0	0.9	0.6	0.0	1.7	0.6	16.9	0.0	0.9	4.4	0.4	1.6	0.0	0.0	0.1	1.0	27.2	0.4	0.2	33.4	0.3	5.5	16.2	7.3	0.1	6.7	7.2	33.8	0.1	9.0	9.1	8.6	19.2	12.7	25.0	12.8	24.6	1.2	1.1	1.3	1.6	1.1	1.8	2.3	1.5	2.1	2.4	1.9	3.6	10.2	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	7.4	7.9	0.0	0.0	0.0	29.5	0.0	0.9	36.7	0.0	1.9	0.4	0.0	0.9	16.6	1.1	0.0	0.0	0.0	6.2	2.2	1.4	0.0	1.2	0.0	0.5	0.0	0.0	100.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.3	0.0	0.0	12.9	0.0	0.0	0.0	0.0	1.2	0.0	0.0	4.4	0.0	0.0	3.5	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.4	8.8	0.2	0.0	0.0
P4HB	"DSI, ERBA2L, GIT, P4Hbeta, PDI, PDIA1, PO4DB, PO4HB, PROHB"	ENSG00000185624	"Prolyl 4-hydroxylase subunit beta"	P07237	17	81843159-81860856	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Chaperone, Isomerase"	"Craniosynostosis, Disease variant, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 1856.8;pancreas: 2446.9"	"Cell type enhanced"	"Detected in all"		"Exocrine glandular cells: 1077.9;Extravillous trophoblasts: 1349.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012463, HPA018884"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	No	No		110000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"CAB012463: , HPA018884: AB_1854896"	"unprognostic (9.47e-3)"	"unprognostic (1.09e-2)"	"unprognostic (2.99e-2)"	"unprognostic (7.14e-3)"	"unprognostic (7.75e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.93e-2)"	"prognostic unfavorable (2.30e-11)"	"unprognostic (1.18e-1)"	"unprognostic (1.04e-2)"	"unprognostic (4.99e-3)"	"unprognostic (3.19e-3)"	266.5	507.8	34.6	209.8	35.7	517.1	225.5	39.1	35.7	272.0	59.6	258.4	640.2	206.5	133.0	618.7	183.4	202.0	318.4	31.7	50.2	270.7	1856.8	301.3	104.0	48.9	37.1	187.8	2446.9	144.3	330.0	334.3	40.8	335.8	173.6	23.3	948.1	184.2	328.5	370.4	554.7	179.8	39.8	428.6	539.2	68.8	58.7	89.3	244.8	150.8	137.9	233.7	322.9	43.7	690.3	580.7	236.8	687.5	813.4	726.7	593.6	1038.5	1081.1	741.9	934.5	550.4	576.9	264.4	501.8	1120.2	407.5	464.1	248.8	647.4	254.1	145.8	320.5	355.2	362.9	953.6	1010.8	1146.4	613.4	618.8	494.8	478.2	596.7	843.0	1250.1	182.1	273.6	978.2	559.5	566.4	260.5	723.2	157.7	791.0	463.8	261.8	342.5	614.0	453.2	492.8	248.7	301.1	586.1	1693.1	808.1	289.6	855.3	1601.2	644.1	980.5	503.1	574.3	586.6	743.5	407.9	204.8	1372.0	591.3	825.4	198.3	268.1	163.0	202.6	154.4	209.8	83.9	138.9	165.7	174.7	68.1	74.9	114.6	72.9	157.0	115.3	311.5	105.6	372.4	34.6	35.7	39.1	35.7	31.7	50.2	48.9	37.1	40.8	39.8	58.7	43.7	122.3	102.5	162.1	23.2	151.4	120.1	163.6	371.0	140.6	59.2	283.0	170.8	24.1	247.4	211.7	112.2	33.3	790.2	208.9	420.7	41.1	671.9	43.5	78.4	196.8	153.9	199.9	140.9	15.3	1077.9	1349.1	272.5	388.9	209.1	99.1	210.4	190.2	840.7	435.9	62.2	16.2	610.9	189.2	186.9	125.5	64.9	141.4	180.3	136.9	20.6	263.3	122.7	230.7	13.6	19.6	575.2	465.6	112.1	664.3	310.6	914.2	105.0	91.3	54.3	157.8	103.4	226.7	83.4	94.1	302.3	144.6	1001.2	138.8	378.4	475.4	220.8
PARVG		ENSG00000138964	"Parvin gamma"	Q9HBI0	22	44172956-44219533	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 49.7;lymphoid tissue: 30.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 56.9;dendritic cells: 51.7;granulocytes: 60.1;Hofbauer cells: 66.7;Kupffer cells: 87.3;Langerhans cells: 53.4;Macrophages: 91.9;monocytes: 62.0;T-cells: 48.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"HL-60: 116.4;NB-4: 44.9;THP-1: 64.7;U-937: 53.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031833, HPA031834"	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 57: B-cells - Immune response"			"HPA031833: AB_2674063, HPA031834: AB_10601242"	"unprognostic (9.83e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.06e-1)"	"prognostic favorable (4.44e-6)"	"unprognostic (2.79e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.19e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.36e-1)"	"prognostic unfavorable (3.43e-6)"	"unprognostic (3.73e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.89e-2)"	3.5	2.9	3.7	26.7	3.5	49.7	1.8	4.4	7.1	2.6	4.0	3.1	3.6	2.4	0.6	2.5	2.2	6.2	1.3	3.8	4.7	1.8	3.1	10.4	30.1	8.2	4.9	0.8	1.4	0.5	1.3	3.0	6.9	2.1	3.4	0.2	2.6	1.1	1.2	1.7	12.7	2.9	5.9	28.9	4.4	1.7	7.9	18.4	1.9	0.4	26.8	4.7	1.5	9.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.8	0.0	0.0	0.0	116.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	16.8	44.9	0.1	0.0	0.0	9.2	0.2	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.0	64.7	0.0	0.0	11.5	0.2	0.0	0.3	0.0	0.3	0.0	53.9	1.9	12.5	62.0	71.3	13.9	57.6	13.9	21.4	8.0	15.2	49.2	20.4	8.9	10.3	72.2	13.1	65.9	33.3	12.1	44.6	3.7	3.5	4.4	7.1	3.8	4.7	8.2	4.9	6.9	5.9	7.9	9.4	1.3	6.4	14.0	1.0	56.9	2.4	0.1	0.0	0.6	0.2	0.7	1.5	1.1	0.0	3.1	0.0	0.0	0.6	51.7	0.1	0.0	0.0	4.2	3.7	0.4	2.9	0.0	10.1	3.9	0.2	0.7	2.3	3.6	2.5	60.1	0.0	3.9	1.3	66.7	0.0	2.9	0.0	0.0	87.3	53.4	2.7	0.0	91.9	5.4	10.3	62.0	0.0	26.8	0.0	1.4	0.0	0.0	0.0	15.9	0.0	0.0	0.5	1.5	0.2	0.0	0.5	0.4	1.1	0.8	0.4	1.8	1.0	48.3	0.0	0.1	0.1
PDE6B	"CSNB3, CSNBAD2, PDEB, rd1, RP40"	ENSG00000133256	"Phosphodiesterase 6B"	P35913	4	625573-670782	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Congenital stationary night blindness, Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"retina: 385.0"	"Cell type enriched"	"Detected in many"	5	"Rod photoreceptor cells: 460.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"EFO-21: 11.5;JURKAT: 17.3;MOLT-4: 31.3;REH: 16.8;SCLC-21H: 20.2;SH-SY5Y: 11.9;U-266/84: 24.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA054148, HPA059929"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 77: Retina - Visual perception"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol		"HPA054148: AB_2682401, HPA059929: AB_2684166"	"unprognostic (2.43e-2)"	"unprognostic (1.33e-4)"	"unprognostic (2.45e-4)"	"unprognostic (7.18e-3)"	"unprognostic (1.88e-2)"	"unprognostic (5.04e-3)"	"unprognostic (7.32e-3)"	"prognostic favorable (5.34e-4)"	"unprognostic (9.70e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.41e-3)"	"unprognostic (1.85e-1)"	1.9	2.2	13.5	5.5	25.7	8.4	4.1	8.2	22.3	2.5	1.9	1.7	1.2	2.7	4.0	1.7	10.2	3.7	5.9	11.2	22.6	4.9	1.0	4.6	14.3	22.8	19.9	2.8	1.8	8.2	4.1	3.1	25.5	2.8	1.3	385.0	3.8	3.0	1.1	2.1	3.0	2.5	9.3	10.1	2.9	4.4	24.1	12.2	12.0	0.1	9.3	3.8	1.4	39.3	0.1	0.0	1.2	0.5	0.3	0.4	0.4	0.0	0.1	0.8	2.0	0.0	0.1	0.3	11.5	0.3	0.9	0.1	2.5	0.6	0.0	0.1	0.0	1.0	0.3	0.1	5.8	0.2	0.4	0.7	0.0	3.5	0.0	0.8	1.1	17.3	0.1	1.0	0.1	0.3	31.3	0.1	9.4	0.7	0.0	16.8	0.2	0.2	2.1	1.3	20.2	11.9	0.0	0.3	0.1	4.2	0.6	0.0	0.4	0.2	1.2	0.2	0.4	7.7	24.0	0.3	0.3	0.3	0.2	16.8	5.4	0.9	14.0	7.7	12.6	12.8	9.3	9.8	8.5	21.4	14.6	15.8	1.4	14.4	8.1	18.2	15.5	9.4	13.5	25.7	8.2	22.3	11.2	22.6	22.8	19.9	25.5	9.3	24.1	39.3	0.5	3.2	5.0	4.2	6.4	0.4	2.1	1.2	2.8	20.7	3.9	2.4	4.4	0.0	3.5	0.0	83.4	0.1	8.4	0.2	1.9	6.9	0.4	7.0	2.2	2.9	1.8	7.4	40.3	0.6	0.3	1.3	1.5	2.5	3.8	5.4	2.2	0.0	11.3	11.8	27.3	0.5	4.1	5.1	1.4	0.3	1.5	3.3	3.6	4.7	6.2	31.1	7.2	10.1	33.9	0.8	0.2	1.5	7.5	1.9	0.0	8.4	11.2	460.1	0.0	1.6	1.1	4.3	11.0	1.9	0.3	0.3	5.9	3.5	0.4	1.3
PILRA	FDF03	ENSG00000085514	"Paired immunoglobin like type 2 receptor alpha"	Q9UKJ1	7	100367530-100400096	"Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 80.8;Kupffer cells: 100.7;Langerhans cells: 65.9;Leydig cells: 52.5;Macrophages: 144.7;monocytes: 72.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 1659.8;non-classical monocyte: 1146.1"	"Group enriched"	"Detected in all"	5	"granulocytes: 1659.8;monocytes: 1146.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 27.9;HMC-1: 25.5;NB-4: 20.4"									HPA056132	Approved				"Secreted to blood"	NA	NA		1500000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA056132: AB_2683048"	"unprognostic (5.53e-2)"	"prognostic favorable (2.99e-4)"	"unprognostic (7.61e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.20e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.01e-3)"	"unprognostic (9.95e-2)"	"unprognostic (8.57e-2)"	"unprognostic (4.56e-2)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (3.47e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.80e-2)"	14.6	9.3	7.2	38.5	7.5	26.0	8.9	13.7	9.6	10.7	7.7	7.6	4.1	8.2	4.7	3.7	14.2	9.3	5.7	6.9	9.3	12.6	9.7	30.4	9.2	12.1	9.4	9.5	5.3	3.6	15.5	11.3	11.7	11.3	5.3	3.8	5.7	4.0	5.3	5.3	8.0	9.8	9.0	31.1	5.9	10.8	9.3	5.0	9.4	2.9	3.5	17.7	6.7	15.5	0.3	0.4	0.6	0.7	27.9	1.8	0.2	0.2	1.4	0.1	0.5	0.0	0.5	0.6	1.7	0.4	0.3	0.8	0.2	0.1	0.0	1.4	1.0	0.6	1.3	0.1	0.3	1.1	25.5	2.0	0.4	0.2	0.6	0.1	0.3	2.5	0.2	1.8	0.2	0.9	2.0	20.4	0.6	0.4	0.3	0.5	0.0	0.4	1.1	0.6	0.8	0.3	0.0	6.9	0.7	0.1	0.1	6.0	0.6	1.2	1.2	0.8	0.2	2.5	2.0	0.6	0.3	2.3	0.4	316.9	584.3	18.5	2.5	863.0	2.1	2.3	0.9	1.0	288.0	1.1	1.0	1.8	1659.8	6.4	1146.1	5.4	2.2	354.1	7.2	7.5	13.7	9.6	6.9	9.3	12.1	9.4	11.7	9.0	9.3	15.5	1.0	3.2	12.4	8.8	2.7	1.8	0.3	0.9	0.0	3.6	2.1	3.0	0.6	2.8	3.9	1.8	4.2	0.6	2.1	0.6	27.4	0.2	0.7	3.9	13.1	4.1	0.0	2.7	15.9	0.4	0.6	2.8	0.5	5.8	10.1	0.8	1.8	1.8	80.8	1.7	14.8	1.3	0.0	100.7	65.9	1.9	52.5	144.7	1.8	28.1	72.3	1.4	3.1	2.0	10.3	0.3	0.1	21.4	0.4	0.5	0.1	0.7	3.1	2.4	0.0	1.0	0.7	1.6	2.6	0.2	0.9	0.8	2.0	0.4	0.9	0.3
PKD1L3		ENSG00000277481	"Polycystin 1 like 3, transient receptor potential channel interacting"	Q7Z443	16	71929538-71999978	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"liver: 1.0"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.9;Excitatory neurons: 2.5;Inhibitory neurons: 2.2;Microglial cells: 1.9;Oligodendrocytes: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA				"Cluster 85: Liver - Metabolism"		"Cluster 54: Cardiomyocytes - Muscle contraction"				"unprognostic (1.75e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.46e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.90e-4)"	"unprognostic (2.22e-1)"	"unprognostic (1.35e-6)"	"unprognostic (6.71e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.93e-3)"	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.1	0.2	0.2	0.0	0.0	2.5	0.0	0.0	0.2	0.0	0.3	0.0	0.5	0.4	0.3	0.5	0.0	2.2	0.3	0.0	0.0	0.0	0.3	0.3	0.3	0.0	1.9	0.0	0.0	0.0	0.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.2	0.7	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0
PLA2G15	"GXVPLA2, LLPL, LYPLA3"	ENSG00000103066	"Phospholipase A2 group XV"	Q8NCC3	16	68245304-68261058	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid degradation, Lipid metabolism"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 58.3"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 116.0;Horizontal cells: 38.7;Kupffer cells: 37.1;Syncytiotrophoblasts: 50.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041702, HPA041727"	Enhanced		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		38000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Vesicles"		"HPA041702: AB_10794486, HPA041727: AB_10793931"	"unprognostic (3.47e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.54e-3)"	"unprognostic (6.84e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.65e-2)"	"unprognostic (4.12e-3)"	"unprognostic (3.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.56e-1)"	"unprognostic (9.29e-2)"	"unprognostic (2.45e-3)"	"unprognostic (2.98e-2)"	"unprognostic (5.40e-3)"	"unprognostic (6.28e-2)"	"unprognostic (3.47e-2)"	15.1	11.5	12.9	7.6	12.5	7.0	9.8	12.8	18.1	6.6	9.2	8.0	6.9	6.2	8.7	6.2	7.4	9.3	35.5	13.1	14.2	33.4	17.3	17.5	13.6	13.1	14.1	7.7	7.4	11.4	11.4	27.3	14.6	8.1	5.9	4.4	9.1	5.7	58.3	13.9	6.5	8.8	12.4	20.3	8.4	10.8	15.9	11.7	13.2	22.4	5.1	8.8	6.4	16.1	10.0	10.0	7.9	25.5	36.7	26.8	19.0	24.6	31.6	35.7	30.2	26.1	18.6	17.4	31.2	34.1	28.5	15.2	8.5	10.4	15.9	6.0	16.4	5.0	10.4	19.0	19.6	4.6	25.0	19.0	11.2	35.2	5.5	44.6	22.5	8.9	7.9	9.8	23.0	21.3	7.2	14.5	5.1	9.4	12.1	9.9	11.3	55.3	17.7	8.7	3.0	5.1	31.2	9.6	19.2	6.6	25.2	23.7	18.8	31.5	15.0	41.1	16.5	34.6	33.5	22.1	28.6	13.8	12.0	19.6	24.1	16.0	4.7	27.5	4.8	5.0	5.2	7.0	14.1	5.3	6.5	5.5	1.0	2.3	32.4	12.2	5.1	14.6	12.9	12.5	12.8	18.1	13.1	14.2	13.1	14.1	14.6	12.4	15.9	16.1	4.4	6.4	3.3	3.6	3.0	4.8	2.4	6.8	2.8	12.1	7.0	6.0	22.5	1.5	5.1	9.2	8.4	20.9	4.9	8.1	5.9	10.1	1.9	4.3	4.8	5.9	0.0	1.7	7.0	7.2	7.6	8.2	8.6	9.0	15.2	6.6	9.3	13.7	116.0	38.7	6.7	8.5	2.0	37.1	6.8	6.1	2.1	21.4	12.4	10.3	7.7	4.4	3.1	5.5	3.9	6.3	5.0	1.5	2.6	2.6	3.0	19.5	2.7	6.1	0.0	5.5	6.7	3.4	2.8	4.1	3.4	50.8	3.9	3.1	4.1	2.0
PLD3	HU-K4	ENSG00000105223	"Phospholipase D family member 3"	Q8IV08	19	40348456-40380439	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response"	"Exonuclease, Hydrolase, Nuclease"	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 711.9"	"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 688.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"basophil: 1727.4"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 1727.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012800, CAB020812"	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum,Cytosol"		NA	NA		450000	"Cluster 10: Basophils - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Endoplasmic reticulum, Cytosol"	Nucleoplasm	"CAB020812: , HPA012800: AB_1855330"	"unprognostic (1.11e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.64e-3)"	"unprognostic (2.56e-3)"	"unprognostic (2.06e-3)"	"unprognostic (2.68e-1)"	"unprognostic (4.52e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.60e-2)"	"prognostic favorable (6.44e-4)"	"unprognostic (4.34e-2)"	"prognostic favorable (2.21e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.38e-2)"	"unprognostic (6.42e-2)"	169.3	200.0	143.3	78.4	159.7	48.3	138.4	46.0	229.7	139.4	54.0	131.4	71.7	155.7	84.7	84.9	133.5	96.7	206.1	202.5	294.4	130.2	121.3	181.5	98.1	132.4	128.5	199.0	151.0	105.9	711.9	123.4	137.9	133.4	49.2	51.4	138.7	106.2	105.1	120.5	105.3	79.1	63.8	197.0	126.5	77.7	197.7	44.3	120.8	82.3	41.4	126.2	126.0	129.6	85.6	257.8	163.7	259.1	444.2	210.2	124.5	206.5	208.6	146.4	166.6	49.4	93.8	36.9	211.0	180.9	47.8	39.3	39.9	81.2	63.5	138.4	145.3	39.9	82.1	63.2	302.7	16.8	435.1	402.5	167.0	112.1	76.6	244.2	125.0	59.3	142.5	144.5	106.7	111.5	29.5	79.6	107.4	138.7	52.8	37.0	124.5	154.2	75.2	63.2	116.7	193.9	99.0	60.6	113.8	169.5	83.6	283.2	222.3	122.8	58.5	105.6	47.0	148.9	173.3	38.8	197.7	66.2	77.9	1727.4	256.7	378.7	75.0	129.5	62.0	34.4	59.5	67.7	235.0	28.1	60.8	61.3	25.7	102.3	64.2	34.7	64.5	208.6	143.3	159.7	46.0	229.7	202.5	294.4	132.4	128.5	137.9	63.8	197.7	129.6	66.7	32.1	69.6	59.4	27.0	35.4	93.6	263.1	39.9	101.5	45.9	61.2	22.0	45.8	90.4	57.0	33.3	158.2	27.2	42.5	21.5	52.5	8.7	32.0	49.8	53.9	72.8	18.7	99.1	58.3	107.2	158.8	38.2	31.5	60.3	134.7	88.2	43.1	688.4	121.1	113.4	41.3	126.1	280.9	59.1	15.7	151.6	261.3	92.5	50.6	54.2	94.1	35.0	53.3	70.2	54.3	42.6	143.7	85.8	57.9	78.8	37.1	35.2	47.6	19.7	73.1	59.7	24.2	67.9	32.4	33.4	195.9	28.8	114.1	41.6	68.2
PLEK	P47	ENSG00000115956	Pleckstrin	P08567	2	68365282-68397453	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"bone marrow: 604.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 310.7;Hofbauer cells: 220.3;Kupffer cells: 213.9;Langerhans cells: 456.5;Macrophages: 412.7;monocytes: 178.3;NK-cells: 355.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 552.9;HL-60: 126.7;HMC-1: 202.5;NB-4: 187.5;THP-1: 215.6;U-266/84: 147.8;U-698: 147.1;U-937: 342.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031838, HPA057341"	Enhanced		Approved	Nucleoli		NA	NA		380000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoli		"HPA031838: AB_10602146, HPA057341: AB_2732609"	"unprognostic (2.57e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.87e-3)"	"unprognostic (4.52e-3)"	"unprognostic (3.52e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.67e-2)"	"unprognostic (3.40e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (3.57e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.56e-1)"	36.4	9.8	4.9	99.4	7.1	604.8	8.2	6.0	10.0	6.9	6.5	13.2	10.4	4.7	3.3	6.0	7.2	21.0	5.4	4.9	5.3	4.0	27.5	35.6	129.9	8.0	6.1	2.6	2.7	2.7	1.9	29.2	8.1	4.2	18.8	0.5	5.7	3.1	1.7	3.4	13.0	22.2	7.3	93.5	11.3	3.2	7.2	33.7	3.8	5.2	118.2	52.3	2.5	12.3	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	93.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	552.9	0.0	0.0	0.0	126.7	202.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.3	58.9	0.0	0.0	0.2	187.5	0.0	0.0	0.0	1.5	0.1	27.3	0.0	0.0	0.0	0.1	0.4	0.0	0.4	0.0	0.0	215.6	0.1	0.0	0.4	0.1	0.5	7.9	147.8	147.1	0.2	342.5	0.1	231.9	297.5	429.2	298.5	351.6	157.6	157.7	52.2	218.7	229.6	103.6	14.5	161.8	573.9	249.5	390.8	474.8	5.7	606.9	4.9	7.1	6.0	10.0	4.9	5.3	8.0	6.1	8.1	7.3	7.2	12.3	3.4	19.2	24.6	0.0	77.0	6.5	0.3	0.0	0.0	0.0	1.4	3.7	2.3	1.5	15.5	1.8	0.0	1.2	310.7	0.0	0.0	0.2	1.5	0.2	0.3	6.3	0.0	21.9	0.6	0.6	1.8	10.2	1.5	0.3	62.0	0.0	5.7	1.5	220.3	0.0	0.2	0.0	0.0	213.9	456.5	5.1	0.6	412.7	17.8	20.6	178.3	0.0	355.3	0.0	0.1	0.1	0.1	0.4	48.4	0.0	0.0	0.7	13.1	0.1	13.1	1.1	1.8	0.8	0.9	0.6	6.7	2.6	78.3	0.4	0.0	0.3
PSTPIP1	"CD2BP1, CD2BP1L, CD2BP1S, H-PIP, PAPAS, PSTPIP"	ENSG00000140368	"Proline-serine-threonine phosphatase interacting protein 1"	O43586	15	76993359-77037475	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell adhesion, Endocytosis, Immunity, Inflammatory response, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 56.6;lymphoid tissue: 33.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 60.0;Enteroendocrine cells: 60.0;Hofbauer cells: 42.5;Kupffer cells: 41.8;Macrophages: 41.8;monocytes: 51.1;NK-cells: 91.6;T-cells: 68.4;Theca cells: 78.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 55.1;HL-60: 14.4;NB-4: 20.9;THP-1: 14.7;U-937: 59.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA010116, HPA010600, HPA072744"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Cytosol"		"HPA010116: , HPA010600: AB_1855870, HPA072744: "	"unprognostic (4.42e-3)"	"unprognostic (1.31e-3)"	"unprognostic (3.56e-2)"	"prognostic favorable (4.74e-5)"	"unprognostic (3.79e-2)"	"unprognostic (1.12e-3)"	"unprognostic (2.16e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.85e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.18e-1)"	"prognostic unfavorable (7.36e-9)"	"unprognostic (1.39e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.42e-2)"	6.0	2.6	2.8	11.7	2.7	56.6	2.3	2.7	3.1	2.0	3.4	3.3	2.5	1.6	0.1	2.0	3.1	2.9	2.4	2.7	2.8	3.4	3.4	10.4	13.5	3.1	3.1	1.0	1.3	0.2	1.6	1.8	3.0	2.9	0.8	0.1	2.4	1.0	1.5	1.8	9.4	1.4	3.1	33.9	2.9	0.7	3.6	4.2	2.9	1.0	5.5	4.3	2.7	3.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.1	0.0	55.1	0.0	0.0	0.0	3.3	0.0	14.4	0.1	0.2	0.1	0.0	0.1	0.0	0.0	3.0	0.0	0.0	0.0	0.0	2.4	20.9	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.1	4.0	0.6	0.0	0.1	0.0	0.0	0.0	14.7	0.0	0.0	0.1	0.1	0.0	0.0	1.3	2.4	0.1	59.8	0.0	4.8	71.5	71.4	39.9	33.5	30.8	13.3	27.2	32.7	59.0	18.5	14.3	22.3	85.3	41.6	38.3	5.2	27.0	42.2	2.8	2.7	2.7	3.1	2.7	2.8	3.1	3.1	3.0	3.1	3.6	3.1	1.1	0.0	5.1	1.0	19.2	9.3	1.2	0.4	0.0	1.1	0.9	1.1	1.9	0.0	2.5	0.0	0.0	0.3	60.0	3.1	0.0	0.0	9.6	0.3	0.3	0.8	60.0	4.8	0.4	0.2	0.7	1.9	0.0	0.3	2.5	0.1	2.2	0.9	42.5	0.0	0.1	6.1	2.0	41.8	36.5	18.6	0.9	41.8	7.2	0.0	51.1	0.2	91.6	5.5	1.0	0.1	2.5	2.6	8.5	0.3	0.3	0.4	0.0	0.4	0.0	0.8	3.1	0.2	1.2	0.2	4.8	0.5	68.4	78.1	0.3	1.2
PTK2B	"CADTK, CAKB, FAK2, PTK, PYK2, RAFTK"	ENSG00000120899	"Protein tyrosine kinase 2 beta"	Q14289	8	27311482-27459391	"Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Angiogenesis, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 106.3;brain: 102.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 109.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 127.4;REH: 141.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003850, HPA026091, HPA026276"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 14: REH - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"		"CAB003850: AB_562205, HPA026091: AB_10599739, HPA026276: AB_10601234"	"unprognostic (2.36e-2)"	"prognostic favorable (3.32e-4)"	"unprognostic (1.06e-1)"	"unprognostic (7.36e-3)"	"unprognostic (3.72e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.74e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (5.11e-4)"	"unprognostic (3.33e-3)"	19.7	10.8	46.9	52.6	54.4	106.3	11.5	22.8	102.9	11.5	38.3	29.8	34.1	9.9	8.9	19.2	15.6	12.7	10.6	96.3	8.5	15.9	15.2	28.6	78.3	0.0	26.0	4.7	12.6	7.1	13.7	8.0	0.0	25.5	23.5	4.4	26.6	12.3	5.0	45.2	48.8	10.7	0.2	78.3	22.2	9.5	27.0	86.0	12.5	5.4	73.6	21.0	15.1	37.0	38.2	10.4	2.8	3.0	76.6	5.5	21.5	2.9	1.9	1.9	2.7	9.9	21.5	127.4	4.0	5.8	3.1	34.3	1.1	31.3	1.1	8.7	0.8	26.4	10.6	2.0	15.7	28.5	45.5	41.6	46.0	2.6	17.3	13.0	1.0	36.0	31.7	85.6	2.1	4.0	49.1	57.0	2.2	33.0	2.6	141.2	0.7	88.3	8.5	29.5	19.2	3.5	13.4	9.3	5.0	6.5	11.5	72.1	17.5	1.3	2.8	2.5	1.0	68.0	32.0	68.9	5.2	60.6	2.4	47.3	48.4	36.9	33.9	43.0	22.2	46.0	17.0	24.3	36.1	46.6	20.8	25.9	45.8	29.0	53.5	11.7	18.2	50.1	46.9	54.4	22.8	102.9	96.3	8.5	0.0	26.0	0.0	0.2	27.0	37.0	6.9	3.2	29.8	16.6	64.3	37.7	38.7	19.7	6.8	5.4	5.9	7.7	3.7	8.6	13.0	14.7	0.0	2.9	33.4	65.5	0.0	8.0	1.2	7.1	1.8	9.6	7.8	20.2	109.2	8.3	26.5	3.5	22.4	5.3	28.5	1.1	5.0	24.1	23.1	8.4	9.2	21.9	10.2	68.4	32.1	1.0	1.5	55.3	8.8	22.5	62.5	2.8	70.0	7.5	15.1	13.3	42.0	0.7	68.1	18.6	44.6	16.1	13.9	3.9	0.0	3.3	3.3	4.2	6.4	4.8	30.1	1.9	46.6	1.0	18.1	17.9
PTPN6	"HCP, HCPH, PTP-1C, SHP-1, SHP1"	ENSG00000111679	"Protein tyrosine phosphatase non-receptor type 6"	P29350	12	6946468-6961316	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 131.8;lymphoid tissue: 153.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 214.6;granulocytes: 137.3;Hofbauer cells: 191.6;Kupffer cells: 146.5;Langerhans cells: 118.2;Macrophages: 152.1;NK-cells: 154.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 170.9;HL-60: 154.3;HMC-1: 648.7;THP-1: 259.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001466, CAB004572, CAB072845"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA		6000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Nucleoli	"CAB004572: AB_628251, CAB072845: , HPA001466: AB_1855930"	"unprognostic (4.28e-3)"	"prognostic favorable (1.87e-4)"	"prognostic unfavorable (5.42e-4)"	"prognostic favorable (6.65e-4)"	"unprognostic (6.54e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.44e-2)"	"unprognostic (6.93e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.98e-3)"	"unprognostic (2.60e-2)"	"unprognostic (5.91e-2)"	"prognostic favorable (2.64e-8)"	14.4	15.6	3.7	102.5	3.9	131.8	11.0	4.3	4.2	11.1	6.0	21.9	30.4	6.2	10.2	12.8	13.9	20.3	4.9	3.6	5.2	12.2	19.3	49.7	153.5	7.0	4.6	2.9	11.9	13.7	10.0	19.8	6.3	11.7	21.3	0.7	17.0	9.0	2.0	18.8	42.0	12.3	5.9	128.0	28.0	3.1	6.3	71.3	12.6	4.5	127.3	27.0	7.5	10.6	16.4	30.8	0.2	0.1	0.1	0.0	28.5	0.0	0.0	0.0	0.0	16.5	36.0	11.9	8.4	0.0	0.0	18.3	0.3	21.6	0.0	7.3	6.5	170.9	3.4	13.9	0.0	154.3	648.7	0.1	15.4	0.0	6.5	0.0	0.0	60.0	0.3	1.3	0.0	34.5	55.4	92.2	8.3	38.0	5.1	50.4	0.2	86.5	16.7	30.2	2.7	0.0	5.2	24.9	0.2	20.9	7.7	259.8	0.4	0.0	0.2	0.1	0.2	0.4	0.2	5.5	0.4	66.3	0.5	676.7	368.3	1112.5	263.4	728.6	169.3	595.0	125.3	195.9	377.0	650.0	142.7	182.6	674.8	238.6	1117.7	98.7	146.8	789.3	3.7	3.9	4.3	4.2	3.6	5.2	7.0	4.6	6.3	5.9	6.3	10.6	10.5	6.4	13.8	0.7	214.6	9.1	8.2	18.8	29.6	0.0	8.6	10.0	2.1	11.5	15.3	5.5	0.0	25.6	77.7	16.0	15.6	15.8	50.4	12.1	1.5	7.5	24.7	22.9	0.9	15.4	18.3	3.0	25.0	11.8	137.3	10.9	8.9	11.6	191.6	0.0	0.9	13.2	18.3	146.5	118.2	10.5	0.9	152.1	14.2	3.7	99.7	0.5	154.5	2.0	0.1	12.6	16.9	0.0	53.5	3.9	22.8	14.3	17.2	0.5	6.6	1.6	4.0	0.3	1.3	14.6	8.7	18.5	86.2	24.5	15.6	7.8
RENBP	"RBP, RNBP"	ENSG00000102032	"Renin binding protein"	P51606	X	153935269-153944687	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 43.0;lymphoid tissue: 67.0"	"Cell type enhanced"	"Detected in many"		"granulocytes: 127.7;Hofbauer cells: 183.4;Kupffer cells: 70.7;Proximal tubular cells: 204.2"	"Cancer enhanced"	"Detected in all"		"melanoma: 57.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"granulocytes: 2.7;monocytes: 1.6"	"Cell line enhanced"	"Detected in many"		"EFO-21: 35.5;HMC-1: 121.4;SK-MEL-30: 86.4;U-266/84: 74.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000428, HPA000522"	Enhanced					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA000428: AB_1079799, HPA000522: AB_1079798"	"unprognostic (3.08e-1)"	"prognostic favorable (3.95e-4)"	"unprognostic (1.12e-2)"	"unprognostic (3.29e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.99e-1)"	"prognostic favorable (3.08e-5)"	"unprognostic (2.39e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.25e-2)"	"unprognostic (8.51e-2)"	22.2	19.2	14.6	13.5	18.2	10.9	11.1	16.0	20.6	5.0	12.3	13.8	8.4	3.9	2.5	2.9	5.6	6.2	11.5	14.6	18.8	43.0	5.3	24.6	16.5	18.4	19.8	1.7	1.8	2.1	6.0	10.3	18.0	3.8	4.2	2.2	5.8	2.0	2.2	9.7	13.9	4.7	15.2	67.0	5.9	1.2	19.4	6.2	5.4	0.1	6.3	6.2	4.5	19.6	0.0	0.0	3.3	0.1	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	35.5	0.0	0.1	0.0	7.1	0.0	0.0	0.0	1.5	28.2	0.0	2.3	20.4	0.0	121.4	0.8	0.0	0.0	0.0	0.0	0.0	1.0	8.2	10.3	0.0	0.6	7.5	0.3	0.4	0.3	0.0	13.6	0.0	0.1	0.0	0.0	0.1	2.0	0.0	0.0	86.4	3.0	0.3	9.9	1.3	0.0	0.8	0.0	0.1	12.5	74.8	5.0	2.5	13.3	9.8	1.7	0.9	2.7	0.1	0.7	0.1	0.4	0.0	0.0	0.1	0.2	0.4	0.2	2.0	0.1	1.6	0.3	0.0	0.5	14.6	18.2	16.0	20.6	14.6	18.8	18.4	19.8	18.0	15.2	19.4	19.6	1.9	0.0	2.2	7.2	8.0	4.7	1.3	0.3	0.6	2.4	0.4	0.6	1.0	2.8	0.4	9.2	0.0	1.3	2.6	0.4	37.2	1.4	0.1	0.1	0.5	10.7	1.8	3.0	0.2	0.4	6.0	4.5	0.0	0.3	127.7	1.3	52.1	0.8	183.4	15.2	1.7	1.0	0.0	70.7	13.3	0.4	0.3	49.2	28.4	6.5	40.7	10.7	8.2	0.5	6.2	0.5	5.3	0.4	4.0	1.4	12.3	204.2	0.2	0.8	13.1	2.2	4.9	0.1	1.4	0.4	2.0	2.9	7.5	0.7	0.7	0.6
RGL1	RGL	ENSG00000143344	"Ral guanine nucleotide dissociation stimulator like 1"	Q9NZL6	1	183636085-183928532	"Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 133.5;Excitatory neurons: 176.1;Inhibitory neurons: 141.8;Kupffer cells: 109.1;Oligodendrocytes: 184.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"intermediate monocyte: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 35.0;HSkMC: 54.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019788	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA019788: AB_1856215"	"unprognostic (3.08e-1)"	"unprognostic (5.25e-3)"	"unprognostic (8.73e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.79e-3)"	"prognostic unfavorable (1.49e-5)"	"prognostic favorable (4.32e-4)"	"unprognostic (1.12e-1)"	"unprognostic (6.34e-2)"	"unprognostic (5.77e-3)"	"unprognostic (4.59e-2)"	"unprognostic (2.63e-3)"	"unprognostic (4.87e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.88e-2)"	24.7	16.8	22.7	19.9	25.3	1.6	17.1	17.3	27.0	18.6	21.5	11.3	8.7	18.0	6.3	10.6	15.2	22.5	17.0	27.1	21.7	28.6	16.2	20.9	22.9	23.7	20.7	19.2	6.8	8.9	9.5	16.1	17.4	13.2	12.8	15.7	7.7	11.6	2.7	8.9	10.6	22.2	21.1	45.4	6.9	14.7	23.9	8.7	9.1	7.7	10.1	18.7	8.9	28.5	0.3	1.5	26.3	4.0	35.0	16.1	26.7	12.4	20.6	5.5	6.8	12.2	0.7	0.3	11.3	8.8	4.3	0.6	1.8	3.1	5.4	0.4	1.9	0.2	2.6	12.6	9.3	0.4	1.5	54.9	0.7	14.0	3.3	26.2	20.8	2.7	0.0	19.6	11.8	0.1	2.9	0.2	9.6	0.9	0.7	23.7	1.7	24.3	1.5	7.5	3.3	7.9	3.9	4.2	2.1	8.5	0.2	0.3	15.3	7.9	3.1	24.7	6.8	2.0	0.5	0.1	8.3	0.3	22.2	0.0	0.8	0.0	0.0	2.1	0.1	0.0	0.3	0.0	0.9	0.0	0.4	0.2	0.0	0.0	0.8	0.0	0.2	0.5	22.7	25.3	17.3	27.0	27.1	21.7	23.7	20.7	17.4	21.1	23.9	28.5	9.4	9.6	12.3	133.5	1.6	8.2	2.2	2.5	5.2	5.1	6.7	4.6	8.7	5.7	9.0	5.5	0.0	5.1	0.6	2.6	5.9	4.0	13.8	7.9	23.2	19.7	0.0	0.4	176.1	0.9	2.6	22.0	3.6	24.1	3.8	11.0	41.4	2.6	43.3	8.4	141.8	0.8	4.1	109.1	50.4	17.6	13.1	43.7	5.4	76.8	1.7	23.0	0.0	38.7	184.3	1.0	0.1	20.7	0.1	3.5	2.8	30.1	14.2	2.0	26.3	1.2	9.7	4.0	2.5	5.8	4.7	5.2	2.2	13.1	0.6	2.9
RHOG	"ARHG, MGC125835, MGC125836"	ENSG00000177105	"Ras homolog family member G"	P84095	11	3826978-3840959	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 273.1"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 365.2;Langerhans cells: 356.6;monocytes: 391.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 625.4"	"Low region specificity"	"Detected in all"							HPA039871	Enhanced					NA	NA		86000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 3: Monocytes - Immune response regulation"			"HPA039871: AB_10673428"	"unprognostic (2.39e-2)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (1.81e-4)"	"unprognostic (2.26e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.21e-2)"	"unprognostic (4.27e-3)"	"unprognostic (7.28e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.53e-1)"	"prognostic unfavorable (9.49e-8)"	"unprognostic (9.38e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.48e-1)"	61.2	39.5	62.6	82.5	90.0	273.1	45.7	84.0	70.5	46.2	56.0	50.1	44.7	46.7	19.5	82.6	44.6	34.4	47.0	60.4	71.2	35.6	39.3	87.5	85.2	91.1	83.6	38.0	30.5	18.3	25.4	43.5	91.7	36.8	28.3	4.3	39.1	28.4	53.0	50.1	64.2	39.2	76.5	168.4	42.2	15.3	81.7	68.0	29.0	27.0	67.3	56.5	48.6	107.2	74.1	99.0	19.8	34.1	74.8	84.1	21.4	48.1	59.6	73.7	77.8	61.0	78.7	74.9	24.9	89.2	74.9	85.3	31.2	68.0	47.6	66.6	75.3	170.3	44.7	57.9	75.3	150.0	625.4	82.0	61.1	46.1	44.4	42.6	85.8	99.5	101.3	80.8	61.0	86.5	126.5	206.8	31.5	53.4	78.8	63.7	21.4	44.4	53.1	50.9	10.6	26.7	34.0	77.7	39.4	22.5	41.0	111.6	67.2	88.8	44.5	95.3	57.2	44.8	66.4	42.5	81.0	135.8	50.6	441.3	351.1	739.9	114.8	468.1	101.8	79.8	125.6	128.7	310.8	78.1	87.4	101.6	981.2	97.9	561.9	77.2	206.6	346.7	62.6	90.0	84.0	70.5	60.4	71.2	91.1	83.6	91.7	76.5	81.7	107.2	38.4	19.2	21.5	2.9	109.0	68.7	62.4	35.3	22.8	0.9	24.0	26.3	6.6	20.0	26.9	20.2	0.0	100.4	105.2	99.1	15.6	67.2	1.6	10.2	20.6	58.5	16.2	71.9	1.9	56.6	82.1	38.2	22.4	19.1	200.0	62.8	43.5	19.5	247.7	3.3	1.9	26.7	14.2	365.2	356.6	3.6	38.5	250.6	53.4	8.4	391.7	18.0	166.9	3.0	45.9	86.6	143.6	36.1	45.1	70.4	135.4	24.8	9.7	3.0	19.7	21.6	34.0	10.2	23.9	45.1	59.5	124.2	124.8	11.2	28.9	95.7
RNASE1	"RAC1, RNS1"	ENSG00000129538	"Ribonuclease A family member 1, pancreatic"	P07998	14	20801228-20802855	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Endonuclease, Hydrolase, Lyase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"pancreas: 9121.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 826.6;Alveolar cells type 1: 929.5;Alveolar cells type 2: 818.4;Gastric mucus-secreting cells: 821.1;Hepatic stellate cells: 650.3;Hofbauer cells: 1583.4;Intestinal goblet cells: 663.8;Macrophages: 632.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 9.7;myeloid DC: 20.3"	"Group enriched"	"Detected in many"	9	"dendritic cells: 20.3;monocytes: 9.7"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 286.8;OE19: 67.4;RT4: 114.2;TIME: 179.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001140	Enhanced		Approved	Nucleoplasm,Vesicles	"Secreted to digestive system"	NA	NA		1100000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	Nucleoplasm	"HPA001140: AB_1079816"	"unprognostic (2.32e-2)"	"unprognostic (3.16e-2)"	"unprognostic (9.51e-3)"	"unprognostic (7.77e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.42e-3)"	"unprognostic (6.59e-3)"	"unprognostic (4.69e-2)"	"unprognostic (7.92e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.56e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.67e-1)"	694.2	501.3	336.6	131.3	466.1	6.2	353.3	404.4	556.1	203.9	294.9	378.4	176.7	139.4	112.0	194.0	232.0	406.4	377.7	351.3	380.9	253.0	54.5	775.9	187.8	438.9	408.3	190.6	9121.6	60.6	43.9	897.4	403.7	83.9	425.2	3.1	168.0	149.7	127.6	118.1	201.8	285.6	357.3	353.1	1003.5	977.5	465.4	177.6	119.7	280.6	68.8	374.7	107.9	533.7	0.0	1.4	0.5	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	6.7	0.0	0.3	1.7	0.0	2.2	0.6	0.0	1.4	0.0	0.1	0.1	5.3	0.1	0.8	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	286.8	0.0	31.4	0.4	0.0	0.0	0.3	2.0	1.2	67.4	0.0	0.2	0.1	1.5	0.2	114.2	1.2	1.4	0.0	0.8	0.3	2.0	0.3	0.1	179.3	0.0	2.7	1.8	0.3	0.6	0.1	0.1	4.6	0.1	3.8	1.6	9.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	20.3	0.1	0.0	0.0	0.1	0.0	0.0	5.0	0.0	2.4	336.6	466.1	404.4	556.1	351.3	380.9	438.9	408.3	403.7	357.3	465.4	533.7	826.6	929.5	818.4	1.6	11.1	35.6	1.0	1.9	15.9	0.1	6.2	11.7	59.8	27.1	174.0	16.5	0.0	12.9	5.7	261.8	0.0	8.8	20.0	3.8	1.9	581.7	48.7	28.0	0.5	315.2	14.6	58.4	821.1	3.4	25.2	103.8	650.3	7.9	1583.4	1.7	0.8	663.8	8.2	267.9	197.5	57.1	32.0	632.8	40.9	36.5	3.4	0.8	0.0	1.0	232.3	286.8	246.7	10.9	7.5	1.4	81.7	0.9	34.9	2.7	98.6	20.7	31.4	16.4	6.6	16.6	28.1	25.9	10.6	392.8	162.9	3.8
RNF135	MGC13061	ENSG00000181481	"Ring finger protein 135"	Q8IUD6	17	30970984-30999911	"Enzymes, Human disease related genes, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Kupffer cells: 73.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 63.3"					"Low region specificity"	"Detected in all"			"HPA021576, HPA052404"	Approved		Approved	Vesicles		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"HPA021576: AB_1856331, HPA052404: AB_2681817"	"unprognostic (1.13e-1)"	"unprognostic (1.87e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.68e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.60e-2)"	"unprognostic (4.16e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (7.51e-5)"	"unprognostic (6.44e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.47e-1)"	20.9	12.9	11.1	13.5	12.5	11.6	18.6	11.2	14.2	16.0	15.1	17.5	13.6	13.3	16.5	22.4	15.7	9.6	8.5	10.4	11.3	21.6	8.6	15.5	13.9	13.9	13.2	12.6	13.5	16.8	5.6	18.1	12.4	14.0	18.0	2.3	15.2	15.2	7.4	26.2	13.9	13.7	12.8	25.8	11.9	5.1	16.4	7.9	15.8	10.1	12.6	14.8	17.3	13.8	12.7	25.6	1.5	25.4	34.0	28.5	22.7	9.7	14.9	9.4	8.4	0.0	9.4	11.5	14.8	19.0	17.0	17.0	13.2	12.1	7.8	10.0	5.6	4.8	8.1	0.0	24.3	12.8	10.7	27.7	63.3	10.1	33.5	16.1	15.8	0.0	0.0	34.9	15.6	17.0	0.1	13.5	10.5	25.7	14.4	27.9	0.0	39.2	13.6	18.2	9.8	0.5	14.9	5.9	14.9	16.6	39.4	20.2	13.3	0.0	3.5	15.6	11.5	0.4	1.3	7.3	16.5	22.1	13.3	25.3	61.6	31.3	12.8	57.3	7.2	28.4	6.8	6.8	46.4	28.4	3.7	6.2	54.0	13.9	70.2	17.1	10.1	29.2	11.1	12.5	11.2	14.2	10.4	11.3	13.9	13.2	12.4	12.8	16.4	13.8	14.1	3.2	5.9	7.8	14.1	9.3	13.4	16.8	22.2	0.1	13.1	15.0	4.0	7.2	7.8	11.0	0.0	47.5	10.5	23.4	29.4	9.9	0.4	14.5	12.8	13.2	4.9	11.2	0.8	18.6	37.1	13.2	5.6	12.4	1.3	14.1	25.4	2.7	51.1	0.0	1.0	12.0	8.2	73.9	8.4	1.6	16.8	35.5	16.0	26.2	45.3	3.9	19.6	9.0	0.7	11.9	13.1	15.4	9.0	22.2	27.5	49.3	10.4	0.6	26.3	8.2	14.2	0.7	4.0	24.1	14.6	43.6	7.5	10.6	14.6	11.2
RNF149	FLJ90504	ENSG00000163162	"Ring finger protein 149"	Q8NC42	2	101271219-101308701	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Kupffer cells: 278.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"neutrophil: 619.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 619.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011424	Approved		Approved	"Vesicles,Plasma membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Vesicles, Plasma membrane"		"HPA011424: AB_1079825"	"unprognostic (2.56e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.17e-2)"	"unprognostic (5.17e-3)"	"unprognostic (4.16e-2)"	"unprognostic (4.77e-3)"	"unprognostic (5.61e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.69e-3)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (2.04e-8)"	"unprognostic (1.39e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.70e-1)"	"prognostic favorable (2.91e-4)"	26.7	15.2	7.7	40.3	7.5	52.3	16.3	7.7	9.7	17.7	12.3	15.7	16.8	12.4	16.3	35.5	16.9	18.9	12.5	7.6	8.9	16.3	26.6	30.5	18.3	9.9	8.5	15.9	22.3	17.9	10.4	21.8	9.6	12.6	15.8	7.8	18.3	10.1	8.5	25.6	18.2	12.9	8.5	53.1	19.1	15.8	9.1	15.2	12.2	9.4	19.6	29.1	22.7	10.9	19.9	11.4	8.8	11.3	31.6	31.3	49.7	24.0	31.8	32.1	35.8	29.0	51.6	6.1	28.3	23.9	42.9	39.0	12.5	24.6	29.7	16.9	16.6	12.4	9.9	50.0	42.1	13.4	19.2	28.9	40.0	37.9	25.1	24.7	58.9	13.0	10.7	18.0	32.4	16.9	18.8	14.0	6.1	27.1	20.0	11.5	14.2	23.4	38.0	48.0	11.5	8.5	14.4	36.0	37.2	9.5	9.7	17.8	39.6	16.2	9.1	24.5	5.3	35.5	22.5	0.2	5.2	18.6	12.2	44.0	73.6	90.3	43.8	118.1	41.8	13.2	40.0	45.3	27.9	8.5	28.2	30.2	619.9	15.3	134.1	52.5	53.8	69.8	7.7	7.5	7.7	9.7	7.6	8.9	9.9	8.5	9.6	8.5	9.1	10.9	19.9	48.1	48.1	44.7	55.2	76.9	78.1	63.5	54.7	20.4	29.7	15.9	13.0	41.5	48.4	55.2	56.3	65.2	112.4	53.1	1.9	59.1	97.9	41.8	31.9	30.0	8.5	22.7	82.8	42.2	73.0	53.5	37.2	63.1	39.2	17.3	27.1	46.2	85.9	8.4	71.6	31.7	12.2	278.6	144.2	37.2	30.7	209.0	40.9	50.6	116.5	11.6	61.8	34.7	59.6	54.3	52.3	19.5	125.5	73.5	45.9	25.8	44.8	20.7	59.2	40.5	30.1	36.6	40.3	128.3	91.6	128.1	115.7	23.8	32.8	154.1
S100A11	S100C	ENSG00000163191	"S100 calcium binding protein A11"	P31949	1	152032506-152047907	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 4751.5"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 5473.4;Extravillous trophoblasts: 6093.0;Pancreatic endocrine cells: 6926.5;Urothelial cells: 6250.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 17820.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034320, HPA042745"	Enhanced		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA		7900000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Cytosol"	"Nuclear speckles"	"CAB034320: AB_2183487, HPA042745: AB_2678142"	"unprognostic (1.85e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.12e-2)"	"unprognostic (7.61e-2)"	"prognostic unfavorable (3.64e-5)"	"unprognostic (3.34e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.28e-3)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (3.24e-6)"	"unprognostic (2.91e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.43e-3)"	"unprognostic (8.86e-2)"	656.7	214.3	92.6	487.2	92.8	415.2	574.7	99.1	222.3	1070.5	106.8	303.0	181.6	297.7	675.4	4751.5	611.1	437.8	354.1	92.3	104.4	882.5	127.6	776.0	206.7	118.1	108.6	152.0	264.1	905.1	210.7	723.2	118.0	536.4	328.7	8.4	1247.1	544.1	91.0	894.7	239.5	468.3	110.2	713.7	482.6	68.9	124.1	303.5	325.3	150.9	959.9	1527.7	1771.1	126.8	1889.0	1483.7	70.5	542.1	1960.9	2451.3	1172.4	1796.3	2626.0	1439.7	1464.8	697.6	2066.0	2.5	1571.4	2355.4	1142.4	2595.4	73.7	3254.0	814.0	913.6	149.2	162.6	830.1	409.1	1511.3	149.6	1098.4	1867.2	3255.1	1577.8	1974.9	826.9	1116.1	0.3	340.9	352.1	2137.7	3058.8	19.8	694.0	513.9	4043.1	1491.9	2.5	757.1	1426.0	4361.1	3196.5	2.5	115.8	1367.7	1797.9	1255.3	1727.2	1378.9	1612.5	1584.8	757.0	533.1	1188.8	975.7	2.5	17.0	8.2	1713.0	490.9	915.2	7956.3	4682.6	7210.4	713.6	4560.1	939.4	354.9	1346.4	845.1	3020.5	252.7	391.5	437.0	17820.3	740.5	4871.8	1042.8	1269.9	5289.9	92.6	92.8	99.1	222.3	92.3	104.4	118.1	108.6	118.0	110.2	124.1	126.8	718.5	137.8	189.4	1.3	136.6	2210.3	3924.9	5473.4	1027.8	0.7	686.8	823.8	30.8	546.2	2673.9	2284.2	0.0	3257.0	384.0	421.7	1019.3	4344.5	277.6	1738.8	561.2	617.8	277.7	52.6	0.0	4330.2	6093.0	890.7	676.4	1503.0	437.6	251.1	372.6	11.6	3806.0	0.0	0.0	479.6	1485.2	1216.7	2054.0	634.0	320.9	1971.8	1243.3	15.9	2265.2	0.8	371.8	0.0	0.0	6926.5	690.2	258.4	153.8	4365.0	343.9	925.4	2674.2	2.4	210.4	536.2	1054.9	14.5	34.8	4207.9	2822.4	3753.1	470.4	334.8	500.2	6250.2
SAMSN1	"HACS1, NASH1, SASH2, SH3D6B, SLy2"	ENSG00000155307	"SAM domain, SH3 domain and nuclear localization signals 1"	Q9NSI8	21	14485228-14658821	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 192.9;lymphoid tissue: 80.1"	"Cell type enhanced"	"Detected in many"		"granulocytes: 1174.1;Langerhans cells: 317.9;Macrophages: 414.6;monocytes: 829.9;T-cells: 332.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 314.2"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"HEL: 273.7;K-562: 331.6;Karpas-707: 137.3"	"Region enriched"	"Detected in many"	6	"olfactory bulb: 20.7"	"Low region specificity"	"Detected in all"			"HPA010645, HPA017055, HPA046639"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"	Nucleoplasm	"HPA010645: AB_1856559, HPA017055: AB_1856560, HPA046639: AB_2679732"	"unprognostic (7.62e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (4.52e-6)"	"unprognostic (9.14e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.68e-2)"	32.3	6.7	2.4	80.1	2.8	192.9	4.7	3.3	4.9	5.7	4.2	11.0	7.0	3.4	1.9	5.3	6.3	22.7	4.5	2.5	3.5	4.2	17.5	22.9	35.4	6.2	4.5	1.3	3.1	2.0	2.1	15.5	6.1	3.9	15.3	12.7	2.8	2.2	0.7	1.5	15.1	10.8	5.1	32.0	9.3	1.2	4.6	22.4	2.2	1.2	41.0	39.7	2.5	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.1	0.0	0.0	0.0	0.0	1.8	0.0	14.0	0.0	273.7	0.0	0.0	0.0	32.5	12.7	0.1	0.0	0.0	37.9	10.2	3.6	4.8	331.6	137.3	0.0	0.0	15.9	39.5	0.1	0.0	0.2	26.8	0.3	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	35.0	0.0	0.0	0.0	0.0	58.2	0.5	0.3	1.4	20.7	0.0	314.2	38.7	234.6	22.1	52.3	15.4	27.3	42.8	33.3	25.0	15.4	26.8	19.1	49.4	18.0	83.0	0.9	60.3	33.6	2.4	2.8	3.3	4.9	2.5	3.5	6.2	4.5	6.1	5.1	4.6	8.9	4.8	22.4	54.9	0.7	127.5	15.6	1.1	0.0	1.8	64.9	2.7	3.0	1.2	1.5	11.2	36.8	0.0	0.5	147.9	0.7	0.0	0.6	0.0	0.8	0.2	8.0	0.0	13.7	1.0	6.5	0.7	11.3	10.7	0.6	1174.1	0.1	4.6	1.8	62.0	0.0	0.8	0.8	0.0	183.7	317.9	0.4	0.6	414.6	21.4	131.2	829.9	1.6	24.7	2.5	0.6	0.7	1.1	0.0	119.3	0.5	0.0	0.5	8.0	4.7	0.0	2.2	3.7	0.1	0.2	1.2	13.2	0.5	332.8	0.1	0.9	0.9
SCAMP2		ENSG00000140497	"Secretory carrier membrane protein 2"	O15127	15	74843730-74873365	"Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014699, HPA019194"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA		71000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 10: Non-specific - Unknown function"	"Golgi apparatus, Vesicles"		"HPA014699: AB_1856605, HPA019194: AB_1856604"	"unprognostic (1.74e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.23e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.53e-2)"	"unprognostic (7.23e-2)"	"unprognostic (9.73e-3)"	"unprognostic (7.26e-2)"	"unprognostic (8.44e-2)"	"unprognostic (1.97e-1)"	"prognostic favorable (1.12e-6)"	"unprognostic (3.40e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.10e-2)"	43.1	46.7	27.8	40.3	32.8	51.5	40.7	31.9	31.2	40.5	38.8	76.0	75.7	36.9	36.9	103.4	47.4	35.4	32.4	26.1	29.8	44.9	42.0	49.6	47.9	40.7	30.9	26.5	54.5	85.6	29.4	48.9	36.7	35.5	72.7	4.7	92.7	32.4	34.2	68.3	80.1	33.6	33.6	66.8	64.9	36.2	33.3	33.0	38.3	18.9	53.4	38.1	49.4	35.4	44.7	57.3	24.2	37.6	72.0	37.2	72.0	45.0	56.6	46.9	50.1	83.0	102.6	36.5	57.8	68.1	67.7	157.8	72.3	55.9	19.4	145.8	71.1	92.8	31.2	57.6	54.3	48.0	170.9	48.0	97.6	44.4	32.0	37.0	46.0	42.0	31.3	67.5	33.3	68.1	24.6	55.3	24.1	111.0	36.6	42.6	22.3	126.4	54.0	63.1	24.9	25.0	36.7	64.3	42.4	35.4	88.5	76.3	43.4	40.2	23.9	43.8	53.0	46.1	73.2	37.6	37.8	112.2	30.2	118.3	111.3	90.0	94.1	106.9	76.1	80.8	85.3	95.9	81.8	70.9	69.4	75.8	74.4	83.8	119.3	128.7	105.3	120.8	27.8	32.8	31.9	31.2	26.1	29.8	40.7	30.9	36.7	33.6	33.3	35.4	36.0	73.7	31.7	17.9	49.5	17.5	41.7	40.5	19.4	6.8	28.0	24.8	14.4	24.3	53.1	40.5	2.1	156.9	63.4	116.8	15.6	67.4	132.3	30.8	22.0	36.2	37.3	29.0	7.7	92.8	61.9	37.2	54.0	40.6	79.2	31.3	26.4	27.7	164.7	6.7	6.1	77.5	42.7	78.3	44.5	56.2	32.0	77.0	32.0	21.5	56.9	41.4	63.8	12.1	17.9	96.1	75.5	23.0	73.1	54.0	105.7	48.1	52.6	8.4	26.3	25.6	35.8	47.1	35.3	39.6	22.3	136.4	55.1	40.0	64.2	58.5
SLC29A3	"ENT3, FLJ11160"	ENSG00000198246	"Solute carrier family 29 member 3"	Q9BZD2	10	71319259-71381423	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 46.1;Extravillous trophoblasts: 45.3;Hofbauer cells: 34.7;Syncytiotrophoblasts: 31.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 31.8;Hep G2: 35.9;RT4: 29.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046085, HPA054976, HPA057905"	Approved		Enhanced	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus, Vesicles"		"HPA046085: AB_2679531, HPA054976: AB_2682659, HPA057905: AB_2683550"	"unprognostic (1.73e-1)"	"unprognostic (2.38e-3)"	"unprognostic (3.23e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (6.07e-6)"	"unprognostic (1.28e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.80e-2)"	"prognostic unfavorable (5.53e-5)"	"unprognostic (3.37e-1)"	"unprognostic (1.36e-1)"	"prognostic favorable (1.16e-4)"	"unprognostic (3.43e-3)"	4.7	2.6	3.1	4.1	3.9	1.1	4.8	3.7	3.7	7.3	2.7	4.4	2.1	6.8	2.5	2.2	5.8	4.4	2.4	3.0	3.6	2.5	9.4	6.7	7.1	4.7	3.7	9.7	5.2	3.5	1.7	11.2	4.2	5.1	3.5	0.3	4.9	2.9	1.4	2.6	3.7	5.1	4.2	6.5	6.1	3.7	4.4	3.7	3.8	0.6	3.8	9.8	4.4	5.0	2.1	12.3	1.8	7.8	6.8	5.3	31.8	2.3	2.2	0.7	0.4	13.8	8.8	7.4	6.4	4.7	3.2	18.3	5.7	2.9	0.1	5.6	5.6	2.2	1.0	35.9	3.3	1.8	4.5	5.2	12.9	0.3	0.6	1.5	3.2	8.5	6.5	6.8	0.9	19.1	4.2	3.8	4.2	19.2	4.5	5.7	0.6	5.9	2.3	29.5	8.5	9.6	6.4	20.3	1.7	5.2	3.2	4.0	5.2	0.2	3.8	2.3	0.1	1.8	3.1	4.0	7.6	24.0	1.3	4.2	19.3	2.2	5.4	15.3	4.6	4.9	4.5	5.1	29.1	1.9	3.5	5.0	1.5	9.4	10.3	20.2	5.5	9.5	3.1	3.9	3.7	3.7	3.0	3.6	4.7	3.7	4.2	4.2	4.4	5.0	2.0	3.2	1.1	2.0	3.1	0.3	1.5	4.0	1.8	2.3	2.7	3.8	0.8	1.5	3.8	0.0	0.0	46.1	6.3	2.6	0.0	6.1	3.6	1.8	3.2	1.8	1.8	4.2	2.4	8.9	45.3	4.7	7.1	2.4	2.5	10.2	3.3	5.4	34.7	0.0	1.3	2.5	8.2	11.8	4.4	15.2	2.8	10.9	1.8	16.9	8.5	3.0	3.1	2.5	2.7	7.9	13.1	1.5	6.0	3.2	0.1	2.0	2.6	0.4	0.0	0.2	2.5	0.6	5.0	0.7	0.0	31.7	2.9	10.0	2.5	1.7
SLC2A9	"Glut9, GLUTX, URATv1"	ENSG00000109667	"Solute carrier family 2 member 9"	Q9NRM0	4	9771153-10054936	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 29.3;liver: 21.4"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 27.4;Proximal tubular cells: 72.6"	"Cancer enhanced"	"Detected in many"		"renal cancer: 6.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 36.9;myeloid DC: 30.5"	"Group enriched"	"Detected in many"	30	"dendritic cells: 30.5;monocytes: 36.9"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 48.1;Hep G2: 23.6;hTCEpi: 19.9;THP-1: 20.5;U-937: 13.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA066229, HPA075669"	Enhanced					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA066229: AB_2685639, HPA075669: "	"unprognostic (3.21e-1)"	"unprognostic (8.99e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.56e-2)"	"unprognostic (8.94e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.23e-1)"	"prognostic favorable (1.32e-11)"	"unprognostic (1.01e-1)"	"unprognostic (3.88e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.20e-1)"	1.6	2.6	1.0	2.0	1.2	2.1	4.2	1.3	1.2	2.5	2.7	1.8	10.7	1.4	2.4	5.2	3.5	2.4	2.3	1.1	1.6	29.3	21.4	4.2	2.0	2.3	1.5	1.6	1.0	2.4	1.4	7.6	2.0	3.5	1.6	1.2	16.6	18.8	0.5	2.2	8.4	2.0	1.8	1.8	1.0	0.7	2.0	4.2	2.7	0.5	1.4	6.4	4.0	3.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.3	0.1	0.0	0.3	2.4	0.0	3.5	0.7	0.0	7.3	0.0	48.1	0.0	8.2	0.3	0.0	0.0	23.6	1.6	0.1	6.3	3.4	19.9	0.0	4.8	0.0	0.1	0.8	0.0	0.1	0.1	0.0	0.3	2.4	0.0	0.4	0.1	1.5	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	20.5	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	13.5	0.1	0.0	36.9	0.9	0.3	7.6	0.3	0.3	0.3	0.1	30.5	0.1	0.2	0.1	1.1	0.2	0.9	12.2	0.2	9.1	1.0	1.2	1.3	1.2	1.1	1.6	2.3	1.5	2.0	1.8	2.0	3.0	1.4	0.0	0.0	8.1	1.3	0.9	13.4	27.4	6.2	0.0	4.6	6.1	2.4	0.0	5.7	3.7	2.1	18.7	0.5	1.7	3.9	0.5	5.1	4.1	2.1	1.5	0.0	1.3	4.4	1.1	1.8	1.6	1.1	11.5	1.3	0.5	2.2	5.2	10.3	0.0	5.6	0.9	10.2	8.7	3.7	3.4	0.0	8.8	0.0	15.9	4.4	1.2	1.0	10.6	1.1	0.6	0.5	0.4	0.3	2.0	8.1	72.6	3.0	0.4	0.0	4.6	1.6	1.1	1.9	5.4	0.6	8.5	0.9	0.7	2.5	7.7
SOWAHD	ANKRD58	ENSG00000187808	"Sosondowah ankyrin repeat domain family member D"	A6NJG2	X	119758588-119760202	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 4.1;lymphoid tissue: 7.1;testis: 5.0"	"Cell type enhanced"	"Detected in some"		"B-cells: 12.2;Extravillous trophoblasts: 38.3;Hofbauer cells: 17.5;Proximal enterocytes: 9.1;Rod photoreceptor cells: 8.2;Syncytiotrophoblasts: 9.4"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 8.5"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 11.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.3;NB-4: 2.9;SK-BR-3: 3.2;THP-1: 8.3;U-937: 7.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA065955	Uncertain					NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA065955: AB_2685586"	"unprognostic (1.78e-2)"	"unprognostic (9.37e-2)"	"unprognostic (3.10e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.45e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.04e-5)"	"unprognostic (5.82e-2)"	"unprognostic (3.14e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.74e-3)"	0.3	0.4	0.7	1.8	0.6	2.1	0.2	0.6	0.9	0.2	0.3	1.2	2.1	0.1	0.0	0.2	0.3	0.2	0.2	0.6	0.6	1.1	0.3	1.6	2.5	1.1	0.6	0.3	0.3	0.7	0.1	1.1	0.9	0.2	0.5	0.7	1.7	0.1	0.0	0.3	4.1	0.1	1.0	7.1	1.2	5.0	1.1	0.6	0.1	0.2	1.5	0.3	0.1	1.5	0.4	0.0	0.1	0.1	0.0	0.0	4.3	0.0	0.0	0.4	0.6	0.8	0.1	0.2	0.6	0.0	0.5	0.0	0.0	0.0	0.1	0.7	0.5	0.0	0.0	1.2	0.2	0.8	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.1	0.4	0.0	2.9	0.9	0.8	0.3	2.5	0.1	0.1	0.0	0.1	0.2	0.1	0.9	3.2	0.1	0.3	0.5	8.3	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.1	0.0	7.4	0.0	0.0	3.1	1.9	0.0	3.3	0.0	9.1	0.4	0.3	2.0	11.7	1.7	0.9	3.3	0.3	2.9	1.0	0.0	0.7	0.7	0.6	0.6	0.9	0.6	0.6	1.1	0.6	0.9	1.0	1.1	1.5	0.2	0.0	0.0	0.0	12.2	0.0	0.1	0.0	0.0	0.8	0.3	0.5	0.5	1.5	0.0	3.7	0.0	6.1	2.7	3.7	0.0	0.4	0.6	0.1	0.0	0.4	0.0	0.0	0.0	0.4	38.3	0.1	0.5	0.2	0.0	0.2	0.0	0.0	17.5	1.7	0.0	0.9	0.0	5.4	0.6	1.2	0.0	6.5	0.0	0.0	3.4	0.6	1.0	0.0	0.0	0.0	0.5	0.0	1.1	0.0	9.1	0.2	0.0	8.2	0.0	0.0	0.2	0.1	0.9	0.1	0.1	9.4	0.5	0.1	2.3	0.0
TCHH	THH	ENSG00000159450	Trichohyalin	Q07283	1	152106317-152115454	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"skin 1: 41.4"	"Cell type enhanced"	"Detected in some"		"Kupffer cells: 26.2;Langerhans cells: 9.5;Macrophages: 21.8;Spermatocytes: 22.6;Spermatogonia: 29.1"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 3.6;SCLC-21H: 1.1;THP-1: 2.0"	"Low region specificity"	"Detected in many"							HPA028375	Approved					NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 41: Macrophages - Immune response"			"HPA028375: AB_10601722"	"unprognostic (7.70e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.30e-2)"	"unprognostic (4.97e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.12e-5)"	"unprognostic (2.03e-1)"	"unprognostic (6.55e-2)"	"unprognostic (5.90e-6)"	"unprognostic (5.58e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.71e-2)"	"unprognostic (9.28e-7)"	0.7	0.1	0.1	0.1	0.1	0.0	0.5	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.2	0.2	0.1	0.1	0.3	0.2	0.0	0.1	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	41.4	0.2	0.0	0.0	2.2	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.0	0.7	0.0	0.0	3.6	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.1	1.0	0.1	0.1	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.3	0.0	0.0	0.3	2.0	0.0	0.0	0.9	0.2	0.1	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.3	0.2	0.2	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.5	6.4	0.1	0.5	2.8	0.5	1.2	2.5	2.0	0.0	0.3	1.8	0.0	0.6	0.0	0.3	0.0	0.0	0.2	1.4	0.2	3.5	1.8	0.0	0.5	0.2	7.5	0.9	0.0	0.8	0.0	0.1	2.5	0.0	0.6	0.0	0.5	0.5	0.0	26.2	9.5	0.2	0.3	21.8	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.2	0.1	0.7	0.0	1.3	0.0	0.0	0.7	0.0	0.0	3.2	1.4	22.6	29.1	1.0	2.4	5.2	0.8	0.1	0.0	0.1
TEC	PSCTK4	ENSG00000135605	"Tec protein tyrosine kinase"	P42680	4	48135783-48269838	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 13.9;Glandular and luminal cells: 25.1;granulocytes: 19.6;Plasma cells: 15.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"basophil: 20.7;eosinophil: 13.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 20.7"	"Cell line enhanced"	"Detected in many"		"HEL: 13.5;HMC-1: 20.3;U-266/70: 20.3;U-266/84: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA005733, HPA024657"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"		"HPA005733: AB_1857878, HPA024657: AB_2671637"	"unprognostic (7.19e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.07e-3)"	"unprognostic (4.21e-2)"	"unprognostic (8.57e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.36e-2)"	"prognostic favorable (7.12e-4)"	"unprognostic (7.46e-3)"	"unprognostic (7.83e-2)"	"unprognostic (1.01e-4)"	"unprognostic (4.24e-2)"	"unprognostic (2.16e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.96e-3)"	0.9	1.7	0.1	2.1	0.2	6.1	1.4	0.1	0.4	1.2	1.0	1.3	1.6	1.1	4.2	3.4	1.9	1.1	1.3	0.0	0.4	1.1	2.5	2.0	3.1	1.1	0.3	0.4	0.8	1.2	0.6	1.1	1.1	0.5	1.3	1.8	2.3	1.0	0.6	3.6	1.5	0.8	0.3	1.7	1.1	1.2	0.7	2.0	1.3	0.5	3.3	1.0	1.6	0.2	3.0	0.8	0.0	0.0	0.0	0.0	0.1	0.5	2.2	1.3	2.7	0.0	2.2	1.9	2.0	0.0	0.1	0.6	1.1	0.0	1.8	0.1	0.8	13.5	1.0	0.1	0.0	2.2	20.3	0.0	0.3	1.7	0.0	1.4	0.0	0.6	7.5	0.5	4.1	1.0	1.3	4.9	0.4	1.4	0.8	3.1	2.7	0.0	3.4	0.9	0.0	0.2	0.6	0.3	0.5	1.1	0.7	4.2	0.0	0.0	0.0	2.8	0.0	20.3	15.4	2.6	0.0	3.0	0.1	20.7	0.6	13.3	0.1	0.7	0.3	1.0	0.2	0.5	1.5	0.7	0.5	0.5	0.5	3.6	0.1	0.1	0.1	0.4	0.1	0.2	0.1	0.4	0.0	0.4	1.1	0.3	1.1	0.3	0.7	0.2	0.6	6.4	6.8	0.7	6.8	2.5	1.7	0.2	2.8	0.9	1.7	1.1	1.8	7.2	2.6	0.0	0.0	1.5	3.3	2.1	0.0	1.7	6.4	13.9	1.5	1.2	3.0	12.6	6.7	1.1	0.1	0.8	0.0	25.1	19.6	0.7	0.0	2.9	4.9	0.0	1.6	1.4	4.1	4.6	1.8	2.6	0.0	5.9	1.8	10.3	1.7	6.6	0.0	0.5	0.2	1.0	0.6	0.4	15.4	1.3	3.0	2.0	0.2	3.1	6.6	1.8	0.8	0.7	1.4	9.8	3.0	0.8	3.4	0.3	2.1	1.6
TET3	"hCG_40738, MGC22014"	ENSG00000187605	"Tet methylcytosine dioxygenase 3"	O43151	2	73984910-74108176	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Chromatin regulator, Developmental protein, Dioxygenase, DNA-binding, Oxidoreductase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.7;skin 1: 16.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 88.5;Oligodendrocytes: 86.7;Suprabasal keratinocytes: 68.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050845	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Vesicles, Cytosol"	"HPA050845: AB_2681256"	"unprognostic (1.07e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.44e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.83e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (3.58e-5)"	"unprognostic (2.05e-1)"	"unprognostic (5.30e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.10e-1)"	2.2	1.6	3.7	5.2	2.4	19.7	3.0	6.3	13.7	2.5	0.0	4.1	5.4	2.0	1.4	7.6	1.9	2.5	1.2	9.3	1.7	1.6	3.9	4.1	3.7	2.0	1.5	1.5	2.6	2.0	1.5	4.6	2.2	2.5	4.3	3.6	4.2	1.1	1.2	16.2	6.0	2.1	0.6	3.8	4.3	1.6	2.7	5.8	2.3	1.3	4.1	3.4	4.0	5.8	9.0	8.0	14.5	8.9	1.2	1.3	26.4	1.8	2.4	3.4	2.7	16.6	8.1	14.9	3.5	2.4	1.6	9.4	13.0	5.2	3.6	6.7	5.2	19.2	7.0	5.6	5.1	20.2	11.3	2.0	13.3	4.2	9.9	4.3	5.3	10.3	13.4	4.8	2.0	14.6	10.0	13.0	8.1	7.7	2.7	15.4	9.1	5.2	3.8	16.5	18.1	15.5	4.0	10.3	4.9	5.7	6.6	16.1	6.7	3.7	15.4	1.8	6.8	4.2	2.0	12.7	2.4	13.9	4.9	0.1	0.4	0.2	0.0	0.4	0.1	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.4	0.1	0.1	0.2	0.1	0.2	3.7	2.4	6.3	13.7	9.3	1.7	2.0	1.5	2.2	0.6	2.7	5.8	4.2	6.4	9.0	31.3	6.4	49.5	3.5	4.2	14.8	16.3	8.0	5.8	2.9	2.8	8.0	1.8	20.9	7.0	7.3	10.5	0.0	3.5	4.7	18.8	11.9	6.6	6.0	24.8	88.5	4.4	30.1	3.4	13.7	29.6	2.5	6.2	3.6	6.1	10.1	10.1	45.7	8.0	8.2	26.9	23.2	0.8	0.6	26.9	10.6	54.4	27.1	1.5	2.1	41.7	86.7	6.2	7.7	3.0	4.8	6.2	10.3	1.5	11.9	8.6	0.0	3.8	7.7	0.5	2.6	24.4	68.2	2.5	5.5	2.3	6.9	7.0
TMEM106A	MGC20235	ENSG00000184988	"Transmembrane protein 106A"	Q96A25	17	43211835-43220041	"Predicted membrane proteins, Transporters"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 21.9"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 45.6;Hofbauer cells: 45.3;Kupffer cells: 44.8;Langerhans cells: 35.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 26.7"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 26.7"	"Cell line enhanced"	"Detected in many"		"HMC-1: 16.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"				"unprognostic (9.71e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (9.61e-5)"	"unprognostic (4.95e-3)"	"unprognostic (8.62e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.11e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.99e-2)"	"unprognostic (6.08e-2)"	"unprognostic (7.89e-3)"	"unprognostic (1.39e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.30e-2)"	4.9	2.4	1.7	10.2	2.1	3.3	4.1	1.2	2.9	3.8	2.4	3.6	4.0	3.6	1.7	1.5	3.3	3.6	2.1	1.6	2.5	21.9	3.5	5.2	6.9	6.2	3.0	7.8	3.1	2.4	1.6	10.1	3.8	2.5	5.3	0.8	2.8	3.1	1.1	1.3	3.4	8.8	2.8	9.7	4.8	3.3	6.1	4.0	5.3	1.5	6.1	4.8	2.4	4.1	3.1	0.9	0.4	0.2	3.8	4.1	2.3	7.8	5.0	6.7	10.5	2.3	6.4	4.5	1.5	12.1	2.6	1.3	0.8	1.0	7.8	7.1	0.0	3.2	2.7	10.7	2.2	0.1	16.8	2.6	0.2	12.5	0.3	2.4	6.0	5.3	0.1	3.2	8.5	1.3	5.5	2.1	0.3	0.0	0.0	4.0	1.3	2.7	2.9	0.2	0.6	0.0	1.5	3.7	1.8	1.6	5.5	4.5	6.8	3.3	0.4	3.3	1.6	5.0	0.5	1.4	2.8	5.4	6.7	26.7	5.1	5.7	1.5	5.6	0.7	1.9	1.0	1.5	4.2	3.2	0.7	1.3	1.4	2.1	2.0	6.0	2.9	2.2	1.7	2.1	1.2	2.9	1.6	2.5	6.2	3.0	3.8	2.8	6.1	4.1	4.5	3.2	4.5	1.3	13.6	2.4	11.0	2.4	0.6	4.3	6.5	4.2	1.2	0.0	3.9	7.3	2.1	5.0	22.7	3.9	3.9	2.0	5.9	2.6	7.1	6.5	3.0	2.5	1.0	4.0	8.3	6.6	10.7	3.9	8.2	45.6	5.0	1.7	45.3	0.0	1.0	4.5	0.0	44.8	35.6	2.7	14.0	25.2	0.0	17.8	16.5	1.2	14.4	3.5	4.0	5.5	3.4	7.2	5.4	10.9	2.1	17.8	6.0	3.7	13.1	4.0	4.6	7.4	3.6	0.5	1.7	5.2	7.3	3.2	2.9	13.1
TMEM236	"bA162I21.2, bA16O1.2, FAM23A, FAM23B"	ENSG00000148483	"Transmembrane protein 236"	Q5W0B7	10	17752201-17800868	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"intestine: 33.5"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 81.1;Enteroendocrine cells: 23.4;Intestinal goblet cells: 28.8;Paneth cells: 48.1;Proximal enterocytes: 96.5;Undifferentiated cells: 19.0"	"Group enriched"	"Detected in some"	4	"colorectal cancer: 1.7;pancreatic cancer: 0.5;stomach cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"MOLT-4: 10.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA045096	Enhanced					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA045096: AB_2732516"	"unprognostic (4.95e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.88e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.42e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.43e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.54e-2)"	0.7	0.6	0.3	1.7	0.3	0.5	0.4	0.8	0.5	0.5	0.4	14.1	21.8	0.3	0.2	0.3	0.2	0.4	0.3	0.3	0.1	0.2	0.1	0.7	0.3	0.1	0.0	0.3	0.5	0.1	0.0	1.5	0.2	0.1	14.0	0.3	0.1	0.2	0.3	0.3	33.5	1.0	0.0	0.3	0.4	0.2	0.1	0.2	0.1	0.1	0.1	0.4	0.1	0.7	0.2	0.0	0.1	0.1	0.0	0.0	0.3	0.2	0.0	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.3	0.3	0.2	0.0	0.2	0.9	0.1	0.2	0.1	0.0	0.1	0.2	0.4	0.1	0.2	0.1	0.2	10.3	0.1	0.1	0.1	0.0	0.3	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.0	0.4	0.2	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.3	0.3	0.8	0.5	0.3	0.1	0.1	0.0	0.2	0.0	0.1	0.7	0.2	0.0	0.5	0.0	0.2	0.1	0.5	0.0	0.0	0.3	7.3	0.3	0.9	0.0	0.0	0.0	0.0	0.1	0.1	81.1	0.0	0.1	1.1	0.1	0.1	0.2	23.4	0.4	0.4	0.9	0.2	0.2	0.0	0.5	1.3	0.1	1.1	0.0	7.2	0.0	0.4	28.8	0.0	4.8	0.8	1.1	0.0	5.9	0.0	3.7	0.0	0.1	0.0	0.0	0.6	0.7	48.1	0.0	0.0	0.4	96.5	0.0	0.0	0.9	0.0	0.7	0.3	0.4	0.1	0.2	0.0	0.3	0.4	0.2	19.0	0.6
TNFRSF11A	"CD265, FEO, LOH18CR1, PDB2, RANK"	ENSG00000141655	"TNF receptor superfamily member 11a"	Q9Y6Q6	18	62325287-62391288	"CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Deafness, Disease variant, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 30.5;salivary gland: 25.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 35.6;Intestinal goblet cells: 24.0;Paneth cells: 42.3;Proximal enterocytes: 25.5;Undifferentiated cells: 42.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	8	"NK-cell: 5.3"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 5.3"	"Cell line enriched"	"Detected in many"	6	"HDLM-2: 125.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB010391, HPA047976"	Approved		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		110000	"Cluster 48: NK-cells - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	Cytosol	"CAB010391: AB_2205352, HPA047976: AB_2680227"	"unprognostic (4.08e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.73e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.96e-4)"	"unprognostic (4.24e-3)"	"unprognostic (7.79e-4)"	"unprognostic (1.52e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.88e-1)"	"unprognostic (4.69e-5)"	"unprognostic (1.56e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.02e-2)"	"unprognostic (7.07e-2)"	1.8	1.1	0.8	5.7	1.6	0.4	4.1	0.1	1.9	1.4	0.3	17.1	30.5	0.9	0.3	2.8	0.9	7.6	0.6	2.0	1.1	0.4	0.6	1.0	1.2	0.7	1.1	0.4	1.7	0.9	6.8	3.2	0.2	1.3	17.6	0.2	25.4	2.7	0.3	2.7	18.6	1.7	0.7	0.8	5.5	0.9	1.2	1.0	1.2	0.1	1.9	1.6	1.6	2.1	3.2	2.2	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	1.6	0.4	0.6	0.0	3.5	0.4	1.4	2.2	8.3	0.9	0.2	125.9	5.4	0.0	1.3	1.7	0.0	0.5	1.3	0.2	0.4	0.8	3.1	4.2	3.1	0.3	0.0	0.0	0.0	1.1	0.0	0.1	5.9	7.0	19.3	0.4	0.0	0.6	1.5	1.5	20.4	0.7	0.6	3.0	0.1	0.8	1.3	0.4	2.0	0.0	0.1	0.1	0.0	1.2	0.0	0.1	0.3	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	5.3	0.0	0.3	0.6	0.0	0.8	1.6	0.1	1.9	2.0	1.1	0.7	1.1	0.2	0.7	1.2	2.1	0.4	0.0	2.2	0.0	0.4	1.3	3.8	1.1	0.6	0.6	4.5	3.3	1.3	8.6	2.3	0.0	0.0	0.1	3.3	35.6	0.0	8.3	0.3	3.2	0.5	5.3	10.8	0.0	4.0	7.5	0.6	0.7	11.7	6.2	0.0	2.0	7.1	0.3	15.5	3.3	0.2	24.0	0.0	17.0	2.4	0.4	0.6	7.7	1.8	8.4	19.7	0.0	3.1	0.5	0.4	14.7	42.3	0.0	0.5	2.8	25.5	0.0	3.8	0.2	0.0	0.5	0.4	0.8	1.9	1.7	2.3	0.1	0.7	0.0	42.2	4.4
TREM2	"TREM-2, Trem2a, Trem2b, Trem2c"	ENSG00000095970	"Triggering receptor expressed on myeloid cells 2"	Q9NZC2	6	41158506-41163186	"Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 69.8;lung: 30.1"	"Cell type enriched"	"Detected in many"	8	"Hofbauer cells: 1014.1"	"Cancer enhanced"	"Detected in all"		"glioma: 93.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 2.0"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 2.0"	"Group enriched"	"Detected in some"	4	"hTCEpi: 74.6;THP-1: 42.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010917, HPA012571"	Approved				"Secreted in brain"	NA	NA		50000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 4: Macrophages - Innate immune response"			"HPA010917: AB_1080365, HPA012571: AB_1858260"	"unprognostic (3.89e-1)"	"unprognostic (4.44e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (4.83e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.57e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.58e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.85e-2)"	10.7	13.2	28.1	3.5	31.1	0.2	9.8	33.7	61.5	6.5	29.1	3.5	0.9	1.6	2.3	0.6	7.4	9.7	2.1	27.5	32.3	1.3	2.3	30.1	2.6	44.5	34.4	2.4	3.9	7.4	3.9	10.7	42.7	2.0	4.3	1.9	6.0	3.1	0.4	0.5	1.4	4.5	46.7	0.5	2.5	0.7	43.5	1.8	1.7	0.0	0.4	4.5	0.6	69.8	0.0	0.3	0.0	0.0	0.1	0.3	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	1.2	74.6	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	42.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	28.1	31.1	33.7	61.5	27.5	32.3	44.5	34.4	42.7	46.7	43.5	69.8	1.8	6.4	7.5	0.0	0.7	0.8	0.2	79.8	0.0	0.3	1.8	58.8	0.1	1.5	9.6	0.0	0.0	5.0	0.4	0.0	0.0	0.0	0.6	0.0	0.1	10.4	0.0	0.0	0.0	0.0	4.9	1.2	0.0	0.0	2.5	0.0	2.2	0.2	1014.1	0.0	0.0	0.0	2.0	34.7	5.2	1.0	0.6	120.5	0.0	12.2	8.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	3.3	1.0	6.6	0.1	1.0	0.0	0.0	0.0	0.1	7.3	0.8	0.0	0.0	0.1
TRPV4	"CMT2C, OTRPC4, TRP12, VR-OAC, VRL-2, VROAC"	ENSG00000111199	"Transient receptor potential cation channel subfamily V member 4"	Q9HBA0	12	109783087-109833406	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel"	"Charcot-Marie-Tooth disease, Disease variant, Dwarfism, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 50.8;salivary gland: 19.2"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 17.1;Cholangiocytes: 20.0;Cytotrophoblasts: 20.0;Kupffer cells: 19.6;Respiratory ciliated cells: 28.2;Syncytiotrophoblasts: 21.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in single"	5	"hippocampal formation: 4.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 7.9;BJ hTERT+: 9.5;EFO-21: 7.2;HaCaT: 14.2;HUVEC TERT2: 8.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA007150	Uncertain					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA007150: AB_1080393"	"unprognostic (2.98e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.20e-3)"	"unprognostic (6.25e-3)"	"unprognostic (1.09e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.02e-2)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.68e-1)"	"prognostic favorable (4.12e-5)"	"unprognostic (1.20e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.73e-2)"	1.0	0.8	0.2	0.9	0.3	0.1	1.9	0.7	0.5	2.0	50.8	0.4	0.7	0.6	0.4	10.3	4.7	1.4	0.8	4.2	0.2	14.7	8.6	2.2	0.8	0.5	0.4	0.3	4.4	0.3	2.1	5.2	0.3	6.8	0.3	0.0	19.2	0.8	0.1	7.5	0.4	0.7	0.2	2.8	0.7	0.8	0.8	0.1	0.9	0.0	0.9	1.8	2.2	0.4	2.4	0.2	0.0	0.0	2.0	1.2	7.9	4.2	9.5	1.2	0.3	0.0	6.4	0.0	7.2	5.8	0.0	14.2	1.0	0.0	0.4	0.0	1.8	0.0	0.1	3.7	0.6	0.0	0.0	3.4	2.0	2.7	0.0	0.6	8.7	0.0	0.5	0.0	0.4	5.3	0.0	0.0	1.5	0.0	0.0	0.0	0.5	0.0	0.0	4.9	0.0	0.0	0.3	0.6	2.6	3.5	1.1	0.2	4.5	0.0	2.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	5.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.7	0.5	4.2	0.2	0.5	0.4	0.3	0.2	0.8	0.4	0.1	0.0	0.0	0.0	0.7	3.3	8.1	17.1	7.4	0.0	5.1	5.5	1.0	20.0	12.0	11.0	0.0	20.0	0.4	0.0	3.9	2.5	0.2	3.2	1.0	1.4	0.0	0.0	0.3	9.3	5.3	1.2	2.0	1.2	0.0	0.9	0.7	7.7	4.0	0.0	0.4	0.0	6.1	19.6	0.7	0.2	0.9	2.6	7.2	1.9	0.8	0.0	0.0	1.0	0.3	2.0	0.0	0.0	0.0	4.6	0.0	12.5	28.2	0.0	0.0	0.1	1.1	0.3	1.1	4.5	3.8	21.1	0.3	0.2	0.0	3.3
UBXN11	"SOC, SOCI, UBXD5"	ENSG00000158062	"UBX domain protein 11"	Q5T124	1	26281328-26318363	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 131.1;Late spermatids: 327.4;Respiratory ciliated cells: 121.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 93.2;intermediate monocyte: 82.6;myeloid DC: 48.4;non-classical monocyte: 72.2"	"Group enriched"	"Detected in all"	4	"dendritic cells: 48.4;monocytes: 93.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028600, HPA031357"	Approved		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoli, Cytosol"		"HPA028600: AB_10604001, HPA031357: AB_2673840"	"unprognostic (1.78e-3)"	"prognostic favorable (2.54e-5)"	"unprognostic (8.18e-2)"	"prognostic favorable (1.90e-4)"	"unprognostic (2.53e-1)"	"prognostic favorable (4.90e-4)"	"prognostic unfavorable (5.90e-6)"	"unprognostic (8.41e-2)"	"unprognostic (2.70e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.89e-2)"	"unprognostic (5.59e-3)"	"unprognostic (5.00e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.31e-2)"	10.5	10.8	23.2	9.5	25.2	19.3	10.6	17.8	35.1	11.6	45.1	8.4	3.4	9.5	14.7	6.2	31.2	5.1	11.0	26.8	23.9	19.1	7.8	17.7	8.0	25.3	27.9	13.4	11.1	8.0	31.3	4.3	22.0	11.5	2.7	15.0	9.4	6.5	5.6	7.6	8.0	4.1	24.3	21.8	8.8	48.4	25.0	6.8	25.1	3.4	3.9	8.5	7.5	20.1	26.4	11.7	5.7	11.6	4.1	3.1	19.7	5.7	8.8	15.6	11.3	4.6	22.8	15.3	8.5	3.6	10.3	14.0	3.5	9.3	3.9	7.7	13.6	2.6	18.1	11.5	7.2	11.2	5.0	4.7	9.9	26.3	6.7	4.9	4.3	11.1	10.2	10.3	5.4	11.8	6.4	5.4	11.5	7.4	8.8	13.1	4.2	13.8	8.7	3.8	26.9	6.3	14.1	13.1	10.2	2.9	10.3	10.7	4.2	8.9	13.4	13.4	8.7	9.7	29.8	17.7	11.0	15.4	7.5	2.2	93.2	4.6	9.0	82.6	11.4	12.7	13.6	10.8	48.4	16.2	15.2	9.7	6.8	6.1	72.2	7.5	12.5	41.7	23.2	25.2	17.8	35.1	26.8	23.9	25.3	27.9	22.0	24.3	25.0	20.1	4.3	0.0	1.1	5.5	18.8	21.4	15.7	23.4	5.2	11.9	13.2	15.5	1.3	5.7	16.2	23.9	22.9	9.9	10.0	5.5	13.7	14.7	131.1	78.6	9.2	5.1	9.0	6.7	7.0	8.7	20.8	10.0	17.9	8.3	10.2	11.9	6.1	3.0	20.9	23.5	5.1	5.9	18.3	62.4	35.3	327.4	12.8	59.9	10.6	2.8	41.9	24.2	12.3	2.0	1.6	7.6	2.5	10.1	9.5	9.8	1.2	26.7	121.2	54.9	19.7	6.6	11.5	26.1	24.0	5.1	13.4	7.3	23.7	8.7	8.3	12.1
UCP2	"BMIQ4, SLC25A8"	ENSG00000175567	"Uncoupling protein 2"	P55851	11	73974672-73982843	"Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 278.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 404.4;Enteroendocrine cells: 297.3;Erythroid cells: 695.6;Hofbauer cells: 442.2;Kupffer cells: 326.6;monocytes: 533.6;NK-cells: 509.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 360.2;SK-BR-3: 395.6;U-698: 293.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025583, HPA075202"	Approved		Supported	Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 6: Erythroid cells - Oxygen transport"	Mitochondria		"CAB025583: , HPA075202: AB_2732284"	"unprognostic (1.13e-1)"	"prognostic favorable (4.65e-5)"	"unprognostic (8.07e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.82e-3)"	"unprognostic (2.07e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (7.80e-6)"	"unprognostic (3.77e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.77e-3)"	"unprognostic (3.88e-3)"	70.9	20.5	12.2	142.9	14.6	132.8	37.6	12.9	24.1	41.3	22.1	33.2	53.4	17.4	7.6	17.7	175.7	42.3	14.1	12.1	15.9	34.9	26.2	69.3	278.1	19.7	19.8	4.9	12.6	8.1	13.8	27.3	19.8	19.7	44.8	6.9	42.7	23.0	99.1	9.2	56.6	30.4	17.6	183.1	55.2	14.5	22.4	217.3	45.1	141.7	240.2	73.6	4.9	26.1	0.9	78.7	20.2	43.5	9.5	0.0	11.6	14.1	9.3	54.9	14.8	153.1	59.0	360.2	165.1	19.5	5.5	3.5	13.3	0.0	28.6	97.1	5.6	241.5	26.4	28.3	32.2	123.9	77.5	8.9	0.0	43.9	0.0	11.0	5.7	144.6	101.5	119.0	9.5	147.5	108.5	55.8	12.8	9.0	21.7	99.7	120.7	202.0	150.4	211.0	23.6	32.3	68.2	395.6	26.6	55.9	123.3	79.3	10.0	0.2	59.7	14.4	21.5	48.4	24.4	293.8	7.2	45.0	0.4	809.1	1116.7	1465.3	1462.8	1945.8	925.0	1914.8	1176.3	1233.5	1228.7	1851.8	1092.9	1143.1	154.2	1816.8	1692.3	3009.5	2589.5	2966.6	12.2	14.6	12.9	24.1	12.1	15.9	19.7	19.8	19.8	17.6	22.4	26.1	4.7	3.2	27.6	0.3	287.4	3.4	2.7	20.2	0.6	0.9	30.9	19.8	5.2	5.7	43.9	92.0	8.4	8.3	404.4	6.2	7.9	1.9	18.7	122.1	10.5	8.9	297.3	695.6	0.0	7.5	12.1	9.9	46.4	102.4	86.2	12.4	9.7	5.0	442.2	0.0	0.1	31.5	89.5	326.6	146.2	46.0	0.9	232.3	26.6	1.9	533.6	4.3	509.8	1.0	1.0	1.8	45.9	0.4	117.9	12.8	4.5	2.7	137.6	8.1	6.6	6.1	11.2	15.2	14.5	1.9	4.5	11.2	189.9	13.5	21.7	43.4
VENTX	"HPX42B, VENTX2"	ENSG00000151650	"VENT homeobox"	O95231	10	133237855-133241928	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Kupffer cells: 6.2;Langerhans cells: 7.9;Macrophages: 7.8;monocytes: 5.0"	"Cancer enriched"	"Detected in some"	15	"testis cancer: 30.4"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	7	"dendritic cells: 1.8;granulocytes: 1.9;monocytes: 3.2"	"Group enriched"	"Detected in some"	10	"NB-4: 18.2;NTERA-2: 10.9"									HPA050955	Uncertain		Uncertain	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoli fibrillar center"	Cytosol	"HPA050955: AB_2681288"	"unprognostic (9.41e-2)"	"unprognostic (8.89e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.26e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.62e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.00e-3)"	"unprognostic (3.70e-4)"	"unprognostic (4.22e-1)"	"unprognostic (2.51e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.48e-1)"	"unprognostic (7.54e-2)"	"unprognostic (3.14e-1)"	4.8	2.3	1.6	3.6	1.1	2.8	1.9	1.6	1.5	1.5	1.9	1.9	0.4	1.6	0.5	0.5	1.8	1.5	1.5	1.5	1.5	1.7	0.5	3.8	0.5	1.9	1.7	1.5	1.2	0.5	1.4	0.5	1.5	1.3	0.4	0.2	1.3	0.8	0.9	1.2	1.0	1.2	0.9	5.7	0.9	1.0	2.5	0.2	0.8	0.1	0.4	1.4	1.0	1.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	18.2	10.9	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	1.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	1.9	2.6	0.3	0.1	3.2	0.0	0.3	0.1	0.0	1.8	0.2	0.1	0.1	0.9	0.3	2.4	0.1	0.0	0.7	1.6	1.1	1.6	1.5	1.5	1.5	1.9	1.7	1.5	0.9	2.5	1.8	0.0	0.0	1.1	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	6.2	7.9	0.2	0.0	7.8	0.0	0.0	5.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0
WDFY4	"C10orf64, Em:AC060234.3, FLJ45748, KIAA1607"	ENSG00000128815	"WDFY family member 4"	Q6ZS81	10	48684876-48982956	"Predicted intracellular proteins, Predicted membrane proteins"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 11.7;lymphoid tissue: 28.5"	"Cell type enhanced"	"Detected in some"		"B-cells: 44.7;dendritic cells: 29.9;Early spermatids: 47.2;Langerhans cells: 30.6;Macrophages: 24.6;Microglial cells: 81.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"memory B-cell: 14.3;myeloid DC: 11.3;naive B-cell: 21.2;neutrophil: 10.2;plasmacytoid DC: 32.5"	"Group enriched"	"Detected in many"	7	"B-cells: 21.2;dendritic cells: 32.5;granulocytes: 10.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 61.0;HDLM-2: 56.3;HL-60: 21.5;THP-1: 18.9;U-698: 25.6;U-937: 25.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA040634	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"HPA040634: AB_10795491"	"unprognostic (6.20e-2)"	"unprognostic (6.60e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.38e-4)"	"unprognostic (9.41e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.15e-2)"	"unprognostic (3.74e-1)"	"unprognostic (3.49e-2)"	"unprognostic (9.64e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.76e-2)"	1.9	0.7	3.2	12.1	3.4	11.7	1.4	4.2	4.8	1.1	3.2	1.9	1.5	0.8	1.9	1.4	0.7	3.2	0.6	3.2	4.2	0.8	1.3	5.2	28.5	6.0	4.9	0.6	1.0	0.4	0.3	1.2	6.2	0.8	1.9	0.1	1.3	0.6	0.7	2.6	7.4	1.7	5.9	17.3	2.3	3.7	6.3	12.3	0.6	0.4	23.9	3.1	0.3	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	56.3	0.0	6.5	0.0	0.0	0.0	21.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	6.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	25.6	0.0	25.0	0.0	0.0	3.0	0.0	0.0	2.8	0.0	14.3	0.0	0.1	11.3	21.2	0.0	0.0	10.2	0.0	1.3	32.5	0.0	1.1	3.2	3.4	4.2	4.8	3.2	4.2	6.0	4.9	6.2	5.9	6.3	9.3	0.2	0.0	1.1	2.0	44.7	0.4	0.1	0.0	0.0	0.0	0.1	0.4	1.3	0.0	0.6	1.8	0.0	0.1	29.9	0.0	1.9	0.0	47.2	0.0	0.1	0.3	0.0	0.4	0.7	0.0	0.2	1.1	0.0	0.0	5.7	0.0	0.0	0.0	13.0	0.0	0.4	0.1	0.0	12.9	30.6	17.7	0.3	24.6	1.8	81.5	16.4	0.0	0.0	1.0	0.5	0.0	0.0	0.4	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.2	2.9	0.5	0.2	0.3	0.3	1.5	0.0	0.3	0.1
ZC3H12D	"C6orf95, dJ281H8.1, MCPIP4"	ENSG00000178199	"Zinc finger CCCH-type containing 12D"	A2A288	6	149446795-149485014	"Disease related genes, Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 3.6;intestine: 4.7;lymphoid tissue: 12.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 14.6;Distal enterocytes: 7.7;Kupffer cells: 12.4;Macrophages: 7.4;Proximal enterocytes: 7.5;T-cells: 17.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"HDLM-2: 34.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA036897	Uncertain		Supported	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytoplasmic bodies"		"HPA036897: AB_10672104"	"unprognostic (2.89e-2)"	"unprognostic (3.91e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.47e-6)"	"unprognostic (2.20e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.30e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.28e-4)"	"unprognostic (1.21e-2)"	"unprognostic (9.24e-3)"	"unprognostic (6.99e-2)"	"unprognostic (5.52e-2)"	0.7	0.4	1.0	7.2	0.5	3.6	0.4	0.4	0.9	0.3	0.3	1.5	2.8	0.2	0.2	0.3	0.3	0.6	0.3	0.8	0.9	0.6	0.3	0.8	9.8	1.0	0.5	0.3	0.1	0.0	0.2	0.3	0.8	0.3	1.4	0.5	0.7	0.3	0.4	1.1	4.7	0.5	0.4	5.8	0.8	0.3	0.9	1.1	0.5	0.0	12.6	1.0	0.2	0.9	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.6	0.1	8.0	0.1	0.0	0.2	0.2	0.0	0.0	0.1	34.3	0.2	0.3	1.2	2.7	0.0	2.8	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.7	0.0	0.1	0.0	2.5	0.0	0.0	0.0	7.1	0.0	0.9	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	4.6	0.0	0.2	0.1	0.1	0.1	0.1	0.2	2.9	0.4	2.5	0.1	0.7	0.8	0.1	0.1	0.5	0.2	1.4	1.5	0.7	0.8	1.3	0.9	0.2	0.5	0.3	1.4	0.4	3.5	0.8	1.0	0.5	0.4	0.9	0.8	0.9	1.0	0.5	0.8	0.4	0.9	0.9	1.0	3.2	3.9	1.3	14.6	0.4	0.5	0.0	0.0	0.7	0.3	0.3	1.4	1.5	0.6	0.0	4.2	0.0	3.7	7.7	1.9	0.0	0.4	0.4	0.4	1.3	0.0	0.4	1.2	0.4	0.0	0.7	0.5	0.6	0.0	0.2	1.4	0.3	3.7	0.0	0.7	1.1	0.0	12.4	4.4	0.5	0.0	7.4	1.8	1.0	1.6	0.8	0.0	0.0	0.7	0.3	0.8	0.0	4.6	0.4	7.5	1.6	0.0	1.1	0.0	0.9	0.4	0.2	0.4	0.1	1.4	0.0	17.4	0.0	2.6	0.4